Submitted URL: http://w1.msonr.net/prod/978a0ddf-7440-4a6d-a57a-da494e808d7d/545a7775-efc3-4481-8f80-a3244d80c497
Effective URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Submission: On July 30 via api from US — Scanned from DE

Summary

This website contacted 69 IPs in 11 countries across 59 domains to perform 319 HTTP transactions. The main IP is 104.18.0.165, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercebiotech.com. The Cisco Umbrella rank of the primary domain is 125272.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on May 9th 2023. Valid for: a year.
This is the only time www.fiercebiotech.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 54.242.108.196 14618 (AMAZON-AES)
1 1 34.199.107.80 14618 (AMAZON-AES)
37 104.18.0.165 13335 (CLOUDFLAR...)
1 35.201.104.135 396982 (GOOGLE-CL...)
17 2a00:1450:400... 15169 (GOOGLE)
3 45.133.44.3 39572 (ADVANCEDH...)
18 2a00:1450:400... 15169 (GOOGLE)
5 104.16.93.165 13335 (CLOUDFLAR...)
4 2a00:1450:400... 15169 (GOOGLE)
9 2a00:1450:400... 15169 (GOOGLE)
11 2a00:1450:400... 15169 (GOOGLE)
1 7 204.180.130.190 53866 (QTS-AS)
1 184.72.142.9 14618 (AMAZON-AES)
8 2a00:1450:400... 15169 (GOOGLE)
1 18.66.100.58 16509 (AMAZON-02)
2 34.111.234.236 396982 (GOOGLE-CL...)
2 45.133.44.4 39572 (ADVANCEDH...)
3 2001:4860:480... 15169 (GOOGLE)
1 52.17.99.225 16509 (AMAZON-02)
1 52.45.228.109 14618 (AMAZON-AES)
1 2a00:1450:400... 15169 (GOOGLE)
3 185.239.173.226 55081 (24SHELLS)
1 2a00:1450:400... 15169 (GOOGLE)
5 2600:9000:21f... 16509 (AMAZON-02)
4 2a00:1450:400... 15169 (GOOGLE)
1 2606:4700:10:... 13335 (CLOUDFLAR...)
3 184.30.21.51 16625 (AKAMAI-AS)
1 2001:4de0:ac1... 20446 (STACKPATH...)
3 2600:9000:20e... 16509 (AMAZON-02)
6 18.206.144.175 14618 (AMAZON-AES)
3 2600:9000:218... 16509 (AMAZON-02)
1 185.170.61.158 27381 (CASALE-MEDIA)
3 33 2a00:1450:400... 15169 (GOOGLE)
7 2a00:1450:400... 15169 (GOOGLE)
9 2a00:1450:400... 15169 (GOOGLE)
3 23.35.233.56 16625 (AKAMAI-AS)
4 2.23.193.36 16625 (AKAMAI-AS)
1 85.91.45.166 27381 (CASALE-MEDIA)
1 85.91.45.114 27381 (CASALE-MEDIA)
4 15 185.80.39.216 27381 (CASALE-MEDIA)
3 2a00:1450:400... 15169 (GOOGLE)
5 27 142.250.186.98 15169 (GOOGLE)
3 6 52.46.155.104 16509 (AMAZON-02)
3 3.33.220.150 16509 (AMAZON-02)
2 2 2620:116:800d... 16509 (AMAZON-02)
1 18.200.152.171 16509 (AMAZON-02)
1 1 2a02:fa8:8806... 41041 (VCLK-EU-SE)
3 2a05:d018:cc3... 16509 (AMAZON-02)
3 104.18.10.47 13335 (CLOUDFLAR...)
13 2a00:1450:400... 15169 (GOOGLE)
7 2a00:1450:400... 15169 (GOOGLE)
2 2 185.29.134.244 30419 (MEDIAMATH...)
1 2 2606:4700::68... 13335 (CLOUDFLAR...)
2 2 35.204.158.49 396982 (GOOGLE-CL...)
1 178.250.1.9 44788 (ASN-CRITE...)
6 6 185.64.190.78 62713 (AS-PUBMATIC)
2 2 52.50.218.26 16509 (AMAZON-02)
6 6 46.228.174.117 56396 (AMOBEE)
2 3 151.101.194.49 54113 (FASTLY)
1 141.226.228.48 200478 (TABOOLA-AS)
1 1 54.161.101.43 14618 (AMAZON-AES)
1 18.193.242.108 16509 (AMAZON-02)
1 34.111.151.213 396982 (GOOGLE-CL...)
1 1 185.183.112.155 60350 (VP)
2 2 37.157.2.234 198622 (ADFORM)
1 35.227.252.103 15169 (GOOGLE)
2 2 216.52.2.6 32475 (SINGLEHOP...)
1 1 51.89.9.254 16276 (OVH)
1 2 2001:678:cb4:... 56396 (AMOBEE)
2 2 3.121.2.145 16509 (AMAZON-02)
1 3.71.149.231 16509 (AMAZON-02)
3 4 185.89.210.82 29990 (ASN-APPNEX)
2 99.86.4.16 16509 (AMAZON-02)
4 204.180.130.159 53866 (QTS-AS)
1 5 2600:9000:225... 16509 (AMAZON-02)
1 13.32.99.85 16509 (AMAZON-02)
2 2a03:2880:f08... 32934 (FACEBOOK)
2 3 3.218.41.11 14618 (AMAZON-AES)
2 204.180.130.165 53866 (QTS-AS)
3 52.71.196.103 14618 (AMAZON-AES)
2 2a03:2880:f17... 32934 (FACEBOOK)
1 35.244.174.68 15169 (GOOGLE)
1 54.231.135.88 16509 (AMAZON-02)
319 69
Apex Domain
Subdomains
Transfer
57 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 204
googleads.g.doubleclick.net — Cisco Umbrella Rank: 55
stats.g.doubleclick.net — Cisco Umbrella Rank: 114
cm.g.doubleclick.net — Cisco Umbrella Rank: 239
390 KB
54 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 130
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
tpc.googlesyndication.com — Cisco Umbrella Rank: 155
677 KB
37 fiercebiotech.com
www.fiercebiotech.com — Cisco Umbrella Rank: 125272
315 KB
33 gstatic.com
fonts.gstatic.com
www.gstatic.com
encrypted-tbn1.gstatic.com
encrypted-tbn0.gstatic.com
encrypted-tbn3.gstatic.com
848 KB
18 casalemedia.com
a3257.casalemedia.com — Cisco Umbrella Rank: 632982
a3352.casalemedia.com — Cisco Umbrella Rank: 675153
a5200.casalemedia.com — Cisco Umbrella Rank: 703663
ssum-sec.casalemedia.com — Cisco Umbrella Rank: 477
dsum-sec.casalemedia.com — Cisco Umbrella Rank: 624
dsum.casalemedia.com — Cisco Umbrella Rank: 1529
16 KB
14 dragonforms.com
sample.dragonforms.com — Cisco Umbrella Rank: 74258
hostedcontent.dragonforms.com — Cisco Umbrella Rank: 59798
static-cdn.dragonforms.com — Cisco Umbrella Rank: 60310
40 KB
10 teads.tv
a.teads.tv — Cisco Umbrella Rank: 1453
sync.teads.tv — Cisco Umbrella Rank: 1361
t.teads.tv — Cisco Umbrella Rank: 2494
cdn2.teads.tv — Cisco Umbrella Rank: 20656
139 KB
10 omeda.com
cdn.omeda.com — Cisco Umbrella Rank: 35177
olytics.omeda.com — Cisco Umbrella Rank: 20400
cdp.omeda.com — Cisco Umbrella Rank: 20457
oqs.omeda.com — Cisco Umbrella Rank: 20904
158 KB
9 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 213
393 KB
8 adroll.com
d.adroll.com — Cisco Umbrella Rank: 1411
s.adroll.com — Cisco Umbrella Rank: 2657
27 KB
8 spotible.com
creative.spotible.com — Cisco Umbrella Rank: 41086
cdn.spotible.com — Cisco Umbrella Rank: 50430
1 MB
7 google.com
www.google.com — Cisco Umbrella Rank: 3
536 B
7 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 58
region1.google-analytics.com — Cisco Umbrella Rank: 1914
42 KB
7 mediafuse.com
player.mediafuse.com — Cisco Umbrella Rank: 60844
player.hbmp.mediafuse.com — Cisco Umbrella Rank: 41228
ghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 55893
183 KB
6 pubmatic.com
image6.pubmatic.com — Cisco Umbrella Rank: 767
3 KB
6 amazon-adsystem.com
s.amazon-adsystem.com — Cisco Umbrella Rank: 319
4 KB
5 qtxasset.com
qtxasset.com — Cisco Umbrella Rank: 58450
58 KB
4 dpmsrv.com
s.dpmsrv.com — Cisco Umbrella Rank: 23469
a.dpmsrv.com — Cisco Umbrella Rank: 19151
16 KB
4 adnxs.com
secure.adnxs.com — Cisco Umbrella Rank: 461
ib.adnxs.com — Cisco Umbrella Rank: 245
3 KB
4 1rx.io
sync.1rx.io — Cisco Umbrella Rank: 590
3 KB
4 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 73
291 KB
4 ml314.com
vi.ml314.com — Cisco Umbrella Rank: 7632
ml314.com — Cisco Umbrella Rank: 1798
in.ml314.com — Cisco Umbrella Rank: 9536
12 KB
3 rdcdn.com
rdcdn.com — Cisco Umbrella Rank: 48355
840 B
3 everesttech.net
sync-tm.everesttech.net — Cisco Umbrella Rank: 746
1 KB
3 indexww.com
js-sec.indexww.com — Cisco Umbrella Rank: 682
557 B
3 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 379
793 B
3 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 79
2 KB
3 parsely.com
api.parsely.com — Cisco Umbrella Rank: 9328
cdn.parsely.com — Cisco Umbrella Rank: 2835
p1.parsely.com — Cisco Umbrella Rank: 2098
20 KB
2 facebook.com
www.facebook.com — Cisco Umbrella Rank: 108
262 B
2 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 170
155 KB
2 w55c.net
pm.w55c.net — Cisco Umbrella Rank: 980
2 KB
2 turn.com
ad.turn.com — Cisco Umbrella Rank: 912
r.turn.com — Cisco Umbrella Rank: 3865
869 B
2 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 725
1 KB
2 adform.net
c1.adform.net — Cisco Umbrella Rank: 607
1 KB
2 unrulymedia.com
sync.targeting.unrulymedia.com — Cisco Umbrella Rank: 1371
1 KB
2 360yield.com
match.360yield.com — Cisco Umbrella Rank: 2279
810 B
2 simpli.fi
um.simpli.fi — Cisco Umbrella Rank: 862
1 KB
2 tribalfusion.com
a.tribalfusion.com — Cisco Umbrella Rank: 801
s.tribalfusion.com — Cisco Umbrella Rank: 2021
1 KB
2 mathtag.com
sync.mathtag.com — Cisco Umbrella Rank: 1028
1 KB
2 quantserve.com
cms.quantserve.com — Cisco Umbrella Rank: 802
1012 B
1 amazonaws.com
s3.amazonaws.com
839 B
1 rlcdn.com
idsync.rlcdn.com — Cisco Umbrella Rank: 410
99 B
1 yahoo.com
ups.analytics.yahoo.com — Cisco Umbrella Rank: 321
125 B
1 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 762
334 B
1 openx.net
rtb.openx.net — Cisco Umbrella Rank: 790
245 B
1 adotmob.com
sync.adotmob.com — Cisco Umbrella Rank: 1672
288 B
1 brand-display.com
dmp.brand-display.com — Cisco Umbrella Rank: 1833
1 bidswitch.net
x.bidswitch.net — Cisco Umbrella Rank: 350
146 B
1 stackadapt.com
sync.srv.stackadapt.com — Cisco Umbrella Rank: 764
1 KB
1 taboola.com
sync.taboola.com — Cisco Umbrella Rank: 1093
99 B
1 criteo.com
dis.criteo.com — Cisco Umbrella Rank: 623
363 B
1 dotomi.com
casale-match.dotomi.com — Cisco Umbrella Rank: 3773
186 B
1 demdex.net
dpm.demdex.net — Cisco Umbrella Rank: 216
1 jquery.com
code.jquery.com — Cisco Umbrella Rank: 743
29 KB
1 ad.gt
a.ad.gt — Cisco Umbrella Rank: 2878
4 KB
1 adtelligent.com
player.adtelligent.com — Cisco Umbrella Rank: 6152
4 KB
1 googleadservices.com
partner.googleadservices.com — Cisco Umbrella Rank: 1196
604 B
1 mailshake.com
integrations.api.mailshake.com
233 B
1 msonr.net
w1.msonr.net
333 B
319 59
Domain Requested by
37 www.fiercebiotech.com www.fiercebiotech.com
33 tpc.googlesyndication.com 3 redirects 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
securepubads.g.doubleclick.net
googleads.g.doubleclick.net
pagead2.googlesyndication.com
tpc.googlesyndication.com
27 cm.g.doubleclick.net 5 redirects ssum-sec.casalemedia.com
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
18 securepubads.g.doubleclick.net www.fiercebiotech.com
securepubads.g.doubleclick.net
www.googletagservices.com
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
17 pagead2.googlesyndication.com www.fiercebiotech.com
pagead2.googlesyndication.com
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
olytics.omeda.com
googleads.g.doubleclick.net
tpc.googlesyndication.com
13 encrypted-tbn1.gstatic.com googleads.g.doubleclick.net
11 googleads.g.doubleclick.net pagead2.googlesyndication.com
www.fiercebiotech.com
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
10 dsum-sec.casalemedia.com 3 redirects ssum-sec.casalemedia.com
9 www.googletagservices.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
securepubads.g.doubleclick.net
googleads.g.doubleclick.net
olytics.omeda.com
7 encrypted-tbn0.gstatic.com googleads.g.doubleclick.net
7 www.google.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
googleads.g.doubleclick.net
tpc.googlesyndication.com
7 sample.dragonforms.com 1 redirects www.fiercebiotech.com
sample.dragonforms.com
code.jquery.com
6 image6.pubmatic.com 6 redirects
6 s.amazon-adsystem.com 3 redirects ssum-sec.casalemedia.com
6 creative.spotible.com securepubads.g.doubleclick.net
creative.spotible.com
6 fonts.gstatic.com www.fiercebiotech.com
fonts.googleapis.com
5 s.adroll.com 1 redirects www.googletagmanager.com
s.adroll.com
5 qtxasset.com www.fiercebiotech.com
4 cdp.omeda.com olytics.omeda.com
4 sync.1rx.io 4 redirects
4 encrypted-tbn3.gstatic.com googleads.g.doubleclick.net
4 ssum-sec.casalemedia.com 1 redirects 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
4 t.teads.tv www.fiercebiotech.com
4 hostedcontent.dragonforms.com sample.dragonforms.com
hostedcontent.dragonforms.com
4 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com securepubads.g.doubleclick.net
4 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.fiercebiotech.com
4 www.googletagmanager.com www.fiercebiotech.com
www.googletagmanager.com
www.google-analytics.com
sample.dragonforms.com
3 a.dpmsrv.com s.dpmsrv.com
3 rdcdn.com 2 redirects
3 sync-tm.everesttech.net 2 redirects ssum-sec.casalemedia.com
3 js-sec.indexww.com ssum-sec.casalemedia.com
3 d.adroll.com ssum-sec.casalemedia.com
s.adroll.com
3 match.adsrvr.org ssum-sec.casalemedia.com
3 www.gstatic.com googleads.g.doubleclick.net
3 fonts.googleapis.com googleads.g.doubleclick.net
3 olytics.omeda.com sample.dragonforms.com
www.fiercebiotech.com
www.googletagmanager.com
3 static-cdn.dragonforms.com sample.dragonforms.com
3 a.teads.tv www.fiercebiotech.com
a.teads.tv
3 ghb.hbmp.mediafuse.com player.hbmp.mediafuse.com
3 region1.google-analytics.com www.googletagmanager.com
2 www.facebook.com
2 ib.adnxs.com 1 redirects
2 oqs.omeda.com olytics.omeda.com
2 connect.facebook.net www.fiercebiotech.com
connect.facebook.net
2 cdn.spotible.com www.fiercebiotech.com
2 secure.adnxs.com 2 redirects
2 pm.w55c.net 2 redirects
2 ap.lijit.com 2 redirects
2 c1.adform.net 2 redirects
2 sync.targeting.unrulymedia.com 2 redirects
2 match.360yield.com 2 redirects
2 um.simpli.fi 2 redirects
2 sync.mathtag.com 2 redirects
2 cms.quantserve.com 2 redirects
2 sync.teads.tv a.teads.tv
2 player.hbmp.mediafuse.com player.mediafuse.com
2 ml314.com www.fiercebiotech.com
ml314.com
2 player.mediafuse.com www.fiercebiotech.com
1 s3.amazonaws.com
1 idsync.rlcdn.com
1 s.dpmsrv.com www.fiercebiotech.com
1 ups.analytics.yahoo.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 r.turn.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 ad.turn.com 1 redirects
1 onetag-sys.com 1 redirects
1 rtb.openx.net 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 sync.adotmob.com 1 redirects
1 dmp.brand-display.com ssum-sec.casalemedia.com
1 x.bidswitch.net ssum-sec.casalemedia.com
1 sync.srv.stackadapt.com 1 redirects
1 sync.taboola.com ssum-sec.casalemedia.com
1 dis.criteo.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 s.tribalfusion.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 a.tribalfusion.com 1 redirects
1 cdn2.teads.tv www.fiercebiotech.com
1 dsum.casalemedia.com ssum-sec.casalemedia.com
1 casale-match.dotomi.com 1 redirects
1 dpm.demdex.net ssum-sec.casalemedia.com
1 a5200.casalemedia.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 a3352.casalemedia.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 a3257.casalemedia.com 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
1 code.jquery.com sample.dragonforms.com
1 a.ad.gt player.hbmp.mediafuse.com
1 cdn.omeda.com sample.dragonforms.com
1 player.adtelligent.com player.hbmp.mediafuse.com
1 stats.g.doubleclick.net www.google-analytics.com
1 partner.googleadservices.com pagead2.googlesyndication.com
1 in.ml314.com ml314.com
1 p1.parsely.com www.fiercebiotech.com
1 cdn.parsely.com www.googletagmanager.com
1 api.parsely.com www.fiercebiotech.com
1 vi.ml314.com www.fiercebiotech.com
1 integrations.api.mailshake.com 1 redirects
1 w1.msonr.net 1 redirects
319 94
Subject Issuer Validity Valid
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2023-05-09 -
2024-05-08
a year crt.sh
vi.ml314.com
GTS CA 1D4
2023-06-13 -
2023-09-11
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
player.mediafuse.com
R3
2023-07-14 -
2023-10-12
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2023-06-18 -
2024-06-23
a year crt.sh
*.parsely.com
Amazon RSA 2048 M02
2023-05-06 -
2024-06-03
a year crt.sh
ml314.com
GTS CA 1D4
2023-06-07 -
2023-09-05
3 months crt.sh
player.hbmp.mediafuse.com
R3
2023-06-06 -
2023-09-04
3 months crt.sh
*.ml314.com
Amazon RSA 2048 M02
2023-02-27 -
2023-12-14
10 months crt.sh
*.googleadservices.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
ghb.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2023-06-01 -
2023-08-30
3 months crt.sh
player.adtelligent.com
R3
2023-07-19 -
2023-10-17
3 months crt.sh
teads.tv
R3
2023-06-26 -
2023-09-24
3 months crt.sh
*.jquery.com
Sectigo RSA Domain Validation Secure Server CA
2023-07-11 -
2024-07-14
a year crt.sh
*.spotible.com
Sectigo RSA Domain Validation Secure Server CA
2022-11-14 -
2023-12-15
a year crt.sh
casalemedia.com
Go Daddy Secure Certificate Authority - G2
2022-12-13 -
2024-01-13
a year crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
www.google.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
upload.video.google.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
*.google.com
GTS CA 1C3
2023-07-10 -
2023-10-02
3 months crt.sh
*.adsrvr.org
GlobalSign GCC R3 DV TLS CA 2020
2023-04-12 -
2024-05-13
a year crt.sh
*.demdex.com
DigiCert TLS RSA SHA256 2020 CA1
2022-09-26 -
2023-10-27
a year crt.sh
d.adroll.com
Amazon RSA 2048 M01
2022-11-08 -
2023-12-07
a year crt.sh
*.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-19 -
2023-10-18
3 months crt.sh
*.taboola.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-12-08 -
2023-12-31
a year crt.sh
*.bidswitch.net
Sectigo RSA Domain Validation Secure Server CA
2023-03-23 -
2024-03-23
a year crt.sh
*.brand-display.com
GeoTrust TLS RSA CA G1
2023-05-30 -
2024-06-24
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2022-07-21 -
2023-08-21
a year crt.sh
ups.analytics.yahoo.com
DigiCert SHA2 High Assurance Server CA
2023-07-18 -
2024-01-10
6 months crt.sh
s.adroll.com
Amazon RSA 2048 M01
2023-06-03 -
2024-07-01
a year crt.sh
*.dpmsrv.com
Amazon RSA 2048 M01
2023-03-18 -
2024-04-15
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2023-05-08 -
2023-08-06
3 months crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2023-02-02 -
2024-03-03
a year crt.sh
s3.amazonaws.com
Amazon RSA 2048 M01
2023-07-10 -
2024-06-21
a year crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2023-02-13 -
2024-03-15
a year crt.sh

This page contains 31 frames:

Primary Page: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Frame ID: 90167CF1552632C08C6236BFB6841238
Requests: 125 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20230726/r20190131/zrt_lookup.html
Frame ID: 8467FD154E8BAAF77DF6CB7AE216900A
Requests: 1 HTTP requests in this frame

Frame: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Frame ID: 394F63C6A2D5CBF505854D0CB3F9A771
Requests: 21 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-1234567890123456&output=html&adk=1812271804&adf=3025194257&lmt=1690576062&plat=9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C41%3A32%2C42%3A32&plas=140x675_l%7C140x675_r&format=0x0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&ea=0&pra=5&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&dt=1690724298374&bpp=8&bdt=533&idt=496&shv=r20230726&mjsv=m202307260101&ptt=9&saldr=aa&abxe=1&nras=1&correlator=7712246462879&frm=20&pv=2&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=1&u_tz=0&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759926%2C44759837%2C44759875%2C31076342%2C31076444%2C31076484%2C31076543%2C44788442&oid=2&pvsid=2093194126477304&tmod=1059681379&uas=0&nvt=1&fsapi=1&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&ifi=1&uci=a!1&fsb=1&dtd=560
Frame ID: 35D9222F6D452991B1D3802F05705DBE
Requests: 1 HTTP requests in this frame

Frame: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 913F85E67B3B1BFD9F9D457364063541
Requests: 1 HTTP requests in this frame

Frame: https://a.teads.tv/page/103428/tag
Frame ID: AD55B13F8D86D19ADB79A8BBF39ACC12
Requests: 2 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/allstream.js
Frame ID: EB674DAB2526FD66074553BF2074B9A2
Requests: 2 HTTP requests in this frame

Frame: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 34E2DE779078DF1460E710F9379BF593
Requests: 11 HTTP requests in this frame

Frame: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 5F8CF4F46953851A2BBC79C47483AD06
Requests: 11 HTTP requests in this frame

Frame: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 59E0AC3252C7616F6A846BC30CF76173
Requests: 11 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Frame ID: C574BC07CBD986774F8685DD6CECBEBC
Requests: 21 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss01EOA327HGcLK0yB-2JqtAd2mcyWH4w1opSxuoxaA3O0rLqbD5UioxJWo3JPqQ0AADriFHtAQVR3GXD-NIKWirzD-0qucb_E36HhvqTCKDrzOZlwrROyNc9kFDxFzBjFq08r9nmckhEi8R80fB5lDMi-5YehizQivOWSHgIaVK-Subk5oauZoGySGLKevHopGF7yOhmFQK6OYv2wvw-1Oj_TyBU9gGeq2KpyNnA3M-686jWb4Kk2T6uECMGUhhE_5Wvh8Xg3cCXq31DK-JMTXxV5yLxKAWOlNb_ruYHdppTgJtPYAsg_HCZhxWq-mgku8Y3eyc9CoEtf4pV1xESG5GW4Q1DbDnnF7qeNrzFiiCTKJzqgHzdg&sai=AMfl-YSeCBU_F_3WtEfTh5c3XzDTQhFOxch1vRZ1RnsZ-cg3IbyrcUlF-M8NYNar0JmWSdjUMoVvAu9N2RTdkNPRpouO1mLjWmHoyGTFQg&sig=Cg0ArKJSzKuJDYzit3jOEAE&uach_m=[UACH]&adurl=
Frame ID: 4F88F4D96565A9CA8686FB35C1C147AF
Requests: 7 HTTP requests in this frame

Frame: https://sync.teads.tv/wigo-no-slot
Frame ID: 197BDF7E69B2FBBC60EFF4BF784E8B5C
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Frame ID: FD9FF666440BD86163534A1B74152B37
Requests: 21 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Frame ID: 81D0974A4CC6A69FD2079CD21361862A
Requests: 21 HTTP requests in this frame

Frame: https://sync.teads.tv/iframe?pid=111933&gdprIab={%22reason%22:220,%22status%22:22,%22consent%22:%22%22,%22apiVersion%22:null,%22cmpId%22:null}&fromFormat=true&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&1690724300740
Frame ID: FD8CB5F6C4FB550A76FDF1688E03235F
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Frame ID: 13E03B48B8227F19E68BB4B68B4C772C
Requests: 10 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: 0258F1F4C7BBBE430B1CDFBEBF22CCF7
Requests: 9 HTTP requests in this frame

Frame: data://truncated
Frame ID: 60AF0D2E30E9F1907FB8C89ED9A41B75
Requests: 1 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/storage-delegate.html
Frame ID: B071B2C41BFDC95BF08FDD36E510130E
Requests: 1 HTTP requests in this frame

Frame: https://cdn2.teads.tv/scala/1083571/17e695875816c05e21a1179679e301de/540_940.mp4
Frame ID: 1B098CA709B5575CFFF25A01E017F347
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Frame ID: 55B98706F1D5825CD1C2B965596F7677
Requests: 10 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: DB8303C3DE8868DE26643D7F7AD9FC35
Requests: 9 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Frame ID: 61DAB988DD35984B849252723A4B3863
Requests: 10 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Frame ID: 1D560A813C3193EB19EE15263548C182
Requests: 9 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Frame ID: 664D21F15FCBF97B3AD3E1EA6101ED0B
Requests: 1 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Frame ID: F445F6EE5B3F986C2BBA87CBAEA707B1
Requests: 1 HTTP requests in this frame

Frame: https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Frame ID: AE5860FCAAB0F795F9C30FD6824A6513
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Frame ID: 9D46CD9368CEE7107C048DA919C72788
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: EA9172EA505506033FC7AC3385DB464D
Requests: 2 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: FB5A06D6492D12EFA2906D51F00418A0
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

Power debuts with $7M seed funding, focus on clinical trials

Page URL History Show full URLs

  1. http://w1.msonr.net/prod/978a0ddf-7440-4a6d-a57a-da494e808d7d/545a7775-efc3-4481-8f80-a3244d80c497 HTTP 302
    https://integrations.api.mailshake.com/beacon/click?emailID=978a0ddf-7440-4a6d-a57a-da494e808d7d&linkID=545a7775-ef... HTTP 302
    https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-44... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • (?:a|s)\.adroll\.com

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • tpc\.googlesyndication\.com/safeframe

Overall confidence: 100%
Detected patterns
  • googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

319
Requests

88 %
HTTPS

35 %
IPv6

59
Domains

94
Subdomains

69
IPs

11
Countries

5094 kB
Transfer

11134 kB
Size

57
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://w1.msonr.net/prod/978a0ddf-7440-4a6d-a57a-da494e808d7d/545a7775-efc3-4481-8f80-a3244d80c497 HTTP 302
    https://integrations.api.mailshake.com/beacon/click?emailID=978a0ddf-7440-4a6d-a57a-da494e808d7d&linkID=545a7775-efc3-4481-8f80-a3244d80c497 HTTP 302
    https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 53
  • https://sample.dragonforms.com/LS_short HTTP 302
  • https://sample.dragonforms.com/init.do?omedasite=LS_short
Request Chain 150
  • https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid= HTTP 302
  • https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Request Chain 187
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Request Chain 188
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid= HTTP 302
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Request Chain 190
  • https://cms.quantserve.com/pixel/p-Z8PuJEk6U7Hyq.gif?idmatch=0&gdpr=1 HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=Xd8YaV3cGDtG0k5vCttWOVuOHj5G0x45WI1Mc_7f
Request Chain 192
  • https://casale-match.dotomi.com/match/bounce/current?networkId=19998&version=1&gdpr=1 HTTP 302
  • https://dsum.casalemedia.com/rum?cm_dsp_id=65&external_user_id=&expiration=1690810701&gdpr=1
Request Chain 204
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc HTTP 301
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
Request Chain 211
  • https://sync.mathtag.com/sync/img?mt_exid=4&google_gid=CAESEBlBLWQW1-tdpshy0P-AMJE&google_cver=1&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOxrsoQ4amlygil HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOxrsoQ4amlygil
Request Chain 212
  • https://a.tribalfusion.com/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z&redirect=https%3A//cm.g.doubleclick.net/pixel%3Fgoogle_nid%3Dexp%26google_push%3DAaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z%26google_ula%3D2786954%26google_hm%3D%24TF_USER_ID_ENC%24 HTTP 302
  • https://s.tribalfusion.com/z/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z&redirect=https%3A//cm.g.doubleclick.net/pixel%3Fgoogle_nid%3Dexp%26google_push%3DAaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z%26google_ula%3D2786954%26google_hm%3D%24TF_USER_ID_ENC%24
Request Chain 213
  • https://um.simpli.fi/gp_match?google_gid=CAESEAeyuywbpuMAyugtYz8iylM&google_cver=1&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4KG8HuZME2A54D HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=410A3CBD210E4ECBBFCB28FB6E2B2B6B&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4KG8HuZME2A54D
Request Chain 215
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESEOqLAb46rkvBfoqfMe1N-io&google_cver=1&google_push=AaAOQGGukPmGMD5BZjaZWn7v1yieDqzoM-IOuMF2QgPgHYomvIFjtUIob6YP5swvC6I97KE47NwI6FXdZLIvRCFf3HzMSEzw0Dg2 HTTP 302
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESEOqLAb46rkvBfoqfMe1N-io&google_cver=1&google_push=AaAOQGGukPmGMD5BZjaZWn7v1yieDqzoM-IOuMF2QgPgHYomvIFjtUIob6YP5swvC6I97KE47NwI6FXdZLIvRCFf3HzMSEzw0Dg2&rdf=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGGukPmGMD5BZjaZWn7v1yieDqzoM-IOuMF2QgPgHYomvIFjtUIob6YP5swvC6I97KE47NwI6FXdZLIvRCFf3HzMSEzw0Dg2
Request Chain 216
  • https://match.360yield.com/match/ebda?google_gid=CAESELa9wR9sLoOkC9yBg-E0TdM&google_cver=1&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532PuRAG0r HTTP 302
  • https://match.360yield.com/ul_cb/match/ebda?google_gid=CAESELa9wR9sLoOkC9yBg-E0TdM&google_cver=1&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532PuRAG0r HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=improve_digital_eb&google_hm=YsyrKksXT_OeeUJc5KUDHQ&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532PuRAG0r
Request Chain 217
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&google_gid=CAESEJ--2teFPuPRiqyHUY6wIoY&google_cver=1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4 HTTP 302
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&zcc=1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&cb=1690724301646 HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-1d7b6303-569c-4993-ae31-08396ea207ef-003?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3DAaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4%26google_hm%3DAx17YwNWnEmTrjEIOW6iB-8 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&google_hm=Ax17YwNWnEmTrjEIOW6iB-8
Request Chain 227
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc HTTP 301
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
Request Chain 236
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc HTTP 301
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
Request Chain 237
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid= HTTP 302
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Request Chain 239
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Request Chain 241
  • https://sync-tm.everesttech.net/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1 HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1&_test=ZMZnzQAExL_5hQAb
Request Chain 243
  • https://sync.srv.stackadapt.com/sync?nid=68&gdpr=1 HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=123&external_user_id=E7_xoKAeWlp-KcPAGLya59ly14M
Request Chain 248
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid= HTTP 302
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Request Chain 249
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Request Chain 253
  • https://cms.quantserve.com/pixel/p-Z8PuJEk6U7Hyq.gif?idmatch=0&gdpr=1 HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=rvKYkK7xmMK1pMjC_qDWka_-npC1oJnD-vKS4Km5
Request Chain 254
  • https://sync.adotmob.com/cookie/indexexchange?gdpr=1&gdpr_consent=&r=https%3A%2F%2Fdsum-sec.casalemedia.com%2Fcrum%3Fcm_dsp_id%3D13%26external_user_id%3D%7Bamob_user_id%7D%26expiration%3D%5BEXPIRATION%5D&gpp=&gpp_sid= HTTP 302
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=13&expiration=%5BEXPIRATION%5D&gdpr=1&gdprConsent=
Request Chain 256
  • https://sync.mathtag.com/sync/img?mt_exid=4&google_gid=CAESECQ1S2Rw5prJOCpNoyzb3hc&google_cver=1&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6-vtUOh1H0A HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6-vtUOh1H0A
Request Chain 257
  • https://c1.adform.net/serving/cookie/match/?party=1&google_gid=CAESEEOnn4vsh7-u9gEtVOO05s8&google_cver=1&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8JjFhUoBWRf768K5TL0oQ HTTP 302
  • https://c1.adform.net/serving/cookie/match/?CC=1&party=1&google_gid=CAESEEOnn4vsh7-u9gEtVOO05s8&google_cver=1&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8JjFhUoBWRf768K5TL0oQ HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=1024&google_ula=1641347&google_hm=MTA5NzI5NjY5OTMwODc1NTI2MA&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8JjFhUoBWRf768K5TL0oQ
Request Chain 259
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESEBDyF0YDgONxF4fwVODRWIw&google_cver=1&google_push=AaAOQGEqypDlMxpRRied2QQki6DvSVK-fvwlFlXb6DEcHv40A_n0Sl-O3azCkIJ8rp3is11ayJb1r44BWnYYYiaH2o8UmulBE3o HTTP 302
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESEBDyF0YDgONxF4fwVODRWIw&google_cver=1&google_push=AaAOQGEqypDlMxpRRied2QQki6DvSVK-fvwlFlXb6DEcHv40A_n0Sl-O3azCkIJ8rp3is11ayJb1r44BWnYYYiaH2o8UmulBE3o&rdf=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEqypDlMxpRRied2QQki6DvSVK-fvwlFlXb6DEcHv40A_n0Sl-O3azCkIJ8rp3is11ayJb1r44BWnYYYiaH2o8UmulBE3o
Request Chain 260
  • https://ap.lijit.com/dsp/google/pixelmatch?google_gid=CAESEP36gFtPKCF1zSUpUi9o2t8&google_cver=1&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ HTTP 307
  • https://ap.lijit.com/dsp/google/pixelmatch?google_gid=CAESEP36gFtPKCF1zSUpUi9o2t8&google_cver=1&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ&sovrn_retry=true HTTP 307
  • https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ&google_hm=HETyqGZHt8EOulvRQhmP-hJI
Request Chain 261
  • https://onetag-sys.com/match/?int_id=19&redir=1&google_gid=CAESEOeYDhnlMfypVfQ-dMK6zrY&google_cver=1&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP3YJ1RDF6wAdOdg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=one_tag&google_hm=&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP3YJ1RDF6wAdOdg
Request Chain 262
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&google_gid=CAESELUSW3Zo2U5g7nVDNxlL3TQ&google_cver=1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U HTTP 302
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&zcc=1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&cb=1690724301737 HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-a410a985-63d4-4955-a370-9019dea5ce48-003?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3DAaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U%26google_hm%3DA6QQqYVj1ElVo3CQGd6lzkg HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&google_hm=A6QQqYVj1ElVo3CQGd6lzkg
Request Chain 264
  • https://ad.turn.com/r/cs?pid=3&google_gid=CAESEMNC6f5jQUHAYAYbT6xsrhs&google_cver=1&google_push=AaAOQGH1vq82EffNDAJIGEP6oz5UbeRV29q6R3A2quDfjDjmbVCLqjhFSchh-SAryI0TGkYWrt-affxcZ61FJTcJN1zjqAb222FqSQ HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=turn1&google_cm&google_sc&google_hm=NDQ4ODg0MjU1NjQ3MjIyMjY3Nw==&gdpr=&gdpr_consent= HTTP 302
  • https://r.turn.com/r/cms/id/0/ddc/1/pid/18/uid/?gdpr=&gdpr_consent=&google_gid=CAESEAi_7HL471zEDC-skpttqSc&google_cver=1
Request Chain 265
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fSr3JNATKDhzNIJbFgnSmykawn-RRizG8RpQarNbP1DN9bOKJ5iVdTa6w HTTP 302
  • https://pm.w55c.net/ping_match.gif?scc=1&ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fSr3JNATKDhzNIJbFgnSmykawn-RRizG8RpQarNbP1DN9bOKJ5iVdTa6w HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=UnZJQm9NOXUxUXE2Q041&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fSr3JNATKDhzNIJbFgnSmykawn-RRizG8RpQarNbP1DN9bOKJ5iVdTa6w
Request Chain 266
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESEFxJ_M-Nq3d6JbA2Hr5Xi5s&google_cver=1&google_push=AaAOQGGPF9bsI0EHP5F3CcyIHxur8YPZ74uPrtnrfrLUyS5uMVfFjrO-wU2PP4ZLO6EX6qwBschQuAU5j8FykN0zMpPkz3ShXhPM HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=&google_cver=1&google_gid=CAESEFxJ_M-Nq3d6JbA2Hr5Xi5s&google_push=AaAOQGGPF9bsI0EHP5F3CcyIHxur8YPZ74uPrtnrfrLUyS5uMVfFjrO-wU2PP4ZLO6EX6qwBschQuAU5j8FykN0zMpPkz3ShXhPM
Request Chain 267
  • https://um.simpli.fi/gp_match?google_gid=CAESEJseoBYgXoHAgD39JcjMtSQ&google_cver=1&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQbQ6wFQm1ysEFTPNQ HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=D6E86F92BADF4A1FBF50EFFE981BC6CA&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQbQ6wFQm1ysEFTPNQ
Request Chain 268
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESENJ6Ym4xr3vrYb1zu7cVKvE&google_cver=1&google_push=AaAOQGEmV3Ok1ttGUEAYc3NFfEJVI6M-u_sHevu7ELawIk2TEw9RXlW_QgmH6xJTcE5xH-_qllU1EdGOvXPQijqCLPdvytTvz-FFVw HTTP 302
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%25253A%25252F%25252Fimage8.pubmatic.com%25252FAdServer%25252FImgSync%25253Fsec%25253D1%252526p%25253D156578%252526mpc%25253D4%252526fp%25253D1%252526pu%25253Dhttps%2525253A%2525252F%2525252Fimage4.pubmatic.com%2525252FAdServer%2525252FSPug%2525253Fp%2525253D156578%25252526sc%2525253D1&google_gid=CAESENJ6Ym4xr3vrYb1zu7cVKvE&google_cver=1&google_push=AaAOQGEmV3Ok1ttGUEAYc3NFfEJVI6M-u_sHevu7ELawIk2TEw9RXlW_QgmH6xJTcE5xH-_qllU1EdGOvXPQijqCLPdvytTvz-FFVw&rdf=1 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEmV3Ok1ttGUEAYc3NFfEJVI6M-u_sHevu7ELawIk2TEw9RXlW_QgmH6xJTcE5xH-_qllU1EdGOvXPQijqCLPdvytTvz-FFVw
Request Chain 270
  • https://secure.adnxs.com/getuid?https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=${BASE64_UID_ENC}&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiqogmmruvKLgXSvVkyofrwVvxggGfwSX_pmBhG-fwZ7S2JpRjj4rgNVvmCKXqmhqZ-ntAIbGzqIWjxNs2-4D8ow HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dxandr_eb%26google_hm%3D%24%7BBASE64_UID_ENC%7D%26google_gid%3DCAESEIUMgkRefzh4eR8sYpnbXo4%26google_cver%3D1%26google_push%3DAaAOQGFYOS4a93aiqogmmruvKLgXSvVkyofrwVvxggGfwSX_pmBhG-fwZ7S2JpRjj4rgNVvmCKXqmhqZ-ntAIbGzqIWjxNs2-4D8ow HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=OTE4MDU3NDQ4OTI4NTY1Njc4Mw%3D%3D&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiqogmmruvKLgXSvVkyofrwVvxggGfwSX_pmBhG-fwZ7S2JpRjj4rgNVvmCKXqmhqZ-ntAIbGzqIWjxNs2-4D8ow
Request Chain 296
  • https://rdcdn.com/rt?aid=19932&e=1&img=1 HTTP 302
  • https://rdcdn.com/eow HTTP 302
  • https://rdcdn.com/images/blank.gif
Request Chain 302
  • https://s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/fpconsent.js HTTP 302
  • https://s.adroll.com/j/pre/index.js
Request Chain 304
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&zn%3D%26sn%3D%26q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D851416%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercebiotech.com%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%253FmsID%253D545a7775-efc3-4481-8f80-a3244d80c497 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=9180574489285656783&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=851416&tzOffset=0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Request Chain 316
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=9180574489285656783&pixelIndex=0 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=9180574489285656783&pixelIndex=0&google_gid=CAESEKJM-nkwDi7yNK8TtOyA1vQ&google_cver=1

319 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request power-debuts-7m-seed-funding-focus-clinical-trials
www.fiercebiotech.com/cro/
Redirect Chain
  • http://w1.msonr.net/prod/978a0ddf-7440-4a6d-a57a-da494e808d7d/545a7775-efc3-4481-8f80-a3244d80c497
  • https://integrations.api.mailshake.com/beacon/click?emailID=978a0ddf-7440-4a6d-a57a-da494e808d7d&linkID=545a7775-efc3-4481-8f80-a3244d80c497
  • https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
338 KB
54 KB
Document
General
Full URL
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e414ef5501ce6098b8d10ee8c0d7d9a2c763c6489096afefdf3334c7bf3203e2
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
max-age=31536000, public
cf-cache-status
MISS
cf-ray
7eee004c5c852c77-FRA
content-encoding
br
content-language
en
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
content-type
text/html; charset=UTF-8
date
Sun, 30 Jul 2023 13:38:17 GMT
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Fri, 28 Jul 2023 20:27:42 GMT
link
<https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials>; rel="canonical"
referrer-policy
no-referrer-when-downgrade
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Cookie, Accept-Encoding
x-content-type-options
nosniff
x-drupal-cache
HIT
x-drupal-dynamic-cache
UNCACHEABLE
x-generator
Drupal 9 (https://www.drupal.org)
x-ua-compatible
IE=edge

Redirect headers

access-control-allow-credentials
true
content-length
296
content-type
text/html; charset=utf-8
date
Sun, 30 Jul 2023 13:38:17 GMT
location
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
vary
Origin, Accept, Accept-Encoding
x-powered-by
Express
get
vi.ml314.com/
264 B
389 B
Script
General
Full URL
https://vi.ml314.com/get?eid=66459&tk=NlORAP1pyT9TolCqYpofYXOR4do2bEnp0CI3bC62f2fFHw3d
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.104.135 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
135.104.201.35.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
9dffbd45ce48bf5e8eeb90b3d8567f8270f217c174de81fe3693d6dcdbaa1588
Security Headers
Name Value
Strict-Transport-Security max-age=2592000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=2592000
content-encoding
br
via
1.1 google
date
Sun, 30 Jul 2023 13:38:17 GMT
server
Google Frontend
vary
Accept-Encoding
content-type
application/javascript
cache-control
private,max-age=86400
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
145 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
d9354329b02c3cbae54eb3ffbbf38e80e3578d0417f047375d2f0b8b03c5439d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Origin
https://www.fiercebiotech.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50665
x-xss-protection
0
server
cafe
etag
17464668976227178382
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:17 GMT
hb_748754_18090.js
player.mediafuse.com/prebidlink/383914764235/
923 B
781 B
Script
General
Full URL
https://player.mediafuse.com/prebidlink/383914764235/hb_748754_18090.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
7665f2a504287bfd2eb09327c773e3f1070e5bd3e74e11f182ef47e738a2d686

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
gzip
last-modified
Sun, 30 Jul 2023 04:08:46 GMT
server
nginx
etag
W/"64c5e24e-39b"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Tue, 01 Aug 2023 13:38:18 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
80 KB
28 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
948a4f113aad42e705767c8ff100658f8a9482f8f22fa11c13e9576ff69a13f8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
27721
x-xss-protection
0
server
cafe
etag
116 / 19568 / m202307250102 / config-hash: 5693953215715342715
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:17 GMT
wrapper_hb_748754_18090.js
player.mediafuse.com/prebidlink/383914764235/
2 KB
1 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/383914764235/wrapper_hb_748754_18090.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
0c3dcfcc937a70bbad86dd39d6f3d40c13ea8a3475e0b68603b4fee9bca75891

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
gzip
last-modified
Sun, 30 Jul 2023 04:08:46 GMT
server
nginx
etag
W/"64c5e24e-945"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Tue, 01 Aug 2023 13:38:18 GMT
runtime.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
0
1 KB
Other
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/runtime.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Wed, 12 Apr 2023 14:56:44 GMT
server
cloudflare
age
763776
etag
W/"6436c6ac-69b"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dee8a2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-runtime-core.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
0
25 KB
Other
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-runtime-core.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
cf-polished
origSize=67790
etag
W/"64a73b66-108ce"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dee8c2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-compiler-core.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
0
20 KB
Other
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-compiler-core.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
cf-polished
origSize=54464
etag
W/"64a73b66-d4c0"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dee8d2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-runtime-dom.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
0
10 KB
Other
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-runtime-dom.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
etag
W/"64a73b66-749c"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dee902c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
GettyImages-887410960%20%282%29.jpg
qtxasset.com/cdn-cgi/image/w=705,h=398,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/
0
25 KB
Other
General
Full URL
https://qtxasset.com/cdn-cgi/image/w=705,h=398,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-887410960%20%282%29.jpg?VersionId=IMKy1mCn4Gqkz8PeZyIV5B3Y.eqe1THL
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'
x-content-type-options
nosniff
cf-cache-status
HIT
alt-svc
h3=":443"; ma=86400
content-length
24726
cf-resized
internal=ok/h q=0 n=22+221 c=0+0 v=2023.7.3 l=24726
last-modified
Wed, 18 May 2022 14:11:29 GMT
cf-bgj
imgq:85,h2pri
server
cloudflare
etag
"cfRNglOCP73-UObx_hmE4pAc1MS-FpjRKbcQmmSuhtDQ:b75ed6ce05d7ef1bb1189bf2ece7a965"
vary
Accept, Accept-Encoding
content-type
image/avif
cache-control
public, max-age=31556952
accept-ranges
bytes
cf-ray
7eee004e7cd23730-FRA
gtm.js
www.googletagmanager.com/
213 KB
75 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
a15bcf9de1b6526c514d0ca464febaff9c812af74ed54f47073335de9d71da03
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
76287
x-xss-protection
0
last-modified
Sun, 30 Jul 2023 12:00:00 GMT
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Sun, 30 Jul 2023 13:38:17 GMT
Fierce-23-Brand-Element.svg
qtxasset.com/quartz/qcloud5/
0
741 B
Other
General
Full URL
https://qtxasset.com/quartz/qcloud5/Fierce-23-Brand-Element.svg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
x-amz-version-id
bmuL8lQrt0nnsOMk1Jm4_VUq4.oCq3NS
content-encoding
br
cf-cache-status
HIT
x-amz-request-id
KS4FMF39EWSXFBG6
age
5671780
x-amz-server-side-encryption
AES256
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
x-amz-id-2
NEK+vRLETWvgIZ37wY0e1pwUl2vj1yZEmClWC/1PKZSwBrpF+DEgCx7LpBEtPJjBxaLZWShQnQk=
last-modified
Wed, 22 Feb 2023 14:52:08 GMT
server
cloudflare
etag
W/"70f8c7045215bb1368720bf699506d5f"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=31536000
cf-ray
7eee004e7cd33730-FRA
expires
Mon, 29 Jul 2024 13:38:18 GMT
Fierce%20Biotech%20Mix%20Logo.svg
qtxasset.com/quartz/qcloud5/logos/
3 KB
2 KB
Image
General
Full URL
https://qtxasset.com/quartz/qcloud5/logos/Fierce%20Biotech%20Mix%20Logo.svg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
518f889d84d6e986d0a32e570bd2f9e4be4125ab5c2402fc6a977781f0ddfb6d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
x-amz-version-id
kjNocVjc_k493gwTXe0W9mc5ZLI7M1_6
content-encoding
br
cf-cache-status
HIT
x-amz-request-id
H5AZDTX2RP5R7M25
age
15493574
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
x-amz-id-2
HHoNIA6h8DNcJKhVb2eWi/rmVh1fPRR5BTj9NqZu9jvn1h5/ih5JvHURUEL4QpqzDrDdqRihxjw=
last-modified
Mon, 26 Sep 2022 17:30:15 GMT
server
cloudflare
etag
W/"7713d00f707c45da57c154d0ec758437"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=31536000
cf-ray
7eee004e7cd13730-FRA
expires
Mon, 29 Jul 2024 13:38:18 GMT
bars-regular.svg
www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/
617 B
424 B
Image
General
Full URL
https://www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/bars-regular.svg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
852b3532441a29f2ba7e869ecfbc38eb772c2a3051d4783e49f4dc68c185191e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
761493
etag
W/"646fdb4f-269"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
7eee004dfe962c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
xmark-solid.svg
www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/
633 B
489 B
Image
General
Full URL
https://www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/xmark-solid.svg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cae2660518f22b45acda581d90ed118a6727785eb1e99075a5f5e09a2f918dc1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
761493
etag
W/"646fdb4f-279"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
7eee004dfe982c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
omedaseg.js
www.fiercebiotech.com/modules/custom/quartz_ads/js/
951 B
548 B
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_ads/js/omedaseg.js?v=1
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
db27b46a4a62774e7a25ba94e38849128d93e9d1c9f0ccbf24fe1d0c3f6ed076

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Wed, 12 Apr 2023 14:56:46 GMT
server
cloudflare
age
761493
cf-polished
origSize=1181
etag
W/"6436c6ae-49d"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dfe992c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
global.js
www.fiercebiotech.com/themes/custom/quartz_barrio/js/
6 KB
2 KB
Script
General
Full URL
https://www.fiercebiotech.com/themes/custom/quartz_barrio/js/global.js?v=3.1
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
862716246fb796d1bb62c00a8d05ab75f3868767459dd174c436b3ef753350cd

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:39 GMT
server
cloudflare
age
239746
cf-polished
origSize=8395
etag
W/"64a73b67-20cb"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dfe9a2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
runtime.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
2 KB
924 B
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/runtime.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
daf4fe1515892c71cdd95f5c6eb3a9cc0aa4ad0a93247c9a6e971bf6f169f53e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Wed, 12 Apr 2023 14:56:44 GMT
server
cloudflare
age
763776
etag
W/"6436c6ac-69b"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dfe9d2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-runtime-core.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
66 KB
25 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-runtime-core.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
542a28184522f926e475ece8fefd244ff3c3e1d6b694156d2be685a9746f812e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
cf-polished
origSize=67790
etag
W/"64a73b66-108ce"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004dfe9e2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-compiler-core.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
53 KB
20 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-compiler-core.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
40a4c209d794b190383c83ea7c770a4234472a4a224ed8bf6ff7a38c7aa5c336

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
cf-polished
origSize=54464
etag
W/"64a73b66-d4c0"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ebe2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-runtime-dom.esm-bundler.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
29 KB
10 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-runtime-dom.esm-bundler.js?v=c486ab52a4115578
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e721448de4149c59b99e49159d0b8be3557227c4f317c688d02ab5eafe5ce580

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 06 Jul 2023 22:08:38 GMT
server
cloudflare
age
763776
etag
W/"64a73b66-749c"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ec02c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
vendor-vue-social-sharing.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
42 KB
15 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-vue-social-sharing.js?v=121c
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d6da5e9b28773a4962683b187b59a29a690a7389acc8746461ef2a8b4703ac7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Wed, 12 Apr 2023 14:56:44 GMT
server
cloudflare
age
755781
etag
W/"6436c6ac-a7e6"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ec52c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-1d06dfb1.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
32 KB
9 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-1d06dfb1.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
608097e02a29b4e0529f117d8736728d47b76432ecb8ff5771545f21da82cecd

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
755781
etag
W/"64baba55-7fa8"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ec62c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-46826cd4.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
23 KB
7 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-46826cd4.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8bfec167931638e76d261249490dcb1bd356f5ff635f2b7ab640775a6f8204c2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
760007
etag
W/"64baba55-5c35"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ec82c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-5ebdb320.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
62 KB
14 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-5ebdb320.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
765cf476d0036d6a839472b05a76bda1e912b7bcea8a85466615a96f81c51308

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
755781
etag
W/"64baba55-f766"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ec92c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-80f4f91d.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
71 KB
15 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-80f4f91d.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
444a82c74d7b9711b6bb1188114e3b5903babf5ca11cadbd161123d74f8886ce

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
757547
etag
W/"64baba55-11cfc"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0eca2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-8b39a80f.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
28 KB
7 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-8b39a80f.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b4e2fb954a69fbec249310839570544f574d2d2290f5b6a450cab9b6260bc213

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
755781
etag
W/"64baba55-6fa8"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ecb2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-a7e1bd7d.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
67 KB
15 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-a7e1bd7d.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b61d2f7ab860044189ab4e2b4d95b0936dfd4e31592cebaf49713ded005eca12

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 21 Jul 2023 17:03:17 GMT
server
cloudflare
age
755781
etag
W/"64baba55-10a2d"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ecc2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle-cdd60c62.js
www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/
71 KB
24 KB
Script
General
Full URL
https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d871e085c5801e167e7f68b96f15455c39dda9b8122cde756eddc7d0855b57c0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 20 Jul 2023 22:23:13 GMT
server
cloudflare
age
755781
cf-polished
origSize=73038
etag
W/"64b9b3d1-11d4e"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
7eee004e0ecd2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
css_CtuRgjiR6PjYWxRQiyZkM_4mwQa4naLw0tAdT3p0l6M.css
www.fiercebiotech.com/sites/qcloud5/files/css/
7 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercebiotech.com/sites/qcloud5/files/css/css_CtuRgjiR6PjYWxRQiyZkM_4mwQa4naLw0tAdT3p0l6M.css
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b9e93402d8e2ccc25635c3e54e89db3d67cc810d5b1ca9cb70dbdf506c21d6ff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 22 Jun 2023 23:35:49 GMT
server
cloudflare
age
760948
cf-polished
origSize=6921
etag
W/"6494dad5-1b09"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=315360000
cf-ray
7eee004e0ec22c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
css_fLZSRl2FwDqlWPvSm_Av0kM4NfMjYc1ynC3KJ2Af1b0.css
www.fiercebiotech.com/sites/qcloud5/files/css/
238 KB
23 KB
Stylesheet
General
Full URL
https://www.fiercebiotech.com/sites/qcloud5/files/css/css_fLZSRl2FwDqlWPvSm_Av0kM4NfMjYc1ynC3KJ2Af1b0.css
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e5485aa213667c84a51961dc5a1f2600acc5004aab1333a1cd7b9707a7b967f5

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 20 Jul 2023 22:29:20 GMT
server
cloudflare
age
760948
etag
W/"64b9b540-3b5cc"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=315360000
cf-ray
7eee004e0ece2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
chevron-down-solid-dark.svg
www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/custom/
432 B
348 B
Image
General
Full URL
https://www.fiercebiotech.com/themes/custom/quartz_barrio/images/icons/custom/chevron-down-solid-dark.svg?v=1.0
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b81d74611b86412eaacf368de07f273ab99505e5a80df3de33c4360f8dd9555

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:17 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
760947
etag
W/"646fdb4f-1b0"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
7eee004e0ecf2c77-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
41960da6-2252-4640-8ec4-d56a7d2c4a33
www.fiercebiotech.com/jsonapi/node/article/
51 KB
6 KB
XHR
General
Full URL
https://www.fiercebiotech.com/jsonapi/node/article/41960da6-2252-4640-8ec4-d56a7d2c4a33?include=field_author,field_cat_primary,field_cat_related,field_keywords,field_sponsored_by,field_article_resource_file,field_resource_type
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ddb473a5e77e4b93193284c6162d397514ea2b4ed9eac543f859d7dee311a261
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 28 Jul 2023 14:17:26 GMT
server
cloudflare
etag
W/"1690553846"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f4a98bb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
41960da6-2252-4640-8ec4-d56a7d2c4a33
www.fiercebiotech.com/jsonapi/node/article/
10 KB
2 KB
XHR
General
Full URL
https://www.fiercebiotech.com/jsonapi/node/article/41960da6-2252-4640-8ec4-d56a7d2c4a33?include=field_author,field_cat_primary,field_cat_related,field_keywords,field_sponsored_by,field_gallery&fields[node--article]=published_date,field_byline_prefix_override,field_eyebrow_override,field_byline,path,title,field_date_published,field_content_label_override,field_media_slideshow,field_author,field_cat_primary,field_cat_related,field_keywords,field_sponsored_by,field_gallery&fields[node--person]=path,field_name_first,field_name_last&fields[taxonomy_term--category]=name,path,field_sponsor,field_hide_from_tag_lists&fields[taxonomy_term--keywords]=name,path,field_sponsor&fields[paragraph--sponsor]=field_is_sponsored&fields[node--company]=title,path
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8a06273da12004406db887c374db20974879a73bdddd60bae86711e45c1e5f1f
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 28 Jul 2023 14:17:26 GMT
server
cloudflare
etag
W/"1690553846"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f4a99bb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
41960da6-2252-4640-8ec4-d56a7d2c4a33
www.fiercebiotech.com/jsonapi/node/article/
5 KB
2 KB
XHR
General
Full URL
https://www.fiercebiotech.com/jsonapi/node/article/41960da6-2252-4640-8ec4-d56a7d2c4a33?include=field_media&fields[node--article]=field_caption,field_gallery,field_media&fields[file--file]=uri
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d2d41c2a37cccee3fce2b93c9f7ac27e33093b96646cd5fd328038c1f4377d1
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 28 Jul 2023 14:17:26 GMT
server
cloudflare
etag
W/"1690553846"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f4a9fbb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
1d997308-4bdd-4a02-aaa7-2d9cb9b81d2f
www.fiercebiotech.com/jsonapi/media/image/
4 KB
2 KB
XHR
General
Full URL
https://www.fiercebiotech.com/jsonapi/media/image/1d997308-4bdd-4a02-aaa7-2d9cb9b81d2f?include=field_media_image&fields[file--file]=uri,filemime,filename
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
66f97ec646c2992df1b75f5e9910d1087ea2ea82a3313bbfa675350ff484c674
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 27 Jul 2023 14:33:35 GMT
server
cloudflare
etag
W/"1690468415"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f4aa8bb9e-FRA
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
omeda_iframe
www.fiercebiotech.com/api/v1/config/
193 B
745 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/config/omeda_iframe
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
41c5548067978ac1de20d971fe35fbbd96dd0cd57f82b58e1aa3aef3aa12e80a
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
258936
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 21 Jul 2023 17:09:33 GMT
server
cloudflare
etag
W/"1689959373"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f6ad0bb9e-FRA
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
parsely_site_id
www.fiercebiotech.com/api/v1/config/
29 B
642 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/config/parsely_site_id
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2e8bef1c0272cff37e8a4abbb9af3cc9d83405c6c68acb9ecc1b687b629426dd
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
258967
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 21 Jul 2023 17:09:33 GMT
server
cloudflare
etag
W/"1689959373"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee004f6aeabb9e-FRA
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
Fierce-23-Brand-Element.svg
qtxasset.com/quartz/qcloud5/
1 KB
548 B
Image
General
Full URL
https://qtxasset.com/quartz/qcloud5/Fierce-23-Brand-Element.svg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
befb55188d1fc6bfca46b1da87cce77f09058c0b7a00b67f7cf7233aa4b570d3

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
x-amz-version-id
bmuL8lQrt0nnsOMk1Jm4_VUq4.oCq3NS
content-encoding
br
cf-cache-status
HIT
x-amz-request-id
KS4FMF39EWSXFBG6
age
5671780
x-amz-server-side-encryption
AES256
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
x-amz-id-2
NEK+vRLETWvgIZ37wY0e1pwUl2vj1yZEmClWC/1PKZSwBrpF+DEgCx7LpBEtPJjBxaLZWShQnQk=
last-modified
Wed, 22 Feb 2023 14:52:08 GMT
server
cloudflare
etag
W/"70f8c7045215bb1368720bf699506d5f"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=31536000
cf-ray
7eee004f9e643730-FRA
expires
Mon, 29 Jul 2024 13:38:18 GMT
qFdH35WCmI96Ajtm81GlU9vgwBcI.woff2
fonts.gstatic.com/s/overpass/v7/
38 KB
38 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v7/qFdH35WCmI96Ajtm81GlU9vgwBcI.woff2
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/sites/qcloud5/files/css/css_fLZSRl2FwDqlWPvSm_Av0kM4NfMjYc1ynC3KJ2Af1b0.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
26767f0b7032e460e8500deff8d9077a9f8fdc3f43fceb30d3a6ec067c5e8382
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/
Origin
https://www.fiercebiotech.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 05:38:04 GMT
x-content-type-options
nosniff
age
115214
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
38504
x-xss-protection
0
last-modified
Wed, 10 Nov 2021 18:13:16 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 28 Jul 2024 05:38:04 GMT
qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncWMp9gyUsE.woff
fonts.gstatic.com/s/overpass/v7/
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v7/qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncWMp9gyUsE.woff
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/sites/qcloud5/files/css/css_fLZSRl2FwDqlWPvSm_Av0kM4NfMjYc1ynC3KJ2Af1b0.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c1d222778644925bcc3b323bc56b7564fc200e442c722de525fd8d030525addc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/
Origin
https://www.fiercebiotech.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 23:40:31 GMT
x-content-type-options
nosniff
age
136667
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20164
x-xss-protection
0
last-modified
Wed, 10 Nov 2021 18:12:35 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 27 Jul 2024 23:40:31 GMT
ba2114bf-11d4-4f60-88f3-86ed4682c761
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
635 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/ba2114bf-11d4-4f60-88f3-86ed4682c761
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
204188
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 27 Jul 2023 13:36:52 GMT
server
cloudflare
etag
W/"1690465012"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee00504d2dbb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
7781fda6-aadb-4b1c-b9c7-8c8d224f2d0b
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
636 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/7781fda6-aadb-4b1c-b9c7-8c8d224f2d0b
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
234124
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 27 Jul 2023 13:36:36 GMT
server
cloudflare
etag
W/"1690464996"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee00505d42bb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
1321046
www.fiercebiotech.com/api/v1/term-multi-sponsor-resources-node/
35 B
636 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term-multi-sponsor-resources-node/1321046
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
66bf4c2d75c9ed6d00de0d5494f1e7120f55e8943f4fc41bd5cefccd6fe9d14e
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Fri, 28 Jul 2023 14:48:01 GMT
server
cloudflare
etag
W/"1690555681"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee00505d4fbb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
EJRVQgYoZZY2vCFuvAFWzr-_dSb_.woff2
fonts.gstatic.com/s/ptserif/v16/
13 KB
13 KB
Font
General
Full URL
https://fonts.gstatic.com/s/ptserif/v16/EJRVQgYoZZY2vCFuvAFWzr-_dSb_.woff2
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/sites/qcloud5/files/css/css_fLZSRl2FwDqlWPvSm_Av0kM4NfMjYc1ynC3KJ2Af1b0.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
af414f1b40ee5f8ed0364c9c2c27a6d6e40a5948d8e4792cf2f6eba161d5f192
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/
Origin
https://www.fiercebiotech.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 03:41:04 GMT
x-content-type-options
nosniff
age
295034
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
13300
x-xss-protection
0
last-modified
Wed, 26 Jan 2022 19:09:23 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 26 Jul 2024 03:41:04 GMT
show_ads_impl_with_ama_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/
361 KB
123 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-1234567890123456&plah=www.fiercebiotech.com&bust=31076543
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ab3777c1f26944dddbdab95a113dfa280d8ab7b61870646fc20914d02cde03aa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
126398
x-xss-protection
0
server
cafe
etag
12350804296092352952
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:18 GMT
zrt_lookup.html
googleads.g.doubleclick.net/pagead/html/r20230726/r20190131/ Frame 8467
10 KB
5 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20230726/r20190131/zrt_lookup.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
18e7a53e3b3abd7ac0242719f7f62cb56b8efe7065091585b8ad22cbc2b8c41c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
12805
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=1209600
content-encoding
br
content-length
4544
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 10:04:53 GMT
etag
12368291122986407432
expires
Sun, 13 Aug 2023 10:04:53 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
pubads_impl.js
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/
386 KB
123 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
964783a75f5a7ecc32d48da45cc6025af80e263d6ba6530dc62cc25865b2eb00
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 22:07:18 GMT
content-encoding
br
x-content-type-options
nosniff
age
55860
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
125535
x-xss-protection
0
server
cafe
etag
10403599952857238940
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, immutable, max-age=31536000
timing-allow-origin
*
expires
Sun, 28 Jul 2024 22:07:18 GMT
d722868a-9ad3-4ec1-94ef-8f3f1d8918ba
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
629 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/d722868a-9ad3-4ec1-94ef-8f3f1d8918ba
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 27 Jul 2023 13:54:35 GMT
server
cloudflare
etag
W/"1690466075"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee0051d93fbb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
78542379-44ae-4b58-8cd2-0080cabd821e
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
633 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/78542379-44ae-4b58-8cd2-0080cabd821e
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
32985
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Mon, 24 Jul 2023 18:33:15 GMT
server
cloudflare
etag
W/"1690223595"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee0051d945bb9e-FRA
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
e7b15ade-d7c4-4812-b2ea-8247d36dbdd7
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
636 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/e7b15ade-d7c4-4812-b2ea-8247d36dbdd7
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
204188
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 27 Jul 2023 13:41:55 GMT
server
cloudflare
etag
W/"1690465315"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee0051d94cbb9e-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
1be9a7e2-3e70-4aeb-bd71-8d546729cb08
www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/
21 B
632 B
XHR
General
Full URL
https://www.fiercebiotech.com/api/v1/term/check_is_sponsored_for_active_domain/1be9a7e2-3e70-4aeb-bd71-8d546729cb08
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.0.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
204204
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
x-ua-compatible
IE=edge
referrer-policy
no-referrer-when-downgrade
last-modified
Mon, 24 Jul 2023 18:32:04 GMT
server
cloudflare
etag
W/"1690223524"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
x-generator
Drupal 9 (https://www.drupal.org)
cache-control
max-age=31536000, public
cf-ray
7eee0051e95abb9e-FRA
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
GettyImages-887410960%20%282%29.jpg
qtxasset.com/cdn-cgi/image/w=850,h=478,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/
30 KB
30 KB
Image
General
Full URL
https://qtxasset.com/cdn-cgi/image/w=850,h=478,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-887410960%20%282%29.jpg?VersionId=IMKy1mCn4Gqkz8PeZyIV5B3Y.eqe1THL
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
68a38c70cdcf275ff1085a753d5d2ad47e5c9015d30c307f2a6b191364d30b7c
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'
x-content-type-options
nosniff
cf-cache-status
MISS
alt-svc
h3=":443"; ma=86400
content-length
30795
cf-resized
internal=ok/h q=0 n=22+132 c=0+0 v=2023.7.3 l=30795
last-modified
Wed, 18 May 2022 14:11:29 GMT
cf-bgj
imgq:85,h2pri
server
cloudflare
etag
"cfRNglOCP73-UObx_hmE4pAc1MqeoyMVBK7VyAnF90DQ:b75ed6ce05d7ef1bb1189bf2ece7a965"
vary
Accept, Accept-Encoding
content-type
image/avif
cache-control
public, max-age=31556952
accept-ranges
bytes
cf-ray
7eee0051ed6d39ec-FRA
init.do
sample.dragonforms.com/ Frame 394F
Redirect Chain
  • https://sample.dragonforms.com/LS_short
  • https://sample.dragonforms.com/init.do?omedasite=LS_short
269 B
723 B
Document
General
Full URL
https://sample.dragonforms.com/init.do?omedasite=LS_short
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/vendor-runtime-dom.esm-bundler.js?v=c486ab52a4115578
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
27700283771396d86710e130a67bb11bbe5d0acf594ba7b8abfb6fd8cbc4fb22
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Access-Control-Allow-Origin
*
Connection
keep-alive
Content-Length
269
Content-Type
text/html;charset=ISO-8859-1
Date
Sun, 30 Jul 2023 13:38:24 GMT
Keep-Alive
timeout=5
Server
Apache
Strict-Transport-Security
max-age=31536000
Vary
Accept-Encoding
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block

Redirect headers

Connection
keep-alive
Content-Length
0
Date
Sun, 30 Jul 2023 13:38:24 GMT
Keep-Alive
timeout=5
Location
init.do?omedasite=LS_short
Server
Apache
related
api.parsely.com/v2/
5 KB
2 KB
XHR
General
Full URL
https://api.parsely.com/v2/related?apikey=fiercebiotech.com&url=https:%2F%2Fwww.fiercebiotech.com%2Fundefined&sort=_score&limit=4&exclude=authors:Staff&page=1
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=0ae1005efa25b2faef1686c6dca3
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
184.72.142.9 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-184-72-142-9.compute-1.amazonaws.com
Software
nginx /
Resource Hash
69434dcf569899319d3feb056f81ca5561d2c462e025d22f8f427a03edb7fdb2

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:19 GMT
content-encoding
gzip
server
nginx
x-cache-status
HIT
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=120
expires
Sun, 30 Jul 2023 13:40:19 GMT
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Sun, 30 Jul 2023 11:44:24 GMT
last-modified
Mon, 12 Jun 2023 18:23:07 GMT
server
Golfe2
age
6834
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Sun, 30 Jul 2023 13:44:24 GMT
p.js
cdn.parsely.com/keys/fiercebiotech.com/
47 KB
18 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercebiotech.com/p.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.100.58 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-100-58.fra56.r.cloudfront.net
Software
nginx /
Resource Hash
79d3ce1fd6ca1f40809005d4d753594d61d4226a05894f656f8d37e2026d0da7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
public
date
Sat, 29 Jul 2023 17:36:41 GMT
content-encoding
gzip
via
1.1 4a502b22092e94faddf9a5b056e273ae.cloudfront.net (CloudFront)
last-modified
Fri, 02 Jul 2021 02:33:20 GMT
server
nginx
x-amz-cf-pop
FRA56-P2
age
72337
etag
W/"60de7af0-bd28"
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=86400, public
x-amz-cf-id
6GcwUMixHI8mk_HUIUPuvvYRzpz3YtXYYGyRiNeRj6TSWdpw-Y27TA==
expires
Sun, 30 Jul 2023 17:32:41 GMT
js
www.googletagmanager.com/gtag/
251 KB
85 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-KG49J84SR4
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
86584c6311b265f2e288a8d601ae7ed7dee455340d8b8afe8482f310c6938984
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
87049
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Sun, 30 Jul 2023 13:38:18 GMT
tag.aspx
ml314.com/
31 KB
11 KB
Script
General
Full URL
https://ml314.com/tag.aspx?3062023
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.111.234.236 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
236.234.111.34.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
23f95a90d6e6ba09a92bd4eae99823b0a6b0137a9abe10e3c050c062fb15efe4

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:13:10 GMT
content-encoding
br
age
1508
x-guploader-uploadid
ADPycdvoR47PzRqYORBLt_CHxwV2cxj0YUnuGnNkBUImG5GxpqFNgALwb451J6A3Bkd-IDRYtP0XeKlvmnP4O6cBWi8Er0pnWuKe
x-goog-storage-class
STANDARD
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
10518
last-modified
Mon, 10 Apr 2023 17:13:24 GMT
server
UploadServer
etag
W/"b0965f051977c0dd95ffe2c736cac352"
vary
Accept-Encoding
x-goog-generation
1681146804366265
x-goog-hash
crc32c=wVdAwA==, md5=sJZfBRl3wN2V/+LHNsrDUg==
content-type
application/javascript
cache-id
FRA-fa985ced
cache-control
public,max-age=3600
x-cache-hit
hit
x-goog-stored-content-length
32213
accept-ranges
none
hbw_master_748754_18090.js
player.hbmp.mediafuse.com/prebidlink/469645/
128 KB
43 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/469645/hbw_master_748754_18090.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/383914764235/wrapper_hb_748754_18090.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
edf41f0e9b71117ce17dc6c6f56006e8a439ff8b4b2fb5d1334c343c84730333

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
gzip
last-modified
Sun, 30 Jul 2023 04:08:46 GMT
server
nginx
etag
W/"64c5e24e-20148"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Tue, 01 Aug 2023 13:38:18 GMT
hbp_master_748754_18090.js
player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/
429 KB
137 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18090.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/383914764235/hb_748754_18090.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
5cefa7d9ed7ba581514db5e5b3f5f9abfffc08d50185bfc76ffe32896ace5968

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:18 GMT
content-encoding
gzip
last-modified
Thu, 27 Jul 2023 15:33:56 GMT
server
nginx
etag
W/"64c28e64-6b515"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Tue, 01 Aug 2023 13:38:18 GMT
collect
region1.google-analytics.com/g/
0
259 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-KG49J84SR4&gtm=45je37q0&_p=268259825&cid=1294825810.1690724299&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_s=1&sid=1690724298&sct=1&seg=0&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&dt=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&ep.content_group=CRO
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-KG49J84SR4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:19 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
p1.parsely.com/plogger/
43 B
257 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1690724298752&plid=76844122&idsite=fiercebiotech.com&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&sref=&sts=1690724298743&slts=0&title=Power+debuts+with+%247M+seed+funding%2C+focus+on+clinical+trials&date=Sun+Jul+30+2023+13%3A38%3A18+GMT%2B0000+(GMT)&action=pageview&pvid=7150811&u=pid%3Dbd9d32bbd3203e200084758c32ca6732
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.17.99.225 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-17-99-225.eu-west-1.compute.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sun, 30 Jul 2023 13:38:19 GMT
Cache-Control
no-cache
Last-Modified
Sunday, 30-Jul-2023 13:38:19 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
collect
www.google-analytics.com/j/
16 B
227 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=268259825&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&ul=en-us&de=UTF-8&dt=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YCDACAABBAAAAC~&jid=522873208&gjid=630245653&cid=1294825810.1690724299&tid=UA-336524-7&_gid=820736630.1690724299&_r=1&_slc=1&gtm=45He37q0n81M98WT45&z=810447336
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
3aa8da2b1af8f47cf5061213e2995ce49a61551aa96557c56b3cdbed3c413567
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:18 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
16
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/
35 B
55 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j101&a=268259825&t=event&_s=2&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&ul=en-us&de=UTF-8&dt=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&ec=User%20Article%20Consumption&ea=read%20title&el=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&ev=1&_u=aDDACAABBAAAAC~&jid=&gjid=&cid=1294825810.1690724299&tid=UA-336524-7&_gid=820736630.1690724299&gtm=45He37q0n81M98WT45&z=1306896189
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 03:59:07 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
34751
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
utsync.ashx
ml314.com/
62 B
310 B
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=undefined&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&pv=1690724298859_vo71eiwbp&bl=en-us&cb=7622249&return=&ht=&d=&dc=&si=1690724298859_vo71eiwbp&cid=&s=1600x1200&rp=&v=2.5.3.49
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?3062023
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.111.234.236 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
236.234.111.34.bc.googleusercontent.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:18 GMT
via
1.1 google
server
Microsoft-IIS/10.0
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
content-type
application/javascript; charset=utf-8
p3p
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
62
expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=3062023&v=2.5.3.49
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?3062023
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.45.228.109 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-45-228-109.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sun, 30 Jul 2023 13:38:19 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Mon, 31 Jul 2023 13:38:19 GMT
cookie.js
partner.googleadservices.com/gampad/
401 B
604 B
Script
General
Full URL
https://partner.googleadservices.com/gampad/cookie.js?domain=www.fiercebiotech.com&callback=_gfp_s_&client=ca-pub-1234567890123456
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-1234567890123456&plah=www.fiercebiotech.com&bust=31076543
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
328d9d45dbe2d59730428d1a063867908cd2e1e50322766040ce094755e3410e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
content-type
text/javascript; charset=UTF-8
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
252
x-xss-protection
0
ads
googleads.g.doubleclick.net/pagead/ Frame 35D9
603 B
247 B
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-1234567890123456&output=html&adk=1812271804&adf=3025194257&lmt=1690576062&plat=9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C41%3A32%2C42%3A32&plas=140x675_l%7C140x675_r&format=0x0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&ea=0&pra=5&wgl=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&dt=1690724298374&bpp=8&bdt=533&idt=496&shv=r20230726&mjsv=m202307260101&ptt=9&saldr=aa&abxe=1&nras=1&correlator=7712246462879&frm=20&pv=2&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=1&u_tz=0&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759926%2C44759837%2C44759875%2C31076342%2C31076444%2C31076484%2C31076543%2C44788442&oid=2&pvsid=2093194126477304&tmod=1059681379&uas=0&nvt=1&fsapi=1&fc=1920&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&ifi=1&uci=a!1&fsb=1&dtd=560
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-1234567890123456&plah=www.fiercebiotech.com&bust=31076543
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
00daef3b4a945d15f73efa05e0ce2ca51f2f8252e1da8fae5c2efb0f6dddacce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private
content-encoding
br
content-length
46
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:19 GMT
expires
Sun, 30 Jul 2023 13:38:19 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
/
ghb.hbmp.mediafuse.com/geo/
135 B
412 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/geo/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/469645/hbw_master_748754_18090.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.226 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
ec221f02e697f63d8341d806d3c8934d1ea4a483300e50309a66e5e52c6aff51

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sun, 30 Jul 2023 13:38:19 GMT
Server
Adtelligent
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercebiotech.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
135
tracking
ghb.hbmp.mediafuse.com/adunit/
43 B
441 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=748754&site_id=18090&full_page_url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&adid=phlect.o2&features=4276256&vpbv=A165&tte=1151&lifecycle_tte=2369
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/469645/hbw_master_748754_18090.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.226 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sun, 30 Jul 2023 13:38:19 GMT
Server
Adtelligent
Content-Type
image/gif
Access-Control-Allow-Origin
https://www.fiercebiotech.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
43
collect
stats.g.doubleclick.net/j/
1 B
351 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-336524-7&cid=1294825810.1690724299&jid=522873208&gjid=630245653&_gid=820736630.1690724299&_u=YCDACAAABAAAAC~&z=694787623
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c0c::9d Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
date
Sun, 30 Jul 2023 13:38:19 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
js
www.googletagmanager.com/gtag/
242 KB
81 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-LESW06PJYD&cx=c&_slc=1
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
8d13111280abae1597984e96c31e8a576d55c243afab55c2c8e511658381d4e3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:19 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
83214
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Sun, 30 Jul 2023 13:38:19 GMT
config.json
player.adtelligent.com/exchange_rates/279934/
8 KB
4 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18090.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
0cac808009bfcc42b61e3ade0e57c689c205423cb27fc399d5d2b29804da197a

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
text/plain

Response headers

expires
Tue, 01 Aug 2023 13:38:19 GMT
date
Sun, 30 Jul 2023 13:38:19 GMT
content-encoding
gzip
last-modified
Fri, 28 Jul 2023 12:02:15 GMT
server
nginx
etag
W/"64c3ae47-21fc"
content-type
application/json
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
max-age=172800
x-proxy-cache
HIT
collect
region1.google-analytics.com/g/
0
46 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-LESW06PJYD&gtm=45je37q0&_p=268259825&ul=en-us&sr=1600x1200&cid=1294825810.1690724299&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_eu=ABAI&ngs=1&_s=1&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&dt=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&sid=1690724299&sct=1&seg=0&en=page_view&_fv=1&_ss=1&_ee=1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-LESW06PJYD&cx=c&_slc=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:19 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
spinner.gif
cdn.omeda.com/hosted/images/dragon/generic/ Frame 394F
9 KB
9 KB
Image
General
Full URL
https://cdn.omeda.com/hosted/images/dragon/generic/spinner.gif
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:ec00:c:860d:a440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:35:31 GMT
via
1.1 04ce5a607a98db6d08257633417b84d6.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
FRA2-C2
age
219
x-cache
Hit from cloudfront
content-length
8851
x-xss-protection
1; mode=block
last-modified
Mon, 10 Oct 2016 20:45:12 GMT
server
Apache
etag
W/"8851-1476132312178"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/gif
access-control-allow-origin
*
access-control-expose-headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
accept-ranges
bytes
x-amz-cf-id
l7pjV9Iht_vgH4bB3y30vIHtfw5NW2RnO33p28GDM694YuA40qAyEA==
ads
securepubads.g.doubleclick.net/gampad/
9 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=1046309606744604&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=2&adks=215103460&sfv=1-0-40&ists=1&prev_scp=pos%3D7%26refresh%3Dtrue%26hb_rfBid%3D0&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299914&lmt=1690576062&adxs=160&adys=0&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=1&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=1310x0&msz=1310x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
87cde7e3a0d50565da3c4bea1eed191b23e45a96125fb011b593f02566db17bf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4595
x-xss-protection
0
google-lineitem-id
6214501882
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138437987795
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
398 B
177 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=3588773549908696&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=3&adks=2038634519&sfv=1-0-40&ists=1&prev_scp=pos%3D4%26refresh%3Dtrue%26hb_rfBid%3D0&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299932&lmt=1690576062&adxs=160&adys=0&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=2&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=1310x0&msz=1310x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
839f40c37f4c88c16bc324dfaa50cbb12a5b9410cc3fe4257e065d9812cf12f3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
145
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
409 B
190 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=4079550766347768&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1600x1000&ifi=4&adks=1080924991&sfv=1-0-40&prev_scp=pos%3D5%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299940&lmt=1690576062&adxs=160&adys=0&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=3&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=1310x1&msz=1310x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a91dace5fd27f94061a03d6dafe4bc5fa4500a7f5c0935b7ed7c8fe4ad5d50e1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
158
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
63 KB
24 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=3054296649490508&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250&ifi=5&adks=1528890839&sfv=1-0-40&prev_scp=pos%3D0%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299945&lmt=1690576062&adxs=160&adys=141&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=4&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=1310x1&msz=1310x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
6d4a9753ce2e97fd3d769b770dca35575f51ef917b52971add6e794e1145267b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24220
x-xss-protection
0
google-lineitem-id
6309243730
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138438495865
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
18 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=896572295616262&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=6&adks=2236828588&sfv=1-0-40&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299950&lmt=1690576062&adxs=1135&adys=924&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=5&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=320x250&msz=320x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
50d6a3f1b2331e167bf8d7cd4cddbaee88cc3047f1320e26eed0fc06194ca06d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
469744
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18861
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-mediationtag-id
779404
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
18 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=1826011101022234&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=7&adks=250413873&sfv=1-0-40&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299961&lmt=1690576062&adxs=1120&adys=1278&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=1&ucis=6&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=350x250&msz=350x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f397f4e666b9e83b883504951e6327b1cf1b9ff4ca8ae34ea09cd5d68fd091f9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
469744
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18668
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-mediationtag-id
779404
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
44 KB
19 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=1943823940988721&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=8&adks=250413874&sfv=1-0-40&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299965&lmt=1690576062&adxs=1120&adys=1543&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=2&ucis=7&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=350x250&msz=350x0&fws=644&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
330e88d1e97d756be9ba0bb0c910088d8198326050b129ac8dbf97d96a6d235b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
469744
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18949
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-mediationtag-id
779404
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
398 B
177 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=4023366947951020&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=9&adks=1538487262&sfv=1-0-40&ists=1&prev_scp=pos%3D9%26refresh%3Dtrue%26hb_rfBid%3D0&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299975&lmt=1690576062&adxs=160&adys=2943&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=3&ucis=8&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=1310x0&msz=1310x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
fb751b2dfff03aad8dab268dcb376e1f200bd948e8ea5a0aea09dbd4e9c38ab5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
145
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
329 B
175 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=325426771019705&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=320x50&fluid=height&ifi=10&adks=2711184374&sfv=1-0-40&prev_scp=pos%3D14%26refresh%3Dtrue%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299979&lmt=1690576062&adxs=255&adys=1427&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=4&ucis=9&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=830x1&msz=830x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f62e7be11cf9f105f7aa6e7f74aabcf51bce9cde2258e1f2b1742631109fcc53
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
144
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
10 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=2093194126477304&correlator=997050783896578&eid=44780990&output=ldjh&gdfp_req=1&vrg=202307250102&ptt=17&impl=fifs&iu_parts=298443%2Cquestex.lifesciences%2Cfiercebiotech%2Ccro&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=11&adks=4233382618&sfv=1-0-40&ists=1&prev_scp=pos%3D8%26refresh%3Dtrue%26hb_rfBid%3D0&eri=1&cust_params=section%3DCRO%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1321046%26topic%3D%26keyword%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%26tag%3Dpatient%2520recruitment%252C%2520Fundraising%252C%2520startups%252C%2520Emerging%2520Biopharma%252CVenture%2520Capital%252CCRO%26path%3D%252Fcro%252Fpower-debuts-7m-seed-funding-focus-clinical-trials%26browserLargerThan1460%3D1&sc=1&cookie=ID%3Df182b9d1d1a6d7e5-22ddb5a11ee30080%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA&gpic=UID%3D00000d3129a99992%3AT%3D1690724299%3ART%3D1690724299%3AS%3DALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg&abxe=1&dt=1690724299985&lmt=1690576062&adxs=255&adys=1428&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=5&ucis=a&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&bc=31&uach=WyIiLCIiLCIiLCIiLCIiLFtdLDAsbnVsbCwiIixbXSwwXQ..&nvt=1&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&frm=20&vis=1&psz=830x0&msz=830x0&fws=132&ohw=1600&ga_vid=1294825810.1690724299&ga_sid=1690724299&ga_hid=268259825&ga_fc=true&dlt=1690724297841&idt=798
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
cdf059465216c25327a08fc3f24fc52f36762daf5d7d9ab0dfcb746aefe9e553
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4915
x-xss-protection
0
google-lineitem-id
6334795628
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138440574456
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 913F
6 KB
3 KB
Document
General
Full URL
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Mon, 29 Jul 2024 13:38:20 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
170
a.ad.gt/api/v1/u/matches/
11 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/469645/hbw_master_748754_18090.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f30a8eae1d630055090711cb91ccf5cef1228185f3a19f9b1fcadffeee0cbeaa

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Sun, 30 Jul 2023 13:37:51 GMT
server
cloudflare
age
29
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=14400
cross-origin-resource-policy
cross-origin
cf-ray
7eee005b8f563a52-FRA
loading.do
sample.dragonforms.com/ Frame 394F
22 KB
7 KB
Document
General
Full URL
https://sample.dragonforms.com/loading.do?omedasite=LS_short
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=LS_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
f0fcf21d81d3a7aed66fe15d099a87109fc09978bd02570033ca7716aa8fedd5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/init.do?omedasite=LS_short
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Access-Control-Allow-Origin
*
Connection
keep-alive
Content-Encoding
gzip
Content-Type
text/html;charset=ISO-8859-1
Date
Sun, 30 Jul 2023 13:38:25 GMT
Keep-Alive
timeout=5
Server
Apache
Strict-Transport-Security
max-age=31536000
Transfer-Encoding
chunked
Vary
Accept-Encoding
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
tag
a.teads.tv/page/103428/ Frame AD55
893 B
861 B
Script
General
Full URL
https://a.teads.tv/page/103428/tag
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
184.30.21.51 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a184-30-21-51.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
5772c5185f32dda5764c242078a94d4a3f3e7c10ee856a3c885a9f0126660927

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA, Sec-CH-UA-Full-Version-List, Sec-CH-UA-WoW64
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, must-revalidate, max-age=3600
access-control-allow-credentials
true
content-length
528
expires
Sun, 30 Jul 2023 14:38:20 GMT
truncated
/ Frame AD55
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7d8cb6b8c715157d0408d58ab980e0c806035483ccf5dc62d700ef0c6932f125

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
site_313b.css
hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/ Frame 394F
19 KB
5 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/site_313b.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:ec00:c:860d:a440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
75aa8016193d3f8a36dc043dcb078fb89662b0616a4a55d45d84df688b5f90ed
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:34:16 GMT
content-encoding
br
x-content-type-options
nosniff
via
1.1 04ce5a607a98db6d08257633417b84d6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
age
243
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
last-modified
Wed, 23 Feb 2022 14:15:47 GMT
server
Apache
etag
W/"19163-1645625747327"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
access-control-expose-headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
x-amz-cf-id
tRuYTyeRmxMkfZJg7QEd5lbnEjn7lvB4rbpK7EVmQqktJO9rLwA-ZA==
jquery-2.2.4.min.js
code.jquery.com/ Frame 394F
84 KB
29 KB
Script
General
Full URL
https://code.jquery.com/jquery-2.2.4.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac18::1:a:3a , Netherlands, ASN20446 (STACKPATH-CDN, US),
Reverse DNS
Software
nginx /
Resource Hash
05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e

Request headers

Referer
https://sample.dragonforms.com/
Origin
https://sample.dragonforms.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 1991 12:00:00 GMT
server
nginx
etag
W/"28feccc0-14e4a"
vary
Accept-Encoding
x-hw
1690724300.dop237.fr8.t,1690724300.cds154.fr8.hn,1690724300.cds140.fr8.c
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=315360000, public
accept-ranges
bytes
content-length
29811
conditional.js
static-cdn.dragonforms.com/js/ Frame 394F
35 KB
13 KB
Script
General
Full URL
https://static-cdn.dragonforms.com/js/conditional.js?build=V23.10.0.1-20230714
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:20e1:4000:0:d27a:1440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
89e0d5e92136af3c2f1d53d4bd524e308554a0ddf9e44a5bd89ab2e2bdbddd7a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
date
Sat, 29 Jul 2023 13:56:00 GMT
via
1.1 59d6f4cc9bf66b7389662cc7f6d33f70.cloudfront.net (CloudFront)
x-amz-cf-pop
CDG50-C2
age
85345
x-cache
Hit from cloudfront
content-length
12624
x-xss-protection
1; mode=block
last-modified
Thu, 29 Dec 2022 17:08:56 GMT
server
Apache
etag
W/"35615-1672333736000"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
accept-ranges
bytes
x-amz-cf-id
dLJHzes_aUGUnh9NHKo-id1MHGmngVLKGgP5q6LU8N-c0JQNgbRPIg==
dragonCampaign.js
static-cdn.dragonforms.com/js/ Frame 394F
13 KB
5 KB
Script
General
Full URL
https://static-cdn.dragonforms.com/js/dragonCampaign.js?build=V23.10.0.1-20230714
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:20e1:4000:0:d27a:1440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
f084eb3b60be7c6309cc5ff62056f29deba6ae55270642089f04f035d9cb3738
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
date
Sun, 30 Jul 2023 05:53:16 GMT
via
1.1 59d6f4cc9bf66b7389662cc7f6d33f70.cloudfront.net (CloudFront)
x-amz-cf-pop
CDG50-C2
age
27909
x-cache
Hit from cloudfront
content-length
4907
x-xss-protection
1; mode=block
last-modified
Tue, 01 Nov 2022 12:59:08 GMT
server
Apache
etag
W/"13287-1667307548000"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
accept-ranges
bytes
x-amz-cf-id
Trp2PKAhZU0CmtNUBNtmMjBtQXwRPjYogLbjylwF0MB3AfNq4s4_vQ==
generic.css
static-cdn.dragonforms.com/style/ Frame 394F
2 KB
1 KB
Stylesheet
General
Full URL
https://static-cdn.dragonforms.com/style/generic.css?build=V23.10.0.1-20230714
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:20e1:4000:0:d27a:1440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Sat, 29 Jul 2023 14:02:34 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C2
age
84951
via
1.1 59d6f4cc9bf66b7389662cc7f6d33f70.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
content-length
1056
x-xss-protection
1; mode=block
last-modified
Thu, 10 Jun 2021 15:35:48 GMT
server
Apache
etag
W/"2478-1623339348000"
vary
Accept-Encoding
content-type
text/css;charset=UTF-8
access-control-allow-origin
*
accept-ranges
bytes
x-amz-cf-id
VPN5Kr2kQMr4o342XBpOd5t_I09N-BN1568ux2luyg1nLX5Tbf_MuA==
958.css
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 394F
3 KB
1 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/958.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:ec00:c:860d:a440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:19 GMT
content-encoding
br
x-content-type-options
nosniff
via
1.1 04ce5a607a98db6d08257633417b84d6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
x-cache
RefreshHit from cloudfront
x-xss-protection
1; mode=block
last-modified
Mon, 04 Oct 2021 17:18:21 GMT
server
Apache
etag
W/"2856-1633367901703"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
access-control-expose-headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
x-amz-cf-id
3MCzZFNFNVwVR63J6G_TIcwCYr4ZKjOh-Bmr4eNQo2OFbtp31plMnA==
363.js
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 394F
5 KB
1 KB
Script
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/363.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:ec00:c:860d:a440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:33:31 GMT
content-encoding
br
x-content-type-options
nosniff
via
1.1 04ce5a607a98db6d08257633417b84d6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
age
289
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
last-modified
Fri, 28 May 2021 14:35:55 GMT
server
Apache
etag
W/"5462-1622212555637"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
x-amz-cf-id
P_GaXMWrkpl4aAnyrtN9mYJkOmu3P4tWOH-tJSsv-SU2IXM8b57Dqg==
olyticsLinkAssistance.js
sample.dragonforms.com/js/ Frame 394F
4 KB
2 KB
Script
General
Full URL
https://sample.dragonforms.com/js/olyticsLinkAssistance.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
2deb0d094a307e99fcaa3dfd02f9802de8e485134d85a2f1d2d77d453dc8b934
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=LS_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Strict-Transport-Security
max-age=31536000
Date
Sun, 30 Jul 2023 13:38:25 GMT
X-Content-Type-Options
nosniff
Last-Modified
Mon, 25 Jul 2022 13:12:48 GMT
Server
Apache
Content-Encoding
gzip
ETag
W/"4025-1658754768000"
Vary
Accept-Encoding
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Connection
keep-alive
Accept-Ranges
bytes
Keep-Alive
timeout=5
Content-Length
1823
X-XSS-Protection
1; mode=block
teads-format.min.js
a.teads.tv/media/format/v3/
600 KB
131 KB
Script
General
Full URL
https://a.teads.tv/media/format/v3/teads-format.min.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/page/103428/tag
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
184.30.21.51 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a184-30-21-51.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
02bdfd091f909a233b77e4bd3a1350a2f29346ba77e624a42db18db92e791f9c

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
last-modified
Thu, 27 Jul 2023 09:36:43 GMT
x-amz-request-id
79T79JQSQCQ24XJK
etag
"db11cbc71e8633748490ffe2618f44e8"
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
cache-control
private, must-revalidate, max-age=1800, no-transform
x-bucket
d
accept-ranges
bytes
content-length
133898
x-amz-id-2
l7YLYUXf50ARn7Ir0MiV0tVuFl0xxNPu6oDXi57ELXWUxXSnXsnJ/lab9DPc85JAS0ujG8WMT2Y=
expires
Sun, 30 Jul 2023 14:08:20 GMT
allstream.js
creative.spotible.com/tag/ Frame EB67
4 KB
2 KB
Script
General
Full URL
https://creative.spotible.com/tag/allstream.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
7dae4cc5e14edeba5777dde5e36077420a8ccb6d3b04f5c5724ed19600410bb0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
cache-control
public, max-age=3600
content-encoding
gzip
etag
"22049d4a4af67c084cb6f6d6479f293e_gz"
vary
accept-encoding
content-type
text/javascript
truncated
/ Frame EB67
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
0df1eaf1f271afa113a8edca24af447a0b5062f782b458d39570b2a83bd762f9

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
gtm.js
www.googletagmanager.com/ Frame 394F
130 KB
50 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
a5f066312e6bb6dfd587b36a4308a97bd8232131822d7ce26a76cfd359d43ae0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50796
x-xss-protection
0
last-modified
Sun, 30 Jul 2023 12:00:00 GMT
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Sun, 30 Jul 2023 13:38:20 GMT
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/ Frame 394F
250 KB
70 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=LS_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:218e:3a00:1e:5cef:3780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
eaafa7b35dbc1bfbe920271234077f1c8d869f12abe74948d8984d72bfa8e750
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 08:55:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
via
1.1 25ad1b0937f8931040e6831f872b7398.cloudfront.net (CloudFront)
x-amz-cf-pop
CDG52-P1
age
18897
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
last-modified
Fri, 02 Jun 2023 00:54:56 GMT
server
Apache
etag
W/"256386-1685667296000"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=21600
x-amz-cf-id
y2L0V4UKQovPua-fH-c83Xkjn2sUj2Z2_bxF3E22xoK3Jc1trjI1Zw==
expires
Fri, 07 Jul 2023 08:22:08 GMT
evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576
sample.dragonforms.com/ Frame 394F
293 B
638 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576?demo227890=short&demo227891=&demo227892=&opt227896=1&demo227897=LS-FB-FORM-NSL-ShortForm&dragon_pagenumber=1&jsessionid=E39CE2057D09FC312ED576F49CABB576&timestemp=1690724300385&omedasite=LS_short
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
3861f9a97b280968f74ff648c5b31585999177de35d08f7e6ca5abe7e5a623a1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=LS_short
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Strict-Transport-Security
max-age=31536000
Date
Sun, 30 Jul 2023 13:38:25 GMT
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
293
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576
sample.dragonforms.com/ Frame 394F
293 B
638 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576?demo227890=short&demo227891=&demo227892=&opt227896=1&demo227897=LS-FB-FORM-NSL-ShortForm&dragon_pagenumber=1&jsessionid=E39CE2057D09FC312ED576F49CABB576&timestemp=1690724300394&omedasite=LS_short
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
3861f9a97b280968f74ff648c5b31585999177de35d08f7e6ca5abe7e5a623a1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=LS_short
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Strict-Transport-Security
max-age=31536000
Date
Sun, 30 Jul 2023 13:38:25 GMT
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
293
X-XSS-Protection
1; mode=block
container.html
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 34E2
6 KB
3 KB
Document
General
Full URL
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Mon, 29 Jul 2024 13:38:20 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
container.html
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 5F8C
6 KB
3 KB
Document
General
Full URL
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Mon, 29 Jul 2024 13:38:20 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
container.html
819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 59E0
6 KB
3 KB
Document
General
Full URL
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Mon, 29 Jul 2024 13:38:20 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
adfetch
googleads.g.doubleclick.net/pagead/ Frame C574
169 KB
44 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
afcba172b543881ef65966311d62dc32a2e13f9a98631d3b1d05f3a7cdad3949
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
44680
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
xbfe_backfill.js
googleads.g.doubleclick.net/pagead/ Frame 34E2
7 KB
3 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/xbfe_backfill.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
41559d2aea8b60a1190d8489501bb6a3544ef6b4e0a8021406442bf4aaa6a1c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:39:39 GMT
content-encoding
br
x-content-type-options
nosniff
age
3521
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
3335
x-xss-protection
0
server
cafe
etag
8962344354712869959
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:39:39 GMT
6d138e79-e9e9-44a4-b959-8f37869c6345
a3257.casalemedia.com/impression/v2/859594/85/cj36fj3sfkpvdl1vvl10/ Frame 34E2
43 B
303 B
Image
General
Full URL
https://a3257.casalemedia.com/impression/v2/859594/85/cj36fj3sfkpvdl1vvl10/6d138e79-e9e9-44a4-b959-8f37869c6345?verifieD=1&userID=&cmpro=0&deviceType=2&expiryTime=1690724900&profileIDs=&creativeID=17e348a&pubID=200223&format=banner&channel=site&ap=ZMZnzAAAxdgCO9X4AAcWfBODdd8IQs4r9VHDnw
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.170.61.158 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:20 GMT
Server
Apache
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0
gen_204
pagead2.googlesyndication.com/pagead/ Frame 34E2
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=awbid&awbid_b=AKAmf-Az8jmS3xGhzRyyWMB1muuvUttTSZjL-EXEHbGggJAotCKBTbWavVjdZ1jBE0Dl2SQNacvpOjTffbhK_7jXPu_gVgrEgA&pr=13:ZMZnzAAAAAAAzK4niVfC0S9aHZjQb9P2z4XhqA
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 34E2
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:46:20 GMT
content-encoding
br
x-content-type-options
nosniff
age
57120
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 21:46:20 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 34E2
20 KB
9 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8ecb4fb492aee0a820dfc4a395fb80e2ac2e864bbf38aa1ae28d6d70fb9e6da3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 07:27:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
22227
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8293
x-xss-protection
0
server
cafe
etag
11502554701003060455
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 07:27:53 GMT
l
www.google.com/ads/measurement/ Frame 34E2
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSKLQc63ftCuSpjbuHAIohcqFbyqG23DuCm7JlyXHEHvFbXqz_6PpoK2qYqzvHhmj1P57eC-UkGjMBHrpj_IHCsQcClwQ
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

ext.js
tpc.googlesyndication.com/safeframe/1-0-40/js/ Frame 34E2
24 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-40/js/ext.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
08204982c484faf6890c60557a4e642971f17625ddddc0559dc0e3ca728ac9e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 16:30:13 GMT
content-encoding
br
x-content-type-options
nosniff
age
248887
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6402
x-xss-protection
0
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 26 Jul 2024 16:30:13 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 34E2
179 KB
57 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:20 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 4F88
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss01EOA327HGcLK0yB-2JqtAd2mcyWH4w1opSxuoxaA3O0rLqbD5UioxJWo3JPqQ0AADriFHtAQVR3GXD-NIKWirzD-0qucb_E36HhvqTCKDrzOZlwrROyNc9kFDxFzBjFq08r9nmckhEi8R80fB5lDMi-5YehizQivOWSHgIaVK-Subk5oauZoGySGLKevHopGF7yOhmFQK6OYv2wvw-1Oj_TyBU9gGeq2KpyNnA3M-686jWb4Kk2T6uECMGUhhE_5Wvh8Xg3cCXq31DK-JMTXxV5yLxKAWOlNb_ruYHdppTgJtPYAsg_HCZhxWq-mgku8Y3eyc9CoEtf4pV1xESG5GW4Q1DbDnnF7qeNrzFiiCTKJzqgHzdg&sai=AMfl-YSeCBU_F_3WtEfTh5c3XzDTQhFOxch1vRZ1RnsZ-cg3IbyrcUlF-M8NYNar0JmWSdjUMoVvAu9N2RTdkNPRpouO1mLjWmHoyGTFQg&sig=Cg0ArKJSzKuJDYzit3jOEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
abg_lite_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/ Frame 4F88
23 KB
9 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/abg_lite_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
93028274da1d373cd41165f6a442568ddd482370e8093e45d14a4ad0f6981f19
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 22:52:51 GMT
content-encoding
br
x-content-type-options
nosniff
age
53129
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
9132
x-xss-protection
0
server
cafe
etag
17712579318771444318
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 22:52:51 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 4F88
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:46:20 GMT
content-encoding
br
x-content-type-options
nosniff
age
57120
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 21:46:20 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 4F88
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:20 GMT
16938130258688220793
tpc.googlesyndication.com/simgad/ Frame 4F88
45 KB
45 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16938130258688220793
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202307250102/pubads_impl.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3ebd87f2d77fd3e9e91c8428e779214c25477c750665d3683d57024155fda1d7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 01:29:22 GMT
x-content-type-options
nosniff
age
302938
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
45940
x-xss-protection
0
last-modified
Fri, 02 Jun 2023 15:20:36 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Fri, 26 Jul 2024 01:29:22 GMT
truncated
/ Frame 4F88
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ffcb40fbcac563fda59588771cdd7afa9caa4ef23c6376873228aa93b9ec120a

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576
sample.dragonforms.com/ Frame 394F
293 B
638 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=E39CE2057D09FC312ED576F49CABB576?demo227890=short&demo227891=&demo227892=&opt227896=1&demo227897=LS-FB-FORM-NSL-ShortForm&dragon_pagenumber=1&jsessionid=E39CE2057D09FC312ED576F49CABB576&timestemp=1690724300593&omedasite=LS_short
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.190 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
3861f9a97b280968f74ff648c5b31585999177de35d08f7e6ca5abe7e5a623a1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=LS_short
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Strict-Transport-Security
max-age=31536000
Date
Sun, 30 Jul 2023 13:38:25 GMT
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
293
X-XSS-Protection
1; mode=block
analytics.js
www.google-analytics.com/ Frame 394F
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Sun, 30 Jul 2023 11:44:24 GMT
last-modified
Mon, 12 Jun 2023 18:23:07 GMT
server
Golfe2
age
6836
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Sun, 30 Jul 2023 13:44:24 GMT
wigo-no-slot
sync.teads.tv/ Frame 197B
325 B
477 B
Document
General
Full URL
https://sync.teads.tv/wigo-no-slot
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.35.233.56 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-35-233-56.deploy.static.akamaitechnologies.com
Software
akka-http/10.2.10 /
Resource Hash
d85f6474893e823b6eb6ce2ad936235ff13be5d10d1c1dba6517f6dd3a731c59

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
max-age=0, no-cache, no-store
content-length
325
content-type
text/html; charset=UTF-8
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Sun, 30 Jul 2023 13:38:20 GMT
pragma
no-cache
server
akka-http/10.2.10
track
t.teads.tv/
23 B
104 B
Image
General
Full URL
https://t.teads.tv/track?action=placementCall&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&pageId=103428&pid=111933&debug_metadata=8uaJOG6ppI&fv=1226-for-5387&ts=1690724300685&f=1&referer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.23.193.36 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-23-193-36.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
cache-control
private, max-age=3666
content-length
23
content-type
image/gif
track
t.teads.tv/
23 B
134 B
Image
General
Full URL
https://t.teads.tv/track?action=slotAvailable&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&pageId=103428&pid=111933&slot=polymorph&fv=1226-for-5387&ts=1690724300696&f=1&referer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.23.193.36 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-23-193-36.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

expires
Sat, 26 Jul 1997 05:00:00 GMT
date
Sun, 30 Jul 2023 13:38:20 GMT
cache-control
max-age=0, no-cache, no-store
content-length
23
content-type
image/gif
adfetch
googleads.g.doubleclick.net/pagead/ Frame FD9F
170 KB
44 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
818502f001f9c69158b04d01ca0ddf5a83baf93615494415b06c564b426293d6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
44728
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
xbfe_backfill.js
googleads.g.doubleclick.net/pagead/ Frame 5F8C
7 KB
3 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/xbfe_backfill.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
41559d2aea8b60a1190d8489501bb6a3544ef6b4e0a8021406442bf4aaa6a1c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:39:39 GMT
content-encoding
br
x-content-type-options
nosniff
age
3521
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
3335
x-xss-protection
0
server
cafe
etag
8962344354712869959
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:39:39 GMT
45aacb7a-6d51-4322-8e4f-fb0e9783de89
a3352.casalemedia.com/impression/v2/859594/85/cj36fj2q64197eqmmbhg/ Frame 5F8C
43 B
303 B
Image
General
Full URL
https://a3352.casalemedia.com/impression/v2/859594/85/cj36fj2q64197eqmmbhg/45aacb7a-6d51-4322-8e4f-fb0e9783de89?verifieD=1&userID=&cmpro=0&deviceType=2&expiryTime=1690724900&profileIDs=&creativeID=17e348a&pubID=200223&format=banner&channel=site&ap=ZMZnzAAA4EQCO9u9AAeOuZHjZgBd5IIHvsp4nA
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
85.91.45.166 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:20 GMT
Server
Apache
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0
gen_204
pagead2.googlesyndication.com/pagead/ Frame 5F8C
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=awbid&awbid_b=AKAmf-ASM9KYFQS7Rg0Qi6iyBsxtSeqv5hFoPYj-7pkhi_HE5w5P8qWEwyqSTUTBOYF6nTvzdqpWmdTEm3CBhYXEMu6Z7safuw&pr=13:ZMZnzAAAAAAW3STGjpbd13r_Fsdsfm0tcwkJBQ
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 5F8C
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:46:20 GMT
content-encoding
br
x-content-type-options
nosniff
age
57120
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 21:46:20 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 5F8C
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8ecb4fb492aee0a820dfc4a395fb80e2ac2e864bbf38aa1ae28d6d70fb9e6da3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 07:27:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
22227
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8293
x-xss-protection
0
server
cafe
etag
11502554701003060455
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 07:27:53 GMT
l
www.google.com/ads/measurement/ Frame 5F8C
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQx-XF2_3B3anFSicMkQ27gWkcFiNu2oryzF9cC5NVuOovcQIkKrn-MADdI6LsvA3m9guMa4nrpzoEBtDc6Y3gRp090rg
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

ext.js
tpc.googlesyndication.com/safeframe/1-0-40/js/ Frame 5F8C
24 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-40/js/ext.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
08204982c484faf6890c60557a4e642971f17625ddddc0559dc0e3ca728ac9e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 16:30:13 GMT
content-encoding
br
x-content-type-options
nosniff
age
248887
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6402
x-xss-protection
0
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 26 Jul 2024 16:30:13 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 5F8C
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:20 GMT
adfetch
googleads.g.doubleclick.net/pagead/ Frame 81D0
170 KB
44 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a192bdb8325fc9b2baf91666d21176c29b63c99128d7accd7e3c874a1854daf7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
br
content-length
44829
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:20 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
xbfe_backfill.js
googleads.g.doubleclick.net/pagead/ Frame 59E0
7 KB
3 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/xbfe_backfill.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
41559d2aea8b60a1190d8489501bb6a3544ef6b4e0a8021406442bf4aaa6a1c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:39:39 GMT
content-encoding
br
x-content-type-options
nosniff
age
3521
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
3335
x-xss-protection
0
server
cafe
etag
8962344354712869959
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:39:39 GMT
61208356-fd28-4595-93d1-f589a9d8ab45
a5200.casalemedia.com/impression/v2/859594/85/cj36fj1aspusd5e9q6lg/ Frame 59E0
43 B
303 B
Image
General
Full URL
https://a5200.casalemedia.com/impression/v2/859594/85/cj36fj1aspusd5e9q6lg/61208356-fd28-4595-93d1-f589a9d8ab45?verifieD=1&userID=&cmpro=0&deviceType=2&expiryTime=1690724900&profileIDs=&creativeID=17e348a&pubID=200223&format=banner&channel=site&ap=ZMZnzAAA8acCO9t_AAtE9mQFX74p6ESmZVlnuQ
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
85.91.45.114 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:20 GMT
Server
Apache
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0
gen_204
pagead2.googlesyndication.com/pagead/ Frame 59E0
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=awbid&awbid_b=AKAmf-DivkoufMCnRPIL8nMrv5HcR8I54QfKrHM99vaMoHsHNR_-FPB6qzkLBMD_IdhW0mxXYPHYBm0CJrjTvjdtklucF_E5VA&pr=13:ZMZnzAAAAAAq0qGKuSMW4E_oPHNB29Vg8OK28A
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:20 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 59E0
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:46:20 GMT
content-encoding
br
x-content-type-options
nosniff
age
57120
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 21:46:20 GMT
qs_click_protection_fy2021.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 59E0
20 KB
8 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection_fy2021.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
8ecb4fb492aee0a820dfc4a395fb80e2ac2e864bbf38aa1ae28d6d70fb9e6da3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 07:27:53 GMT
content-encoding
br
x-content-type-options
nosniff
age
22227
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
8293
x-xss-protection
0
server
cafe
etag
11502554701003060455
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 07:27:53 GMT
l
www.google.com/ads/measurement/ Frame 59E0
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQ_QEUFMQ0-e1dCJn8OZjCO_KOe7ZQC4Tq7R2u9eIBqqEb5A3tJ0Ag-Gve2__NBAxv9iq3MUGHBlKkI3T89qY2OBXx2Og
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

ext.js
tpc.googlesyndication.com/safeframe/1-0-40/js/ Frame 59E0
24 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-40/js/ext.js
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
08204982c484faf6890c60557a4e642971f17625ddddc0559dc0e3ca728ac9e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 16:30:13 GMT
content-encoding
br
x-content-type-options
nosniff
age
248887
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6402
x-xss-protection
0
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 26 Jul 2024 16:30:13 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 59E0
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:20 GMT
iframe
sync.teads.tv/ Frame FD8C
153 B
305 B
Document
General
Full URL
https://sync.teads.tv/iframe?pid=111933&gdprIab={%22reason%22:220,%22status%22:22,%22consent%22:%22%22,%22apiVersion%22:null,%22cmpId%22:null}&fromFormat=true&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&1690724300740
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.35.233.56 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-35-233-56.deploy.static.akamaitechnologies.com
Software
akka-http/10.2.10 /
Resource Hash
716a727e47216ad28191f60fb09d59015b1bcb3df8cc32b5bb94f73d534a5732

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
max-age=0, no-cache, no-store
content-length
153
content-type
text/html; charset=UTF-8
date
Sun, 30 Jul 2023 13:38:20 GMT
expires
Sun, 30 Jul 2023 13:38:20 GMT
pragma
no-cache
server
akka-http/10.2.10
1009197
a.teads.tv/vast/get/
13 KB
6 KB
XHR
General
Full URL
https://a.teads.tv/vast/get/1009197?pid=111933
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
184.30.21.51 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a184-30-21-51.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
66d2ae6f0dd37ea1c071a5c32cdb63379674a4037262a1f179e5d9217b3068e8

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA, Sec-CH-UA-Full-Version-List, Sec-CH-UA-WoW64
access-control-max-age
1728000
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/xml; charset=UTF-8
access-control-allow-origin
https://www.fiercebiotech.com
vary
Accept-Encoding
access-control-allow-credentials
true
cache-control
max-age=0, no-cache, no-store
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Accept-Encoding, Accept-Language, Host, Referer, User-Agent
content-length
5339
expires
Sun, 30 Jul 2023 13:38:20 GMT
track
t.teads.tv/
23 B
134 B
Image
General
Full URL
https://t.teads.tv/track?action=adReceived&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&pageId=103428&pid=111933&slot=polymorph&fv=1226-for-5387&ts=1690724300743&f=1&referer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.23.193.36 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-23-193-36.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

expires
Sat, 26 Jul 1997 05:00:00 GMT
date
Sun, 30 Jul 2023 13:38:20 GMT
cache-control
max-age=0, no-cache, no-store
content-length
23
content-type
image/gif
usermatch
ssum-sec.casalemedia.com/ Frame 13E0
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
  • https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
2 KB
2 KB
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
ad468a8c90a205765dae08a05886e3e9ce8a155e7b0ad5e289ca131562e0842f

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Cache-Control
no-cache
Connection
Keep-Alive
Content-Length
1823
Content-Type
text/html
Date
Sun, 30 Jul 2023 13:38:21 GMT
Expires
0
Keep-Alive
timeout=1, max=499
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Pragma
no-cache
Server
Apache

Redirect headers

Cache-Control
no-cache
Connection
Keep-Alive
Content-Length
0
Date
Sun, 30 Jul 2023 13:38:20 GMT
Expires
0
Keep-Alive
timeout=1, max=500
Location
/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Pragma
no-cache
Server
Apache
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame 0258
1 KB
643 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
79520
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sat, 29 Jul 2023 15:33:00 GMT
etag
48472445140208031
expires
Sun, 30 Jul 2023 15:33:00 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
css
fonts.googleapis.com/ Frame C574
2 KB
975 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
c4f393315ffc75417c9c350e709bbcca2d2e9d5640fa0925b32088ff1ed6c84f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 30 Jul 2023 12:27:49 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 30 Jul 2023 13:38:20 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 394F
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50595
x-xss-protection
0
server
cafe
etag
13298127312233461908
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:20 GMT
truncated
/ Frame 34E2
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5f8237942a2a3f26d6570af6d5f28ead053dc54f18fb19c4785e50ebafd202dc

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 4F88
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuxhvnYMwuBYGCItpFzh-HWLiycEiQIKJtpljkm4NfcgwPJb4f3Y0C-QmHwm0_uuWAuzWuex8Lslmrmna9DmnYV8gVkjz77Aq80rmOeIjCP1-x6K91SIc3LU8tBxXFqqIu3vZ9HHNmFvfF5ouScBXGSI6zbbTC0zRaTLY0BhQBbKGfiEkOmGDLErDXBh3uRPCej7muvnxurKoIiQf6jTibHe4JKPAV2pvXfZs6Z6x-Tdd1-__4BXTw5IgzNxDrLioSnB4lVJC7e7JccCRSfe3SuMRaE92LKrhYB0-kTZdf4OeIfAZoBbtkbBOxv8cSBxWc6_Hm71jkSR1Yw7v0SXDHevQ-rJDhKyaDNEnRRIOvckOCSKSItYDqw9w&sai=AMfl-YRgpRoK-sjwJ7RIvjCgKBvsCJ614WncmI-ZKkVonvtOzX1ADchTJceSH_XIIUS6bAv7DenwtCv8FgKBB6GF4zy5r9so2crdFVbQGQ&sig=Cg0ArKJSzEG-M63sxgMlEAE&uach_m=[UACH]&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Sun, 30 Jul 2023 13:38:21 GMT
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
232 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/469645/hbw_master_748754_18090.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.226 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercebiotech.com
Date
Sun, 30 Jul 2023 13:38:20 GMT
Access-Control-Allow-Credentials
true
Server
Adtelligent
Connection
Keep-Alive
X-Robots-Tag
noindex
truncated
/
669 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/ Frame 60AF
669 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/svg+xml
track
t.teads.tv/
23 B
134 B
Image
General
Full URL
https://t.teads.tv/track?action=adAvailable-success&env=js-web&auctid=23d3f306-c92a-43c3-9705-abb66206f21d&pageId=103428&pid=111933&slot=polymorph&gid=1009197&fv=1226-for-5387&ts=1690724301109&f=1&referer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.23.193.36 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-23-193-36.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

expires
Sat, 26 Jul 1997 05:00:00 GMT
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
max-age=0, no-cache, no-store
content-length
23
content-type
image/gif
load_preloaded_resource.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame C574
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/load_preloaded_resource.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e0b374d64219f25c480983127d46b1dad0d87e14292b621df9205a2c3c5ce98a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 05:58:16 GMT
content-encoding
br
x-content-type-options
nosniff
age
27605
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1247
x-xss-protection
0
server
cafe
etag
9347959128929567288
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 05:58:16 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/ Frame C574
30 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/abg_lite.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0b2c524428c1a3604e3d1cdc61c2ae371a8f2fc767f801180fcf892db9e07c3c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:15:21 GMT
content-encoding
br
x-content-type-options
nosniff
age
4980
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11572
x-xss-protection
0
server
cafe
etag
5014499061205845695
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:15:21 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame C574
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
88a577b7767cbe34315ff67366be5530949df573931dd9c762c2c2e0434c5b8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:28:50 GMT
content-encoding
br
x-content-type-options
nosniff
age
4171
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1307
x-xss-protection
0
server
cafe
etag
18393213423120915576
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:28:50 GMT
qs_click_protection.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame C574
29 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f6c4d62e7e9acc1725e7ca85db6ba03fd8258f16e06379e347ecd365c3d0a6f7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 23:17:17 GMT
content-encoding
br
x-content-type-options
nosniff
age
51664
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11370
x-xss-protection
0
server
cafe
etag
15119446580465774222
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 23:17:17 GMT
l
www.google.com/ads/measurement/ Frame C574
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSM24mWt1hPa8GHj3hEENCV8uxYaE1orNPBlmcrHGWV7V5DG-RjpRFoCDE1xOlWMko_86w2BuoSdXvJxb-ZOoqxTLz1ig
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame C574
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:21 GMT
a4344c90b121f03676c437e2d16524c7.js
www.gstatic.com/mysidia/ Frame C574
49 KB
19 KB
Script
General
Full URL
https://www.gstatic.com/mysidia/a4344c90b121f03676c437e2d16524c7.js?tag=mysidia_one_click_handler_one_afma
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c68a092cd58255720dd1f42499305d5a18ab3980c0c5b627fdfd4a9b54a6a4ab
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 05:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
202361
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/mysidia
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
19025
x-xss-protection
0
last-modified
Fri, 28 Jul 2023 03:44:05 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="mysidia"
vary
Accept-Encoding
report-to
{"group":"mysidia","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/mysidia"}]}
content-type
text/javascript
cache-control
public, max-age=7776000
accept-ranges
bytes
expires
Thu, 26 Oct 2023 05:25:40 GMT
css
fonts.googleapis.com/ Frame FD9F
2 KB
662 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
c4f393315ffc75417c9c350e709bbcca2d2e9d5640fa0925b32088ff1ed6c84f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 30 Jul 2023 12:20:56 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 30 Jul 2023 13:38:21 GMT
load_preloaded_resource.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame FD9F
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/load_preloaded_resource.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e0b374d64219f25c480983127d46b1dad0d87e14292b621df9205a2c3c5ce98a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 05:58:16 GMT
content-encoding
br
x-content-type-options
nosniff
age
27605
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1247
x-xss-protection
0
server
cafe
etag
9347959128929567288
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 05:58:16 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/ Frame FD9F
30 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/abg_lite.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0b2c524428c1a3604e3d1cdc61c2ae371a8f2fc767f801180fcf892db9e07c3c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:15:21 GMT
content-encoding
br
x-content-type-options
nosniff
age
4980
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11572
x-xss-protection
0
server
cafe
etag
5014499061205845695
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:15:21 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame FD9F
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
88a577b7767cbe34315ff67366be5530949df573931dd9c762c2c2e0434c5b8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:28:50 GMT
content-encoding
br
x-content-type-options
nosniff
age
4171
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1307
x-xss-protection
0
server
cafe
etag
18393213423120915576
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:28:50 GMT
qs_click_protection.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame FD9F
29 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f6c4d62e7e9acc1725e7ca85db6ba03fd8258f16e06379e347ecd365c3d0a6f7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 23:17:17 GMT
content-encoding
br
x-content-type-options
nosniff
age
51664
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11370
x-xss-protection
0
server
cafe
etag
15119446580465774222
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 23:17:17 GMT
l
www.google.com/ads/measurement/ Frame FD9F
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSVBKFZfa8FJaPiQkAajpMDfHdoKDwjHmNt7ZUE4hHp1FUOtfp8h-PqhCU1eol3JseCEQTsTlHjCZnqsjNnCETmNN1Fbw
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame FD9F
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:21 GMT
a4344c90b121f03676c437e2d16524c7.js
www.gstatic.com/mysidia/ Frame FD9F
49 KB
19 KB
Script
General
Full URL
https://www.gstatic.com/mysidia/a4344c90b121f03676c437e2d16524c7.js?tag=mysidia_one_click_handler_one_afma
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c68a092cd58255720dd1f42499305d5a18ab3980c0c5b627fdfd4a9b54a6a4ab
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 05:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
202361
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/mysidia
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
19025
x-xss-protection
0
last-modified
Fri, 28 Jul 2023 03:44:05 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="mysidia"
vary
Accept-Encoding
report-to
{"group":"mysidia","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/mysidia"}]}
content-type
text/javascript
cache-control
public, max-age=7776000
accept-ranges
bytes
expires
Thu, 26 Oct 2023 05:25:40 GMT
css
fonts.googleapis.com/ Frame 81D0
2 KB
639 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
c4f393315ffc75417c9c350e709bbcca2d2e9d5640fa0925b32088ff1ed6c84f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 30 Jul 2023 12:27:10 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 30 Jul 2023 13:38:21 GMT
load_preloaded_resource.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 81D0
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/load_preloaded_resource.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e0b374d64219f25c480983127d46b1dad0d87e14292b621df9205a2c3c5ce98a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 05:58:16 GMT
content-encoding
br
x-content-type-options
nosniff
age
27605
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1247
x-xss-protection
0
server
cafe
etag
9347959128929567288
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 05:58:16 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/ Frame 81D0
30 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/abg_lite.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0b2c524428c1a3604e3d1cdc61c2ae371a8f2fc767f801180fcf892db9e07c3c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:15:21 GMT
content-encoding
br
x-content-type-options
nosniff
age
4980
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11572
x-xss-protection
0
server
cafe
etag
5014499061205845695
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:15:21 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 81D0
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/window_focus.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
88a577b7767cbe34315ff67366be5530949df573931dd9c762c2c2e0434c5b8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:28:50 GMT
content-encoding
br
x-content-type-options
nosniff
age
4171
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1307
x-xss-protection
0
server
cafe
etag
18393213423120915576
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sun, 13 Aug 2023 12:28:50 GMT
qs_click_protection.js
tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/ Frame 81D0
29 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20230726/r20110914/client/qs_click_protection.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f6c4d62e7e9acc1725e7ca85db6ba03fd8258f16e06379e347ecd365c3d0a6f7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 23:17:17 GMT
content-encoding
br
x-content-type-options
nosniff
age
51664
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11370
x-xss-protection
0
server
cafe
etag
15119446580465774222
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Sat, 12 Aug 2023 23:17:17 GMT
l
www.google.com/ads/measurement/ Frame 81D0
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQpr4_I4F-sg99uhctFwQj0ML5HKWKMLh9GY1eWabwTBNzAKh6EyAJpIQrmqOheiiP1t7R_SjV5Kfkiwa2HAOsdrzNV-w
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 81D0
179 KB
56 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
57355
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1690371356542162"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:21 GMT
a4344c90b121f03676c437e2d16524c7.js
www.gstatic.com/mysidia/ Frame 81D0
49 KB
19 KB
Script
General
Full URL
https://www.gstatic.com/mysidia/a4344c90b121f03676c437e2d16524c7.js?tag=mysidia_one_click_handler_one_afma
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c68a092cd58255720dd1f42499305d5a18ab3980c0c5b627fdfd4a9b54a6a4ab
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 05:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
202361
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/mysidia
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
19025
x-xss-protection
0
last-modified
Fri, 28 Jul 2023 03:44:05 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="mysidia"
vary
Accept-Encoding
report-to
{"group":"mysidia","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/mysidia"}]}
content-type
text/javascript
cache-control
public, max-age=7776000
accept-ranges
bytes
expires
Thu, 26 Oct 2023 05:25:40 GMT
storage-delegate.html
creative.spotible.com/tag/ Frame B071
595 B
695 B
Document
General
Full URL
https://creative.spotible.com/tag/storage-delegate.html
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
d04a32ce120b54e1fc49a0d736454d4a0e9d50963a01323dec083980e9723907

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
public, max-age=3600
content-length
595
content-type
text/html
date
Sun, 30 Jul 2023 13:38:20 GMT
etag
"4e0f2369c49a43fdfda11c23de32be0f"
delivery.js
creative.spotible.com/creative/F0xc/
78 KB
26 KB
Script
General
Full URL
https://creative.spotible.com/creative/F0xc/delivery.js?referrer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
0f419f9cd92714729152f780c08164bbb1393aeae2ac23b140e0b3f617ee6250

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:20 GMT
cache-control
no-cache
content-encoding
gzip
etag
"17795185fc471e5526dcd3e365ee2639_gz"
vary
accept-encoding
content-type
text/javascript;charset=utf-8
gpt.js
www.googletagservices.com/tag/js/ Frame 394F
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
27649
x-xss-protection
0
server
cafe
etag
785 / 19568 / 31076567 / config-hash: 5693953215715342715
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:21 GMT
pixel
cm.g.doubleclick.net/ Frame 13E0
170 B
409 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=index&google_cm&google_hm=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gdpr_consent=&us_privacy=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
crum
dsum-sec.casalemedia.com/ Frame 13E0
Redirect Chain
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
341
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
dcm
s.amazon-adsystem.com/ Frame 13E0
Redirect Chain
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
43 B
568 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
HTTP/1.1
Server
52.46.155.104 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:22 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
027W0Q0ABPNFA0X01NBE
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
83B8YE14M58NYVXR9HWJ
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Location
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
casale
match.adsrvr.org/track/cmf/ Frame 13E0
70 B
264 B
Image
General
Full URL
https://match.adsrvr.org/track/cmf/casale?gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.33.220.150 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a12b7a488abeaa9e4.awsglobalaccelerator.com
Software
/
Resource Hash
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
private,no-cache, must-revalidate
x-aspnet-version
4.0.30319
content-length
70
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
rum
dsum-sec.casalemedia.com/ Frame 13E0
Redirect Chain
  • https://cms.quantserve.com/pixel/p-Z8PuJEk6U7Hyq.gif?idmatch=0&gdpr=1
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=Xd8YaV3cGDtG0k5vCttWOVuOHj5G0x45WI1Mc_7f
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=Xd8YaV3cGDtG0k5vCttWOVuOHj5G0x45WI1Mc_7f
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=497
Content-Length
43
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=86400
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=Xd8YaV3cGDtG0k5vCttWOVuOHj5G0x45WI1Mc_7f
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
0
expires
Fri, 04 Aug 1978 12:00:00 GMT
ibs:dpid=23728&dpuuid=ZMZnzDmk.f3TY-1Sf2WW4QAA%263213
dpm.demdex.net/ Frame 13E0
0
0
Image
General
Full URL
https://dpm.demdex.net/ibs:dpid=23728&dpuuid=ZMZnzDmk.f3TY-1Sf2WW4QAA%263213?gdpr_consent=&us_privacy=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.200.152.171 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-200-152-171.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

rum
dsum.casalemedia.com/ Frame 13E0
Redirect Chain
  • https://casale-match.dotomi.com/match/bounce/current?networkId=19998&version=1&gdpr=1
  • https://dsum.casalemedia.com/rum?cm_dsp_id=65&external_user_id=&expiration=1690810701&gdpr=1
43 B
632 B
Image
General
Full URL
https://dsum.casalemedia.com/rum?cm_dsp_id=65&external_user_id=&expiration=1690810701&gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0

Redirect headers

location
https://dsum.casalemedia.com/rum?cm_dsp_id=65&external_user_id=&expiration=1690810701&gdpr=1
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
no-cache, private, max-age=0, no-store
server
nginx
content-length
0
expires
0
tp_out
d.adroll.com/cm/index/ Frame 13E0
42 B
180 B
Image
General
Full URL
https://d.adroll.com/cm/index/tp_out?advertisable=3GMDZMBFQREVBC75SYYKWH&gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:d018:cc3:fe04:94a6:fd27:12f4:717e Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.22.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
no-transform,public,max-age=300,s-maxage=900
server
nginx/1.22.1
content-length
42
vary
Cookie
content-type
image/gif
htw-pixel.gif
js-sec.indexww.com/ht/ Frame 13E0
43 B
352 B
Image
General
Full URL
https://js-sec.indexww.com/ht/htw-pixel.gif?ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=&C=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.10.47 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cf-cache-status
HIT
last-modified
Tue, 24 Jan 2017 19:36:04 GMT
server
cloudflare
age
1116
etag
"761e21-2b-546dc3a097100"
vary
Accept-Encoding
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
edge-control
cache-maxage=1h
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
7eee00650ae837dd-FRA
content-length
43
expires
Sun, 30 Jul 2023 17:38:21 GMT
540_940.mp4
cdn2.teads.tv/scala/1083571/17e695875816c05e21a1179679e301de/ Frame 1B09
144 KB
0
Media
General
Full URL
https://cdn2.teads.tv/scala/1083571/17e695875816c05e21a1179679e301de/540_940.mp4
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.35.233.56 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-35-233-56.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Accept-Encoding
identity;q=1, *;q=0
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Range
bytes=0-

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
last-modified
Mon, 24 Jul 2023 16:37:44 GMT
server
AmazonS3
x-amz-request-id
96M83702TV8REK1E
etag
"1df3f4427f5b39b5e0c1ffd572babb03"
x-amz-server-side-encryption
AES256
content-type
video/mp4
access-control-allow-origin
*
Content-Range
bytes 0-290453/290454
cache-control
private, max-age=31536000
accept-ranges
bytes
Content-Length
290454
x-amz-id-2
klkvcxaKvarTdHiFgxhymHBG6aWjESrMBjRzACUiPBa8c34sFLAOqvWmJUb9uXnzrpGR89zKRwA=
expires
Mon, 29 Jul 2024 13:38:21 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame C574
35 KB
36 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcTdrJUEVTuT9KR0pObOtUdwJhVqp7sW4epjwPR92VP5mZMSEpQB9ync38BcK4k&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ac5819dc7e9882d90e5ac18e79faf3bf3fb69bc916b3c6918879b9b8faa40ca8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 01:09:54 GMT
x-content-type-options
nosniff
age
44907
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36029
x-xss-protection
0
last-modified
Sat, 15 Apr 2023 19:48:33 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Mon, 29 Jul 2024 01:09:54 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame C574
29 KB
30 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcTT7eYosRtF_55Pel9bpKjpFQOP-sT8wnE-Ypjiqa3IYT_xOqtzhrls_lis1e4&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8056b4c761c0b2608915c5766eebbc2bb28bd4d9a66649b396730f403dd10e2a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:26:59 GMT
x-content-type-options
nosniff
age
58282
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
30100
x-xss-protection
0
last-modified
Fri, 01 Mar 2024 03:06:06 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 21:26:59 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame C574
41 KB
42 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcT8iO2U7CO6_upTvYhkHFbNF9wg4lPfOd5hFOv8qO1KA37qdwGVTd1g0TKe0EM&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
15956d2c3095d247b78831890d6535c7a33fe83bd3b049133a438ee959d48556
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 00:52:18 GMT
x-content-type-options
nosniff
age
132363
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42411
x-xss-protection
0
last-modified
Mon, 31 Jul 2023 03:53:37 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 00:52:18 GMT
shopping
encrypted-tbn3.gstatic.com/ Frame C574
21 KB
21 KB
Image
General
Full URL
https://encrypted-tbn3.gstatic.com/shopping?q=tbn:ANd9GcRIaY7kkadXH5SnlwEzjfQvrLiMs6XG1s57u90OJ5mcmOp0g1dng9fwWgDnjg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9dffa69c86b42874d87a4f145f153ab01f6e6d726fc47cd887b95cad3c523f82
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 19:37:45 GMT
x-content-type-options
nosniff
age
151236
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
21470
x-xss-protection
0
last-modified
Fri, 04 Nov 2022 07:07:04 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sat, 27 Jul 2024 19:37:45 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame C574
17 KB
18 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcT6_S5ME8gkvajDvLqNuP-3QLBmVklQHQdK8qlW7pFzqTjDfqiwz8sSukeOEg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8503954201ae92ce8050534484ff98b82fd4c68b48c7b42b4888d165b4f173c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 21:07:27 GMT
x-content-type-options
nosniff
age
232254
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17890
x-xss-protection
0
last-modified
Fri, 21 Apr 2023 23:51:18 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 21:07:27 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame C574
24 KB
24 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcQr-5ahTYvIlXvds8EbFmto5uLPfsujVLusJ7SK2TtywGhPd_pHmF5Go4eLhT0&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d4a4bd1836268e9c59e5a61d99fc72173b66d4122556a3f35494ee6de0fd6bf9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 14:24:47 GMT
x-content-type-options
nosniff
age
256414
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24392
x-xss-protection
0
last-modified
Mon, 16 Jan 2023 23:28:54 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 14:24:47 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame C574
19 KB
20 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcRELcTOUFgxnInVlUB-w2wySehd9gjUOk1nsKK6faRAgMO5eMCw13-Kfkw1qm8&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
73087a4e156ffd1207ac58c9cf3a3e3f5bd3288017c9eb8364df6a12bed5fb13
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 08:47:05 GMT
x-content-type-options
nosniff
age
103876
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
19876
x-xss-protection
0
last-modified
Fri, 16 Feb 2024 17:11:24 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 08:47:05 GMT
shopping
encrypted-tbn3.gstatic.com/ Frame C574
46 KB
46 KB
Image
General
Full URL
https://encrypted-tbn3.gstatic.com/shopping?q=tbn:ANd9GcTFWfYe548w92KW6qpVgakvu4XgpNFjZNKd1nVAMj9cIomSN5a5XpPKZ2_cCQ&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e0dcfebee962c0c8ec488c8d64e708fff2fb2712f2970698c8e7af26570e79f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 01:09:45 GMT
x-content-type-options
nosniff
age
44916
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
46892
x-xss-protection
0
last-modified
Tue, 30 Jan 2024 18:54:16 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Mon, 29 Jul 2024 01:09:45 GMT
3995853839924061625
tpc.googlesyndication.com/simgad/ Frame C574
Redirect Chain
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
77 KB
77 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3995853839924061625
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
87a92e159459b46d503d7ca9301e076e886bf1eb91abaae349f8b6a69deb2571
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 07:44:21 GMT
x-content-type-options
nosniff
age
107640
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79088
x-xss-protection
0
last-modified
Mon, 24 Apr 2023 17:15:20 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Sun, 28 Jul 2024 07:44:21 GMT

Redirect headers

date
Sat, 29 Jul 2023 20:25:22 GMT
x-content-type-options
nosniff
server
cafe
age
61979
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
location
https://tpc.googlesyndication.com/simgad/3995853839924061625
content-type
text/html; charset=UTF-8
cache-control
public, max-age=2592000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Mon, 28 Aug 2023 20:25:22 GMT
usermatch
ssum-sec.casalemedia.com/ Frame 55B9
2 KB
3 KB
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
80c19f8e41b3c27da8dadd95c33434fff889c54332ad6ea87f44711c1edb8f47

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Cache-Control
no-cache
Connection
Keep-Alive
Content-Length
1847
Content-Type
text/html
Date
Sun, 30 Jul 2023 13:38:21 GMT
Expires
0
Keep-Alive
timeout=1, max=498
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Pragma
no-cache
Server
Apache
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame DB83
1 KB
643 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
79521
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sat, 29 Jul 2023 15:33:00 GMT
etag
48472445140208031
expires
Sun, 30 Jul 2023 15:33:00 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
truncated
/ Frame 5F8C
219 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8149596c69a0006b78550042ddfbb6591a08ba4595dde390bbd3ccc3e904bdec

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
usermatch
ssum-sec.casalemedia.com/ Frame 61DA
2 KB
3 KB
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
5c9b4d60d249c0af9b6635bfcacbc6fc4346168ece6a7d03413326490d3b6b48

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Cache-Control
no-cache
Connection
Keep-Alive
Content-Length
1922
Content-Type
text/html
Date
Sun, 30 Jul 2023 13:38:21 GMT
Expires
0
Keep-Alive
timeout=1, max=497
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Pragma
no-cache
Server
Apache
cookie_push_onload.html
pagead2.googlesyndication.com/pagead/s/ Frame 1D56
1 KB
643 B
Document
General
Full URL
https://pagead2.googlesyndication.com/pagead/s/cookie_push_onload.html
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
79521
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=86400
content-encoding
br
content-length
618
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Sat, 29 Jul 2023 15:33:00 GMT
etag
48472445140208031
expires
Sun, 30 Jul 2023 15:33:00 GMT
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
truncated
/ Frame 59E0
221 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ca71dc26c7fbc6bebb241337131f300bdfdb32c070a47739c5af541e3fa62c2a

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
pixel
cm.g.doubleclick.net/ Frame 0258
Redirect Chain
  • https://sync.mathtag.com/sync/img?mt_exid=4&google_gid=CAESEBlBLWQW1-tdpshy0P-AMJE&google_cver=1&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOx...
  • https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOxrsoQ4amlygil
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOxrsoQ4amlygil
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
MT3 1031 59fd23a master cdg cdg-pixel-x35 config_version:"1438"
Content-Type
image/gif
Access-Control-Allow-Origin
*
location
https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGH1sKmjy18-xRtLDHdkAhwts6m4f6AScV2y4k5S8bYfwDI5vh6JcfVmu0l9c4lVjlr_ZNe3xqz1loPy6bOxrsoQ4amlygil
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=360
Content-Length
0
Expires
Sun, 30 Jul 2023 13:38:20 GMT
i.match
s.tribalfusion.com/z/ Frame 0258
Redirect Chain
  • https://a.tribalfusion.com/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z&...
  • https://s.tribalfusion.com/z/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8...
43 B
447 B
Image
General
Full URL
https://s.tribalfusion.com/z/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z&redirect=https%3A//cm.g.doubleclick.net/pixel%3Fgoogle_nid%3Dexp%26google_push%3DAaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z%26google_ula%3D2786954%26google_hm%3D%24TF_USER_ID_ENC%24
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Server
2606:4700::6812:18ad , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e586a84d8523747f42e510d78e141015b6424cf67d612854e892a7bcedc8ec9e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
cf-cache-status
DYNAMIC
x-function
302
server
cloudflare
content-type
image/gif; charset=utf-8
p3p
CP="NOI DEVo TAIa OUR BUS"
cache-control
no-cache, private
cf-ray
7eee0066bed9362d-FRA
alt-svc
h3=":443"; ma=86400
content-length
43
expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cf-cache-status
DYNAMIC
x-function
206
server
cloudflare
x-reuse-index
498
content-type
text/html
location
https://s.tribalfusion.com/z/i.match?p=b6&u=CAESEEcY9nA_IORp51a7Mu_M_WE&google_cver=1&google_push=AaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z&redirect=https%3A//cm.g.doubleclick.net/pixel%3Fgoogle_nid%3Dexp%26google_push%3DAaAOQGEsiDyIhiVaZbJ4kyyS9Nq2rPe0NffW1v5i4C6PBwDdf9m_OooUzZReEep13s8dDYd2jVFk6smhrDn_PLWPEWZh9VQOIz8Z%26google_ula%3D2786954%26google_hm%3D%24TF_USER_ID_ENC%24
p3p
CP="NOI DEVo TAIa OUR BUS"
cache-control
no-cache, private
cf-ray
7eee00650bbc362d-FRA
alt-svc
h3=":443"; ma=86400
expires
Thu, 01 Jan 1970 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 0258
Redirect Chain
  • https://um.simpli.fi/gp_match?google_gid=CAESEAeyuywbpuMAyugtYz8iylM&google_cver=1&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4KG8HuZME2A54D
  • https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=410A3CBD210E4ECBBFCB28FB6E2B2B6B&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=410A3CBD210E4ECBBFCB28FB6E2B2B6B&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4KG8HuZME2A54D
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=410A3CBD210E4ECBBFCB28FB6E2B2B6B&google_push=AaAOQGGPgOz6bFwVBJzTTBcCIUvYYejOEw8xTdwmqOcnbJoPGXrKNG6r7_4RGX8yPcAZmFWSKC4M2TCOnFXlFf4KG8HuZME2A54D
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Sat, 29 Jul 2023 13:38:21 GMT
usersync.aspx
dis.criteo.com/dis/ Frame 0258
43 B
363 B
Image
General
Full URL
https://dis.criteo.com/dis/usersync.aspx?r=4&p=14&cp=google&cu=1&url=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcjp%26google_hm%3D%40%40CRITEO_USERID%40%40%26google_push%3DAaAOQGE2YIpZ-cuWHEIPdSvc1yXt6nICz1mbymm0crJU8QMMtbygT0ku3uVrtbFi08k0nL5srtSmOEk-XbVKTB5BYTp4Dppp7gyT&google_gid=CAESELpUG4yzpUT0fwVE7JwRBAw&google_cver=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.1.9 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
Kestrel /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:20 GMT
x-errorlevel
0
strict-transport-security
max-age=31536000; preload;
server
Kestrel
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-cache
cross-origin-resource-policy
cross-origin
server-processing-duration-in-ticks
241563
expires
Sun, 30 Jul 2023 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 0258
Redirect Chain
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mp...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGGukPmGMD5BZjaZWn7v1yieDqzoM-IOuMF2QgPgHYomvIFjtUIob6YP5swvC6I97KE47NwI6FXdZLIvRCFf3HzMSEzw0Dg2
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGGukPmGMD5BZjaZWn7v1yieDqzoM-IOuMF2QgPgHYomvIFjtUIob6YP5swvC6I97KE47NwI6FXdZLIvRCFf3HzMSEzw0Dg2
date
Sun, 30 Jul 2023 13:38:21 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
0
content-type
text/html; charset=UTF-8
pixel
cm.g.doubleclick.net/ Frame 0258
Redirect Chain
  • https://match.360yield.com/match/ebda?google_gid=CAESELa9wR9sLoOkC9yBg-E0TdM&google_cver=1&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532P...
  • https://match.360yield.com/ul_cb/match/ebda?google_gid=CAESELa9wR9sLoOkC9yBg-E0TdM&google_cver=1&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKL...
  • https://cm.g.doubleclick.net/pixel?google_nid=improve_digital_eb&google_hm=YsyrKksXT_OeeUJc5KUDHQ&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxK...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=improve_digital_eb&google_hm=YsyrKksXT_OeeUJc5KUDHQ&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532PuRAG0r
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=improve_digital_eb&google_hm=YsyrKksXT_OeeUJc5KUDHQ&google_push=AaAOQGFv4V4VPNAqVCHe1150J81TYxKrfZk4dEDt13Otd9r7AohEEjT64JWdqBPCO3C_u8Oqodvyi9zXR5yBTxKLYu532PuRAG0r
access-control-allow-origin
*
date
Sun, 30 Jul 2023 13:38:21 GMT
content-type
text/plain
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
pixel
cm.g.doubleclick.net/ Frame 0258
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&google_gid=CAESEJ...
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&zcc=1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&redir=https%3A%2F%2Fcm.g.double...
  • https://sync.targeting.unrulymedia.com/csync/RX-1d7b6303-569c-4993-ae31-08396ea207ef-003?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3DAaAOQGEEPaFn2RnzCkvWxGi6K...
  • https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&google_hm=Ax17YwNWnEmTrjEIOW6iB-8
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&google_hm=Ax17YwNWnEmTrjEIOW6iB-8
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEEPaFn2RnzCkvWxGi6KnqSVZSQQMW_4KgpnMWq_YBUYK3anvNNe1uGLMntQp-_LGhcdT3OD3WArotloFobvqeWXLQWXT4&google_hm=Ax17YwNWnEmTrjEIOW6iB-8
date
Sun, 30 Jul 2023 13:38:21 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RX1d7b6303569c4993ae3108396ea207ef003
content-type
text/html
attr
cm.g.doubleclick.net/pixel/ Frame 0258
0
50 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13KyYj2Uf0P1GdGsZnLjJm9IoOZ3fk7q_D0DUp4n6WMwfH4e7XNW3C3H1rkeIlvhQq-ZzDLd
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
shopping
encrypted-tbn0.gstatic.com/ Frame FD9F
29 KB
29 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcTT7eYosRtF_55Pel9bpKjpFQOP-sT8wnE-Ypjiqa3IYT_xOqtzhrls_lis1e4&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8056b4c761c0b2608915c5766eebbc2bb28bd4d9a66649b396730f403dd10e2a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:26:59 GMT
x-content-type-options
nosniff
age
58282
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
30100
x-xss-protection
0
last-modified
Fri, 01 Mar 2024 03:06:06 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 21:26:59 GMT
shopping
encrypted-tbn3.gstatic.com/ Frame FD9F
21 KB
21 KB
Image
General
Full URL
https://encrypted-tbn3.gstatic.com/shopping?q=tbn:ANd9GcRIaY7kkadXH5SnlwEzjfQvrLiMs6XG1s57u90OJ5mcmOp0g1dng9fwWgDnjg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9dffa69c86b42874d87a4f145f153ab01f6e6d726fc47cd887b95cad3c523f82
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 19:37:45 GMT
x-content-type-options
nosniff
age
151236
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
21470
x-xss-protection
0
last-modified
Fri, 04 Nov 2022 07:07:04 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sat, 27 Jul 2024 19:37:45 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame FD9F
35 KB
35 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcTdrJUEVTuT9KR0pObOtUdwJhVqp7sW4epjwPR92VP5mZMSEpQB9ync38BcK4k&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ac5819dc7e9882d90e5ac18e79faf3bf3fb69bc916b3c6918879b9b8faa40ca8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 01:09:54 GMT
x-content-type-options
nosniff
age
44907
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36029
x-xss-protection
0
last-modified
Sat, 15 Apr 2023 19:48:33 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Mon, 29 Jul 2024 01:09:54 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame FD9F
41 KB
41 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcT8iO2U7CO6_upTvYhkHFbNF9wg4lPfOd5hFOv8qO1KA37qdwGVTd1g0TKe0EM&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
15956d2c3095d247b78831890d6535c7a33fe83bd3b049133a438ee959d48556
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 00:52:18 GMT
x-content-type-options
nosniff
age
132363
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42411
x-xss-protection
0
last-modified
Mon, 31 Jul 2023 03:53:37 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 00:52:18 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame FD9F
24 KB
24 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcQr-5ahTYvIlXvds8EbFmto5uLPfsujVLusJ7SK2TtywGhPd_pHmF5Go4eLhT0&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d4a4bd1836268e9c59e5a61d99fc72173b66d4122556a3f35494ee6de0fd6bf9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 14:24:47 GMT
x-content-type-options
nosniff
age
256414
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24392
x-xss-protection
0
last-modified
Mon, 16 Jan 2023 23:28:54 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 14:24:47 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame FD9F
17 KB
18 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcT6_S5ME8gkvajDvLqNuP-3QLBmVklQHQdK8qlW7pFzqTjDfqiwz8sSukeOEg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8503954201ae92ce8050534484ff98b82fd4c68b48c7b42b4888d165b4f173c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 21:07:27 GMT
x-content-type-options
nosniff
age
232254
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17890
x-xss-protection
0
last-modified
Fri, 21 Apr 2023 23:51:18 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 21:07:27 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame FD9F
17 KB
17 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcQlITqF9uln1qUrybL7ADoJBvxf7GQdRo-3Ns41nVPUk7TYLR8nHAp5XNAhdUI&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e0f887fbf8f31f2602ee1b897ede24e2e37e19a9e620f617e185816ec023afdb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 19:22:41 GMT
x-content-type-options
nosniff
age
152140
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
16958
x-xss-protection
0
last-modified
Thu, 30 Mar 2023 02:20:43 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sat, 27 Jul 2024 19:22:41 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame FD9F
20 KB
20 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcSAd_4QA2AFsi9GLGeNGm--Hk0apgruQnxqhp3QxV8MYEsyasYanoPpodACtw&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b4faac680e6757159c6365d482309c52c1285489df688c01c724fcef5f185fc3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 01:10:40 GMT
x-content-type-options
nosniff
age
44861
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20240
x-xss-protection
0
last-modified
Tue, 06 Feb 2024 07:16:23 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Mon, 29 Jul 2024 01:10:40 GMT
3995853839924061625
tpc.googlesyndication.com/simgad/ Frame FD9F
Redirect Chain
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
77 KB
77 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3995853839924061625
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
87a92e159459b46d503d7ca9301e076e886bf1eb91abaae349f8b6a69deb2571
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 07:44:21 GMT
x-content-type-options
nosniff
age
107640
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79088
x-xss-protection
0
last-modified
Mon, 24 Apr 2023 17:15:20 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Sun, 28 Jul 2024 07:44:21 GMT

Redirect headers

date
Sat, 29 Jul 2023 20:25:22 GMT
x-content-type-options
nosniff
server
cafe
age
61979
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
location
https://tpc.googlesyndication.com/simgad/3995853839924061625
content-type
text/html; charset=UTF-8
cache-control
public, max-age=2592000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Mon, 28 Aug 2023 20:25:22 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame 81D0
29 KB
29 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcTT7eYosRtF_55Pel9bpKjpFQOP-sT8wnE-Ypjiqa3IYT_xOqtzhrls_lis1e4&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8056b4c761c0b2608915c5766eebbc2bb28bd4d9a66649b396730f403dd10e2a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 21:26:59 GMT
x-content-type-options
nosniff
age
58282
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
30100
x-xss-protection
0
last-modified
Fri, 01 Mar 2024 03:06:06 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 21:26:59 GMT
shopping
encrypted-tbn3.gstatic.com/ Frame 81D0
21 KB
21 KB
Image
General
Full URL
https://encrypted-tbn3.gstatic.com/shopping?q=tbn:ANd9GcRIaY7kkadXH5SnlwEzjfQvrLiMs6XG1s57u90OJ5mcmOp0g1dng9fwWgDnjg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9dffa69c86b42874d87a4f145f153ab01f6e6d726fc47cd887b95cad3c523f82
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 19:37:45 GMT
x-content-type-options
nosniff
age
151236
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
21470
x-xss-protection
0
last-modified
Fri, 04 Nov 2022 07:07:04 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sat, 27 Jul 2024 19:37:45 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame 81D0
35 KB
35 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcTdrJUEVTuT9KR0pObOtUdwJhVqp7sW4epjwPR92VP5mZMSEpQB9ync38BcK4k&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ac5819dc7e9882d90e5ac18e79faf3bf3fb69bc916b3c6918879b9b8faa40ca8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 01:09:54 GMT
x-content-type-options
nosniff
age
44907
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
36029
x-xss-protection
0
last-modified
Sat, 15 Apr 2023 19:48:33 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Mon, 29 Jul 2024 01:09:54 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame 81D0
41 KB
41 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcT8iO2U7CO6_upTvYhkHFbNF9wg4lPfOd5hFOv8qO1KA37qdwGVTd1g0TKe0EM&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
15956d2c3095d247b78831890d6535c7a33fe83bd3b049133a438ee959d48556
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 00:52:18 GMT
x-content-type-options
nosniff
age
132363
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42411
x-xss-protection
0
last-modified
Mon, 31 Jul 2023 03:53:37 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 00:52:18 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame 81D0
24 KB
24 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcQr-5ahTYvIlXvds8EbFmto5uLPfsujVLusJ7SK2TtywGhPd_pHmF5Go4eLhT0&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d4a4bd1836268e9c59e5a61d99fc72173b66d4122556a3f35494ee6de0fd6bf9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 14:24:47 GMT
x-content-type-options
nosniff
age
256414
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24392
x-xss-protection
0
last-modified
Mon, 16 Jan 2023 23:28:54 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 14:24:47 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame 81D0
17 KB
18 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcT6_S5ME8gkvajDvLqNuP-3QLBmVklQHQdK8qlW7pFzqTjDfqiwz8sSukeOEg&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8503954201ae92ce8050534484ff98b82fd4c68b48c7b42b4888d165b4f173c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Thu, 27 Jul 2023 21:07:27 GMT
x-content-type-options
nosniff
age
232254
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17890
x-xss-protection
0
last-modified
Fri, 21 Apr 2023 23:51:18 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Fri, 26 Jul 2024 21:07:27 GMT
shopping
encrypted-tbn0.gstatic.com/ Frame 81D0
33 KB
33 KB
Image
General
Full URL
https://encrypted-tbn0.gstatic.com/shopping?q=tbn:ANd9GcTtywo-4-GxbJlh9RrioPaX2VXf1XEeHWWyf4C6BZnK9PHABDTZZAAcEJ3ppKU&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
04c427901e1cf06d8a972099bc153b023a27c4363ccb81cde103bcc50a205a9b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 06:59:15 GMT
x-content-type-options
nosniff
age
110346
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
33904
x-xss-protection
0
last-modified
Wed, 19 Apr 2023 08:50:27 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sun, 28 Jul 2024 06:59:15 GMT
shopping
encrypted-tbn1.gstatic.com/ Frame 81D0
17 KB
17 KB
Image
General
Full URL
https://encrypted-tbn1.gstatic.com/shopping?q=tbn:ANd9GcQlITqF9uln1qUrybL7ADoJBvxf7GQdRo-3Ns41nVPUk7TYLR8nHAp5XNAhdUI&usqp=CAI
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e0f887fbf8f31f2602ee1b897ede24e2e37e19a9e620f617e185816ec023afdb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 19:22:41 GMT
x-content-type-options
nosniff
age
152140
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/images-tbn
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
16958
x-xss-protection
0
last-modified
Thu, 30 Mar 2023 02:20:43 GMT
server
sffe
report-to
{"group":"images-tbn","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/images-tbn"}]}
content-type
image/jpeg
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="images-tbn"
expires
Sat, 27 Jul 2024 19:22:41 GMT
3995853839924061625
tpc.googlesyndication.com/simgad/ Frame 81D0
Redirect Chain
  • https://tpc.googlesyndication.com/pageadimg/imgad?id=CICAgOCat6zDHxCwCRiwCTIIZ7MB4_P2Swc
  • https://tpc.googlesyndication.com/simgad/3995853839924061625
77 KB
77 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3995853839924061625
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
87a92e159459b46d503d7ca9301e076e886bf1eb91abaae349f8b6a69deb2571
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 07:44:21 GMT
x-content-type-options
nosniff
age
107640
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79088
x-xss-protection
0
last-modified
Mon, 24 Apr 2023 17:15:20 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
expires
Sun, 28 Jul 2024 07:44:21 GMT

Redirect headers

date
Sat, 29 Jul 2023 20:25:22 GMT
x-content-type-options
nosniff
server
cafe
age
61979
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
location
https://tpc.googlesyndication.com/simgad/3995853839924061625
content-type
text/html; charset=UTF-8
cache-control
public, max-age=2592000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Mon, 28 Aug 2023 20:25:22 GMT
dcm
s.amazon-adsystem.com/ Frame 55B9
Redirect Chain
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
43 B
568 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
52.46.155.104 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:22 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
1GYDC6BYMSA10HJGMG9N
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
DK7RR22RZWD8B8FW4QCP
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Location
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
casale
match.adsrvr.org/track/cmf/ Frame 55B9
70 B
265 B
Image
General
Full URL
https://match.adsrvr.org/track/cmf/casale?gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.33.220.150 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a12b7a488abeaa9e4.awsglobalaccelerator.com
Software
/
Resource Hash
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
private,no-cache, must-revalidate
x-aspnet-version
4.0.30319
content-length
70
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
crum
dsum-sec.casalemedia.com/ Frame 55B9
Redirect Chain
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=499
Content-Length
43
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
341
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 55B9
170 B
232 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=index&google_cm&google_hm=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gdpr_consent=&us_privacy=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ZMAwryCI
sync-tm.everesttech.net/ct/upi/pid/ Frame 55B9
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1
  • https://sync-tm.everesttech.net/ct/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1&_test=ZMZnzQAExL_5hQAb
85 B
193 B
Image
General
Full URL
https://sync-tm.everesttech.net/ct/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1&_test=ZMZnzQAExL_5hQAb
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Server
151.101.194.49 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Jetty(9.4.35.v20201120) /
Resource Hash
acccc501aa6afa3cfac15e8ddccf1561deed2ed08c2f7d652abbdbe9aa71609a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

x-served-by
cache-cph2320030-CPH
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
via
1.1 varnish
server
Jetty(9.4.35.v20201120)
age
1812
x-timer
S1690724302.016109,VS0,VE0
x-cache
HIT
content-type
image/png
cache-control
no-cache
accept-ranges
bytes
content-length
85
x-cache-hits
2437

Redirect headers

x-served-by
cache-cph2320030-CPH
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
via
1.1 varnish
server
Jetty(9.4.35.v20201120)
x-timer
S1690724302.801362,VS0,VE95
x-cache
MISS
p3p
CP="NOI DSP COR LAW PSAo PSDo IVAo IVDo OUR BUS UNI DEM"
access-control-allow-origin
*
location
https://sync-tm.everesttech.net/ct/upi/pid/ZMAwryCI?redir=https%3A%2F%2Fdsum-sec.casalemedia.com%2Frum%3Fcm_dsp_id%3D88%26external_user_id%3D%24%7BTM_USER_ID%7D&gdpr=1&_test=ZMZnzQAExL_5hQAb
cache-control
no-cache
accept-ranges
bytes
content-length
0
x-cache-hits
0
/
sync.taboola.com/sg/indexscod/1/cm/ Frame 55B9
0
99 B
Image
General
Full URL
https://sync.taboola.com/sg/indexscod/1/cm/?us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk.f3TY-1Sf2WW4QAA%263213&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
access-control-allow-credentials
true
server
nginx
x-fastly-to-nlb-rtt
26895
rum
dsum-sec.casalemedia.com/ Frame 55B9
Redirect Chain
  • https://sync.srv.stackadapt.com/sync?nid=68&gdpr=1
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=123&external_user_id=E7_xoKAeWlp-KcPAGLya59ly14M
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=123&external_user_id=E7_xoKAeWlp-KcPAGLya59ly14M
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:22 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=494
Content-Length
43
Expires
0

Redirect headers

Location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=123&external_user_id=E7_xoKAeWlp-KcPAGLya59ly14M
Date
Sun, 30 Jul 2023 13:38:22 GMT
Connection
keep-alive
Content-Length
122
Content-Type
text/html; charset=utf-8
sync
x.bidswitch.net/ Frame 55B9
43 B
146 B
Image
General
Full URL
https://x.bidswitch.net/sync?ssp=index&gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.193.242.108 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-193-242-108.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
43
content-type
image/gif
htw-pixel.gif
js-sec.indexww.com/ht/ Frame 55B9
43 B
102 B
Image
General
Full URL
https://js-sec.indexww.com/ht/htw-pixel.gif?ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.10.47 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cf-cache-status
HIT
last-modified
Tue, 24 Jan 2017 19:36:04 GMT
server
cloudflare
age
1116
etag
"761e21-2b-546dc3a097100"
vary
Accept-Encoding
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
edge-control
cache-maxage=1h
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
7eee00654b3c37dd-FRA
content-length
43
expires
Sun, 30 Jul 2023 17:38:21 GMT
truncated
/ Frame FD9F
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fe90d114ed4f762dd50543858d328c3b4d78fca8325e3f87c1f1fba16379ed3a

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
casale
match.adsrvr.org/track/cmf/ Frame 61DA
70 B
264 B
Image
General
Full URL
https://match.adsrvr.org/track/cmf/casale?gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.33.220.150 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
a12b7a488abeaa9e4.awsglobalaccelerator.com
Software
/
Resource Hash
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
private,no-cache, must-revalidate
x-aspnet-version
4.0.30319
content-length
70
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
dcm
s.amazon-adsystem.com/ Frame 61DA
Redirect Chain
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=
  • https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
43 B
568 B
Image
General
Full URL
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
52.46.155.104 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:22 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
R2RB3A4FKVKVBQN761RM
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
6FCPDH70G858X5KV2AW2
Vary
Content-Type,Accept-Encoding,User-Agent
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Location
https://s.amazon-adsystem.com/dcm?pid=78af914c-e755-4b90-bded-1b172aedc763&us_privacy=&gdpr=1&gdpr_consent=&id=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gpp=&gpp_sid=&dcc=t
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
crum
dsum-sec.casalemedia.com/ Frame 61DA
Redirect Chain
  • https://dsum-sec.casalemedia.com/rrum?ixi=1&cm_dsp_id=85&cb=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dcasale_media2_dbm%26google_cm%26google_sc%26google_hm%3D&gdpr=1
  • https://cm.g.doubleclick.net/pixel?gdpr=1&google_nid=casale_media2_dbm&google_cm&google_sc&google_hm=ZMZnzDmk.f3TY-1Sf2WW4QAA
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=500
Content-Length
43
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=45&external_user_id=CAESEKhjUyjfQPWOMMeJ68kMj4k&google_cver=1&gdpr=1&google_hm=2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
341
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 61DA
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=index&google_cm&google_hm=ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB&gdpr_consent=&us_privacy=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
tp_out
d.adroll.com/cm/index/ Frame 61DA
42 B
181 B
Image
General
Full URL
https://d.adroll.com/cm/index/tp_out?advertisable=3GMDZMBFQREVBC75SYYKWH&gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:d018:cc3:fe04:94a6:fd27:12f4:717e Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.22.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
no-transform,public,max-age=300,s-maxage=900
server
nginx/1.22.1
content-length
42
vary
Cookie
content-type
image/gif
index
dmp.brand-display.com/cm/api/ Frame 61DA
0
0
Image
General
Full URL
https://dmp.brand-display.com/cm/api/index?cm_dsp_id=191&cm_user_id=%3cIndex_user_id%3e&gdpr=1
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.111.151.213 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
213.151.111.34.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

rum
dsum-sec.casalemedia.com/ Frame 61DA
Redirect Chain
  • https://cms.quantserve.com/pixel/p-Z8PuJEk6U7Hyq.gif?idmatch=0&gdpr=1
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=rvKYkK7xmMK1pMjC_qDWka_-npC1oJnD-vKS4Km5
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=rvKYkK7xmMK1pMjC_qDWka_-npC1oJnD-vKS4Km5
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=496
Content-Length
43
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=86400
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=81&&external_user_id=rvKYkK7xmMK1pMjC_qDWka_-npC1oJnD-vKS4Km5
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
0
expires
Fri, 04 Aug 1978 12:00:00 GMT
crum
dsum-sec.casalemedia.com/ Frame 61DA
Redirect Chain
  • https://sync.adotmob.com/cookie/indexexchange?gdpr=1&gdpr_consent=&r=https%3A%2F%2Fdsum-sec.casalemedia.com%2Fcrum%3Fcm_dsp_id%3D13%26external_user_id%3D%7Bamob_user_id%7D%26expiration%3D%5BEXPIRAT...
  • https://dsum-sec.casalemedia.com/crum?cm_dsp_id=13&expiration=%5BEXPIRATION%5D&gdpr=1&gdprConsent=
43 B
632 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=13&expiration=%5BEXPIRATION%5D&gdpr=1&gdprConsent=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
HTTP/1.1
Server
185.80.39.216 , Canada, ASN27381 (CASALE-MEDIA, CA),
Reverse DNS
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
image/gif
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=1, max=495
Content-Length
43
Expires
0

Redirect headers

location
https://dsum-sec.casalemedia.com/crum?cm_dsp_id=13&expiration=%5BEXPIRATION%5D&gdpr=1&gdprConsent=
date
Sun, 30 Jul 2023 13:38:21 GMT
access-control-allow-credentials
true
x-powered-by
Express
keep-alive
timeout=5
vary
Origin
content-length
0
htw-pixel.gif
js-sec.indexww.com/ht/ Frame 61DA
43 B
103 B
Image
General
Full URL
https://js-sec.indexww.com/ht/htw-pixel.gif?ZMZnzDmk-f3TY_1Sf2WW4QAADI0AAAIB=&gdpr=1&gpp=&gpp_sid=
Requested by
Host: ssum-sec.casalemedia.com
URL: https://ssum-sec.casalemedia.com/usermatch?ix_um=1&cb=https%3A%2F%2Fjs-sec.indexww.com%2Fht%2Fhtw-pixel.gif%3F&s=200223&us_privacy=&gdpr_consent=&gdpr=1&gpp=&gpp_sid=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.10.47 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ssum-sec.casalemedia.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
cf-cache-status
HIT
last-modified
Tue, 24 Jan 2017 19:36:04 GMT
server
cloudflare
age
1116
etag
"761e21-2b-546dc3a097100"
vary
Accept-Encoding
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
edge-control
cache-maxage=1h
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
7eee0065dc3c37dd-FRA
content-length
43
expires
Sun, 30 Jul 2023 17:38:21 GMT
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://sync.mathtag.com/sync/img?mt_exid=4&google_gid=CAESECQ1S2Rw5prJOCpNoyzb3hc&google_cver=1&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6...
  • https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6-vtUOh1H0A
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6-vtUOh1H0A
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Date
Sun, 30 Jul 2023 13:38:21 GMT
Server
MT3 1031 59fd23a master cdg cdg-pixel-x26 config_version:"1438"
Content-Type
image/gif
Access-Control-Allow-Origin
*
location
https://cm.g.doubleclick.net/pixel?google_nid=mediamath&google_hm=&google_push=AaAOQGGII3G-D2elPrxPc0dyuxYKH9MAbcBkjCs1L7JOZwBvqTSiO94fC12oYqcPNvUFkg92UHig522Tt7_u8nZ6-vtUOh1H0A
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=360
Content-Length
0
Expires
Sun, 30 Jul 2023 13:38:20 GMT
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://c1.adform.net/serving/cookie/match/?party=1&google_gid=CAESEEOnn4vsh7-u9gEtVOO05s8&google_cver=1&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8Jj...
  • https://c1.adform.net/serving/cookie/match/?CC=1&party=1&google_gid=CAESEEOnn4vsh7-u9gEtVOO05s8&google_cver=1&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacG...
  • https://cm.g.doubleclick.net/pixel?google_nid=1024&google_ula=1641347&google_hm=MTA5NzI5NjY5OTMwODc1NTI2MA&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=1024&google_ula=1641347&google_hm=MTA5NzI5NjY5OTMwODc1NTI2MA&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8JjFhUoBWRf768K5TL0oQ
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
GET
location
https://cm.g.doubleclick.net/pixel?google_nid=1024&google_ula=1641347&google_hm=MTA5NzI5NjY5OTMwODc1NTI2MA&google_push=AaAOQGHo2eZ3S5FJ7p08F1GyZp4hy0SvlLSJLcR79MCF7hIMdclgYDdY3o2H36Wx_zgghBeXacGGQ8JjFhUoBWRf768K5TL0oQ
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
content-length
0
expires
-1
dds
rtb.openx.net/sync/ Frame DB83
43 B
245 B
Image
General
Full URL
https://rtb.openx.net/sync/dds?google_gid=CAESECVIqCKy2S1EIdr9vsOGXjo&google_cver=1&google_push=AaAOQGFy6njqkNV47Y_2s6iAIn7rLKCtpPAURLdq_FSMQVbEbBxVFSg0Xek8rOwWdwh2aGgzvG7ftXQiM8HW-vdqboJ1-t7GPlk
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.227.252.103 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
103.252.227.35.bc.googleusercontent.com
Software
/
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
via
1.1 google
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mp...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEqypDlMxpRRied2QQki6DvSVK-fvwlFlXb6DEcHv40A_n0Sl-O3azCkIJ8rp3is11ayJb1r44BWnYYYiaH2o8UmulBE3o
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEqypDlMxpRRied2QQki6DvSVK-fvwlFlXb6DEcHv40A_n0Sl-O3azCkIJ8rp3is11ayJb1r44BWnYYYiaH2o8UmulBE3o
date
Sun, 30 Jul 2023 13:38:20 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
0
content-type
text/html; charset=UTF-8
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://ap.lijit.com/dsp/google/pixelmatch?google_gid=CAESEP36gFtPKCF1zSUpUi9o2t8&google_cver=1&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxb...
  • https://ap.lijit.com/dsp/google/pixelmatch?google_gid=CAESEP36gFtPKCF1zSUpUi9o2t8&google_cver=1&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxb...
  • https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ&google_hm=HETyqGZHt8EOulvRQhmP-hJI
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ&google_hm=HETyqGZHt8EOulvRQhmP-hJI
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Date
Sun, 30 Jul 2023 13:38:21 GMT
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Location
https://cm.g.doubleclick.net/pixel?google_nid=sovrn&google_push=AaAOQGG1hnvmQSKK-IhxeUepgMZWaFfqRBMU-dAXIwWwwXUh7EQ4c9pNG2cxnJpiE1tm-XTG0XGFrY_2M7FmXrLxbK_EbWj3LQ&google_hm=HETyqGZHt8EOulvRQhmP-hJI
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ad_ap2ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
Content-Length
0
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://onetag-sys.com/match/?int_id=19&redir=1&google_gid=CAESEOeYDhnlMfypVfQ-dMK6zrY&google_cver=1&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP...
  • https://cm.g.doubleclick.net/pixel?google_nid=one_tag&google_hm=&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP3YJ1RDF6wAdOdg
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=one_tag&google_hm=&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP3YJ1RDF6wAdOdg
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=one_tag&google_hm=&google_push=AaAOQGHN1VQgTOZ3umPKhW_0Xwucvdnwcw_FGNtlUBPacI2Fx4EmKwQUd3-OQD1ButaTUZUdnizVlRdsRIEP3YJ1RDF6wAdOdg
strict-transport-security
max-age=15552000
cache-control
no-transform, no-cache
content-length
0
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
pixel
cm.g.doubleclick.net/ Frame DB83
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3D%5BRX_SPD%5D%26google_hm%3D%5BRX_UUID_B64_BIN%5D&google_gid=CAESEL...
  • https://sync.1rx.io/usersync2/rmpssp?sub=google&zcc=1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&redir=https%3A%2F%2Fcm.g.double...
  • https://sync.targeting.unrulymedia.com/csync/RX-a410a985-63d4-4955-a370-9019dea5ce48-003?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dr1%26google_push%3DAaAOQGEHOIFZa_UhL3GGAWur5...
  • https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&google_hm=A6QQqYVj1ElVo3CQGd6lzkg
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&google_hm=A6QQqYVj1ElVo3CQGd6lzkg
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=r1&google_push=AaAOQGEHOIFZa_UhL3GGAWur5m_RUDUs7X3MX2cZ3JdNGxY8HPojjppI9Q9j83ZIvDJW0GywL4itFTweCjHhq1So-EDEyhsAS2U&google_hm=A6QQqYVj1ElVo3CQGd6lzkg
date
Sun, 30 Jul 2023 13:38:21 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXa410a98563d44955a3709019dea5ce48003
content-type
text/html
attr
cm.g.doubleclick.net/pixel/ Frame DB83
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13JlwBAAE7pfamDAByXVPT_k0VjzsCejVFP9HDHKT45oOF5oeNLyYKqCa3qr7JOsppdxruMg
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
/
r.turn.com/r/cms/id/0/ddc/1/pid/18/uid/ Frame 1D56
Redirect Chain
  • https://ad.turn.com/r/cs?pid=3&google_gid=CAESEMNC6f5jQUHAYAYbT6xsrhs&google_cver=1&google_push=AaAOQGH1vq82EffNDAJIGEP6oz5UbeRV29q6R3A2quDfjDjmbVCLqjhFSchh-SAryI0TGkYWrt-affxcZ61FJTcJN1zjqAb222FqSQ
  • https://cm.g.doubleclick.net/pixel?google_nid=turn1&google_cm&google_sc&google_hm=NDQ4ODg0MjU1NjQ3MjIyMjY3Nw==&gdpr=&gdpr_consent=
  • https://r.turn.com/r/cms/id/0/ddc/1/pid/18/uid/?gdpr=&gdpr_consent=&google_gid=CAESEAi_7HL471zEDC-skpttqSc&google_cver=1
43 B
398 B
Image
General
Full URL
https://r.turn.com/r/cms/id/0/ddc/1/pid/18/uid/?gdpr=&gdpr_consent=&google_gid=CAESEAi_7HL471zEDC-skpttqSc&google_cver=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Server
2001:678:cb4:bbbb::11 , United Kingdom, ASN56396 (AMOBEE, GB),
Reverse DNS
Software
/
Resource Hash
48a33ca9f42b91902d57ad8ac52e1ce32b92c8c10c732f2dbb6fe960ebfd9438

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
cache-control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
content-length
43
p3p
policyref="/w3c/p3p.xml", CP="NOI CURa DEVa TAIa PSAa PSDa IVAa IVDa OUR IND UNI NAV"

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://r.turn.com/r/cms/id/0/ddc/1/pid/18/uid/?gdpr=&gdpr_consent=&google_gid=CAESEAi_7HL471zEDC-skpttqSc&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
329
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 1D56
Redirect Chain
  • https://pm.w55c.net/ping_match.gif?ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cve...
  • https://pm.w55c.net/ping_match.gif?scc=1&ei=GOOGLE&rurl=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3D9675309%26google_hm%3D_wfivefivec64esc_&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&goog...
  • https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=UnZJQm9NOXUxUXE2Q041&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fS...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=UnZJQm9NOXUxUXE2Q041&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fSr3JNATKDhzNIJbFgnSmykawn-RRizG8RpQarNbP1DN9bOKJ5iVdTa6w
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Sun, 30 Jul 2023 13:38:21 GMT
Strict-Transport-Security
max-age=2592000; includeSubDomains
Server
PingMatch/v2.0.30-785-gcf3d607#rel-ec2-master i-0cf754cf2c3fcf8db@eu-central-1a@dxedge-app-eu-central-1-prod-asg
Location
https://cm.g.doubleclick.net/pixel?google_nid=9675309&google_hm=UnZJQm9NOXUxUXE2Q041&google_gid=CAESEMfA5OW2FrkhGLanKkm_beU&google_cver=1&google_push=AaAOQGFSXOoh_ZgtpjYcCFtZob7MAB_E4Pf3Mhx1-BBp1fSr3JNATKDhzNIJbFgnSmykawn-RRizG8RpQarNbP1DN9bOKJ5iVdTa6w
Cache-Control
no-cache, must-revalidate
Connection
keep-alive
Content-Length
0
Expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/ Frame 1D56
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/5w3jqr4k?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dg8f47s39e399f3fe%26google_hm%3D%24%7BTM_USER_ID_BASE64ENC_URLENC%7D&google_gid=CAESE...
  • https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=&google_cver=1&google_gid=CAESEFxJ_M-Nq3d6JbA2Hr5Xi5s&google_push=AaAOQGGPF9bsI0EHP5F3CcyIHxur8YPZ74uPrtnrfrLUyS5uMVfFjrO-wU...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=&google_cver=1&google_gid=CAESEFxJ_M-Nq3d6JbA2Hr5Xi5s&google_push=AaAOQGGPF9bsI0EHP5F3CcyIHxur8YPZ74uPrtnrfrLUyS5uMVfFjrO-wU2PP4ZLO6EX6qwBschQuAU5j8FykN0zMpPkz3ShXhPM
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

x-served-by
cache-cph2320030-CPH
pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
via
1.1 varnish
server
Jetty(9.4.35.v20201120)
x-timer
S1690724302.801560,VS0,VE95
x-cache
MISS
p3p
CP="NOI DSP COR LAW PSAo PSDo IVAo IVDo OUR BUS UNI DEM"
access-control-allow-origin
*
location
https://cm.g.doubleclick.net/pixel?google_nid=g8f47s39e399f3fe&google_hm=&google_cver=1&google_gid=CAESEFxJ_M-Nq3d6JbA2Hr5Xi5s&google_push=AaAOQGGPF9bsI0EHP5F3CcyIHxur8YPZ74uPrtnrfrLUyS5uMVfFjrO-wU2PP4ZLO6EX6qwBschQuAU5j8FykN0zMpPkz3ShXhPM
cache-control
no-cache
accept-ranges
bytes
content-length
0
x-cache-hits
0
pixel
cm.g.doubleclick.net/ Frame 1D56
Redirect Chain
  • https://um.simpli.fi/gp_match?google_gid=CAESEJseoBYgXoHAgD39JcjMtSQ&google_cver=1&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQbQ6wFQm1ysEFTPNQ
  • https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=D6E86F92BADF4A1FBF50EFFE981BC6CA&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQb...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=D6E86F92BADF4A1FBF50EFFE981BC6CA&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQbQ6wFQm1ysEFTPNQ
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=63072000; includeSubdomains; preload
x-content-type-options
nosniff
server
openresty
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
location
https://cm.g.doubleclick.net/pixel?google_nid=simplifi&google_hm=D6E86F92BADF4A1FBF50EFFE981BC6CA&google_push=AaAOQGE38EFm1YkQeGNmZb1r4CU_MwUj90nH8qbcP4LnXOv4cv_mIUonuWHOrtir8mGqDWla_ArF_Miq-yPGUQbQ6wFQm1ysEFTPNQ
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-headers
DNT,X-Mx-ReqToken,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type
content-length
142
expires
Sat, 29 Jul 2023 13:38:21 GMT
pixel
cm.g.doubleclick.net/ Frame 1D56
Redirect Chain
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=1&rd=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dpmeb%26google_sc%3D1%26google_hm%3D%23%23B64_16B_PM_UID%26google_redir%3Dhttps%...
  • https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mp...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEmV3Ok1ttGUEAYc3NFfEJVI6M-u_sHevu7ELawIk2TEw9RXlW_QgmH6xJTcE5xH-_qllU1EdGOvXPQijqCLPdvytTvz-FFVw
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=pmeb&google_sc=1&google_hm=FYAszbJxS5OrvnrsiY0Ing%3D%3D&google_redir=https%3A%2F%2Fimage8.pubmatic.com%2FAdServer%2FImgSync%3Fsec%3D1%26p%3D156578%26mpc%3D4%26fp%3D1%26pu%3Dhttps%253A%252F%252Fimage4.pubmatic.com%252FAdServer%252FSPug%253Fp%253D156578%2526sc%253D1&google_push=AaAOQGEmV3Ok1ttGUEAYc3NFfEJVI6M-u_sHevu7ELawIk2TEw9RXlW_QgmH6xJTcE5xH-_qllU1EdGOvXPQijqCLPdvytTvz-FFVw
date
Sun, 30 Jul 2023 13:38:20 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
0
content-type
text/html; charset=UTF-8
sync
ups.analytics.yahoo.com/ups/58281/ Frame 1D56
0
125 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/58281/sync?redir=true&google_gid=CAESEEYiq_gLT17tC8SBWSE9M-Y&google_cver=1&google_push=AaAOQGFepTdVr5KSx7kC430AaP0MrXs33h6stlpSAr_XIWszB6SNf_R3mMTsbqyUXslguCi-TNATw3zNkdX06765djEKqKt6m17JuVU
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
3.71.149.231 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-3-71-149-231.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.10.64 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.64
age
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
pixel
cm.g.doubleclick.net/ Frame 1D56
Redirect Chain
  • https://secure.adnxs.com/getuid?https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=${BASE64_UID_ENC}&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiq...
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dxandr_eb%26google_hm%3D%24%7BBASE64_UID_ENC%7D%26google_gid%3DCAESEIUMgkRefzh4eR8sYpnbXo4%26goo...
  • https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=OTE4MDU3NDQ4OTI4NTY1Njc4Mw%3D%3D&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiqogmmruvKLgXSvVkyo...
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=OTE4MDU3NDQ4OTI4NTY1Njc4Mw%3D%3D&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiqogmmruvKLgXSvVkyofrwVvxggGfwSX_pmBhG-fwZ7S2JpRjj4rgNVvmCKXqmhqZ-ntAIbGzqIWjxNs2-4D8ow
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:21 GMT
an-x-request-uuid
6accc8f0-c264-4482-9040-216d88fdb459
server
nginx/1.21.3
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://cm.g.doubleclick.net/pixel?google_nid=xandr_eb&google_hm=OTE4MDU3NDQ4OTI4NTY1Njc4Mw%3D%3D&google_gid=CAESEIUMgkRefzh4eR8sYpnbXo4&google_cver=1&google_push=AaAOQGFYOS4a93aiqogmmruvKLgXSvVkyofrwVvxggGfwSX_pmBhG-fwZ7S2JpRjj4rgNVvmCKXqmhqZ-ntAIbGzqIWjxNs2-4D8ow
x-proxy-origin
217.114.215.131; 217.114.215.131; 952.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
attr
cm.g.doubleclick.net/pixel/ Frame 1D56
0
12 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel/attr?d=AHNF13J1evteNd37toJ-Sx3PjS2w4gwOBZjBFA9mG66TpMduyLULvn8rHZySCT3XbYIEAd2iuQ6t9nI
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://pagead2.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:21 GMT
server
HTTP server (unknown)
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
content-type
text/html
truncated
/ Frame C574
219 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
541342cb8883e2e67cb464fb8869443cc630394b994f233bcc4ad72ace08a7eb

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
fonts.gstatic.com/s/googlesansdisplay/v21/ Frame C574
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/googlesansdisplay/v21/ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
acc5497e76f832d950d14fcfa047dc3c864f7a0aae4c7a20521c0c655a53033b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://googleads.g.doubleclick.net
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 09:20:48 GMT
x-content-type-options
nosniff
age
101853
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20784
x-xss-protection
0
last-modified
Tue, 19 Apr 2022 19:21:31 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 28 Jul 2024 09:20:48 GMT
truncated
/ Frame 81D0
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cf10355a5c8d65784d49e8e943b0a193d29f89c5f63218ed059b92ce62d56449

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Content-Type
image/png
ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
fonts.gstatic.com/s/googlesansdisplay/v21/ Frame FD9F
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/googlesansdisplay/v21/ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
acc5497e76f832d950d14fcfa047dc3c864f7a0aae4c7a20521c0c655a53033b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://googleads.g.doubleclick.net
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 09:20:48 GMT
x-content-type-options
nosniff
age
101853
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20784
x-xss-protection
0
last-modified
Tue, 19 Apr 2022 19:21:31 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 28 Jul 2024 09:20:48 GMT
ppdbackground05192023.jpg
cdn.spotible.com/creative/F0xc/hashed/ba0ecae70c52527d6dea6c9e5141c4be/
993 KB
994 KB
Image
General
Full URL
https://cdn.spotible.com/creative/F0xc/hashed/ba0ecae70c52527d6dea6c9e5141c4be/ppdbackground05192023.jpg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.4.16 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-4-16.fra6.r.cloudfront.net
Software
/
Resource Hash
685316e33a221d88556076ed38c8a8e7b4ab24c5fbb04359876ba04522e2f73f

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Wed, 26 Jul 2023 01:04:49 GMT
via
1.1 62dc260e32d7b9197a4511447f6a264a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
age
390812
etag
"ba0ecae70c52527d6dea6c9e5141c4be"
x-cache
Hit from cloudfront
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
content-length
1016873
x-amz-cf-id
mLv7fi0FKj4PVGtLhXXOE-ew9ai16SfYduz5puGDnBUIs9_4Zm8tpQ==
Fierce-Pharma-web-roller-foreground-720x900.jpg
cdn.spotible.com/creative/F0xc/hashed/dd6dea014348e5d42d0c4c9878817560/
245 KB
246 KB
Image
General
Full URL
https://cdn.spotible.com/creative/F0xc/hashed/dd6dea014348e5d42d0c4c9878817560/Fierce-Pharma-web-roller-foreground-720x900.jpg
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.4.16 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-4-16.fra6.r.cloudfront.net
Software
/
Resource Hash
400d057eb35236224a79263c14b87a5c94c3489b6f24c1d91a710970f8391dda

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Wed, 26 Jul 2023 01:04:49 GMT
via
1.1 62dc260e32d7b9197a4511447f6a264a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
age
390812
etag
"dd6dea014348e5d42d0c4c9878817560"
x-cache
Hit from cloudfront
content-type
image/jpeg
cache-control
public, max-age=604800
accept-ranges
bytes
content-length
250879
x-amz-cf-id
KOgMgGIKJQmh4fp4sKNYPE4cnjcO9UnPHAWCIwQiD0iEDpOSYKK6Kg==
ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
fonts.gstatic.com/s/googlesansdisplay/v21/ Frame 81D0
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/googlesansdisplay/v21/ea8FacM9Wef3EJPWRrHjgE4B6CnlZxHVDv79oQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Google%20Sans%20Display%3A400
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
acc5497e76f832d950d14fcfa047dc3c864f7a0aae4c7a20521c0c655a53033b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://googleads.g.doubleclick.net
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sat, 29 Jul 2023 09:20:48 GMT
x-content-type-options
nosniff
age
101853
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20784
x-xss-protection
0
last-modified
Tue, 19 Apr 2022 19:21:31 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 28 Jul 2024 09:20:48 GMT
adview
googleads.g.doubleclick.net/pagead/ Frame C574
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=CeotSzGfGZMmDDIij9fgP86WAqA_b1OXrcarL-JrXEa-2vs-IChABILflhCFglQKgAaHAmPEoyAEJqAMByAPLBKoEgwJP0P9RTCEcD1pLxW4z4F-aIvcw7sNX03mFWrothPRKwz3Q-CxB-2tF6qx-iBvRTG_r_yb4Rgv_w_1ykTehXbuM3ltm1NANTJHHBCpC0j9YGHXdnX_O4IzykG8-YN8MCTUg2um8VHD7p0tieabT0Yw3wupxFDWzpa4PzGK-BV540lHJvNDClVMthMcDwdPq1_sUyRGjFh_uJz2tO7sIOUx2UpXsTKzoM88tcmADZluiHhsxho0U6Ak2rmbvEtNgmXiD61BroJfYFhVGs0rHs9-YvUaGUQ6wssSIwN8Qai5lEnynwnquK-006JybbLEECmAvwR5ZH8xiXH2RknR0gPYfY6lrwATTtuamvQSSBQQIBBgBkgUECAUYBKAGLoAHnfykowSoB9m2sQKoB47OG6gHk9gbqAfulrECqAf-nrECqAeko7ECqAemvhvYBwDSCBYIgOGAEBABGAAyAqoCOgKAQEi9_cE68ggNYmlkZGVyLTg1OTU5NIAKBMgLAaIMCCoGCgTDsLEC2BML0BUBgBcBshcICgYIABIAGAA&sigh=iUzhQMa0H34&uach_m=[UACH]&pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q&cid=CAQSKQBpAlJWHlje0-5fQjHoO9iKPraLPigt1hPQhccYfT-W4MS5Vtv4mdWiGAE&template_id=494&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Sun, 30 Jul 2023 13:38:21 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adview
securepubads.g.doubleclick.net/pagead/ Frame 34E2
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=Cx3M5zGfGZNiLA_ir78EP_Kyc6AOeoaGuXKH56P6fA8CNtwEQASAAYJWCgIDAB4IBF2NhLXB1Yi01OTk3Njg5MzgwNTgzMzAxyAEJ4AIAqAMByAMCqgSHA0_QaSS8B1F5_JXYUrypH3MDaw0CF1TusiFLNqlAnT6Um752GFw_ATKy_XHAv9ip6lU2PCJUW9V8DRemzmKkSg9ADxHVwYupHJJWpMiH2UctwdyUBn6FoZBdufyfVMM_SHtSIt-ruyC8k7s7a0CaYnPX3mvE93EvQ7OhQjEEsvN1NDAhSE61jLGfd0a4cK_q30P2lU0hmCb2i8Y2UaLvROoyrbKt4oTvpku5JpJ1IG75xAR-ATrZ_NDAi_rs8b_Uaebx0NJKkN6pRSahjqMTW-TBAZDKCTdvjGyMMtf7qrDgKsIvbxVN48vkodVe5mPh5hf8pHxFF4RrTFReNT2-20QXVS0IeDFAIs-Z44AAHQ7IFTCG_VCIQVaUH8P_xukYs-LmZ-Wn_2pq4o7kUtEzVXCWFUznmFu9IMAke3riJ8WBvNFRBZutBiSdnOuH-al9nIbf49tN47zs2NGy6Skg1JIRkUetY8hWHmqBL-6ZuJ4tua3FynSidknQETNhmB3CCHuCk4nzix7gBAGABqmX-5_srpr_BKAGIagHpr4bqAeW2BuoB6qbsQKoB4OtsQKoB_-esQKoB9-fsQLYBwDSCBQIgOGAEBABMgKqAjoCgEBIvf3BOoAKA_oLAggBgAwB0BUBgBcBshccChoSFHB1Yi01OTk3Njg5MzgwNTgzMzAxGMubEg&sigh=urs8x5XkveU&uach_m=[UACH]&cid=CAQSKQBpAlJWa3aRoKvASGYb--1QPZUiu-bUAmCzZRJJ9D0n8SrfuamHGdOTGAE&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
pagead2.googlesyndication.com/bg/ Frame 664D
37 KB
14 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBRls0AWmGNAFqizQBz4w0AbqNNAFBjjQBt440AeGONAHsjjQB8Y40AfKONAESjzQBE480ASOPNAEnjzQBKY80ATGPNAE2jzQBN480AUKPNAFLjzQBTo80AVCPNAFYjzQBYo80AUtzQQFTc0EBH4QHAmj5iAKH_YgC6v2IAidCqgIoQqoCKUKqApRqqgL-eKoCTXqqAoCbqgKBm6oCgpuqAqKoqgJkrKoCw72qAtu_qgLQyKoCltSqAjrZqgKg5aoCXe6qAnTyqgJj-KoCJvuqAkH7qgKEJ6sCVCirAvsrqwLUNqsCsDerAiU6qwIpOqsCLTqrAuY6qwINPKsCIzyrAlw-qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCSlOrAkNYqwIgXKsC0mqrAtNuqwIbcasC8XGrAgRyqwI5cqsC2XKrAkNzqwKAc6sClXSrAsp0qwJLdqsC7XarAhh3qwIdd6sCInerAid3qwIsd6sCs3erArF4qwKzeKsCCnmrAlZ7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasCKIarAnKIqwKXiKsCDYmrAjiJqwJ2iasC7YmrAvSJqwKgiqsC4IqrAgOLqwLGi6sC7YurAgeMqwKqjKsC4IyrAiKNqwJSjqsCnZKrAtCGIwpGb6YPzoH7Egqo-xI_sfsSiLT7EtO5-xIGyfsSVsr7Ejvw-xL9APwSngv8EkoO_BL0DvwSVg_8Ev4R_BIgE_wSrhP8Eg4U_BK8FPwSHhX8EjcV_BKcFfwSvvPlFvdWaxpbAJIpokn6QmOxG3g&awbid_c=AKAmf-Abrc0P3ohzLzZGKccNqh7omevQbyapbs8Z5YrCZEgUsF6QRlUwsLLt_nIRNBVObgaiqHbWCacQPOxiOVkmxHZnWh1pMb1EmRXQnznWos-L5qKCliACqlXKVYegYMd4ZHDm1cg0FjHHIZP1X59u2CbqxjLqDfWqmdOTdE-XcX08U963od71B5ApUT7YmN6WAy-1dXCDgZm4BK5G3mgXS9hfbLwC8S00iN1bX4bPMA27rALkDDIu9kJNRHI74hpbkgAqs6dv_8MdmnBD-Mqmeiv-iC_8j4VTDZfyYMnJdSC8l4LttcLrgcQ_55Gi-nxz7FHdzI6gqwaSZzcqCE9F-vl7Y-cmKucaLTih3Dh0Eje6nVdILzIW3LmD7E4owccwcftUF5eulSDr7h_ZmyKLpZIbxj-sDupZqsnQtSVMKJrrDQR58Uh9_7lqBiTmG2X6TA9azrJUTFyqaDgqh69gbNMp0YjI_wTuMUKch_wa_2NMA4ZNVJ-PKnFMWoqv3uUfR-uQZq1tnHCVSU0ObBFmefWKfWlaTlyrCJpBxPyOvG9Pepuy190d-qq4vjfbSkziPfO3YvogDvfPAqsv8JpbUeMC50IugQ&awbid_d=AKAmf-Ctc2VcIzjS1_ev4msU7LG8-7rnbmoGD2oh7I5-8JMB0pYIktslNz4U3kkW_VmUZW_NuiyL4ZtYT_uvRy4gU_TVFu-0HwCKNz7KMaVrvsZT0H6mNiuos-t-2H2UlLwLsGbDwQ7siX8vftnCISCrumnRfUNuBrXXAB9inQVzFBtzav9v22mXCSlgH7mF5D6VM4egIwtS5e1p5y71IGnjQ-dGQoLMw2LDtW3sMM3FPOsDFUQA_ctqFryTntRGIqZmDNzzib3fSKCY9nzBSrX_d-PJjZWHxp9UiJgkYOryG0v1f2aBbuEw9OPQzz-KXb32beP-yEkXpvNBF3C58rjO950xOuPxpnnGchNrJZa5djx5cruLhTv-qHfmycR8frGNPBqLzW1FVTQLp9aXw9vmAILAqDNfTE38cfSFc8bnYVfWa5F6Hyjhp9R_udFpDND5oMOpsEjEqBqrXkhrxKi1klAa2y8Musg1TUxja2LFOLZS1d-O6-Y8eB_6P_SU0Pte-WXJxrNMWW6Dh9BV5IHNUqqUEw4uf8WJ4_HHmS6gUB5uwVVKPJ6XSe-xUcWR5shLzsmIHzKhA_0xLsy3Ph0xeEGnrY0CJd587eWy_FUoJ7p6-l8zdw2x28lWmp_kzOBLIJuXjC9Y6HnhJZIbBDG6sT283a7aDBxRSVh6dVt0y3iIkbxJIR5zQI41z0uUtdCzyrf5Kzt6TvJzNf5xe3_eoLQy0vaCf2SmDk9v33F8DouIHnl8S7JrO6hK60M70T5fDhOh-v_DeGuJC6k2jW_7-XBEcFCqqFcQlKjK5cOGnjouDBCcVr8lV6oKeuuuO38PjhBLZLjEzRoB1nJsrGACeuOWgMThYkOm4Cb7r57YyPrCzKpAPZslWOw9mWOyMsJYkk68lzVapM17s3_QmiG-kiB-Jl35fxZ-j4waPu30ea1lG5ps5eYJO7Xap2XIQ-rKfxbxx2mUkreBfCTE855yHdLIu2-icyHAJcnLlIcODgR5ItflPsHUgVzoJJ8K7sY7TWbNYhgNC1pq4bToiLU2-9yiM0QeZYqdKCxYigq3XHkkrxHaBnqoriE3sGf6u7qQzF7HXTgEz2RZKquYfKYPZ9xNBMrdffc0wfKlsrUf_IJx7wmHTHKHvuE9UIYXKGQ-fhAhHI_y_VIdxqxjpsaF-pCZaq2Hj3pY8qjZ8F9JwmCvQSCYyDE8U4pZcDm0kuuNUcqA4qM-&cid=CAQSGwBpAlJWv393ZVJiTeub3vJe7e2plTz37UVSLBgB&exk=726758184&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAA2QMpsBUJiE2bP_UKqsAPKh7Qj3Q
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
616caa77f3b26bf752bc7e76e496c90f09e972978a16e9fd7111d8f23009f504
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 15:07:26 GMT
content-encoding
br
x-content-type-options
nosniff
age
167455
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14704
x-xss-protection
0
last-modified
Mon, 24 Jul 2023 13:39:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sat, 27 Jul 2024 15:07:26 GMT
adview
googleads.g.doubleclick.net/pagead/ Frame FD9F
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=CYMVOzGfGZM7aDL-M2fcP8euwmA_b1OXrcarL-JrXEa-2vs-IChABILflhCFglQKgAaHAmPEoyAEJqAMByAPLBKoEjwJP0Nf4GoB5P6jcodAMef2_9isxwLTwjkDReeSg3LKNF9Q8_gOy6y22cg-fQUMVNp_7lMKL5DmNlBlVon9uh6gT4AWSR0S8aSqSsMatrVt4uJEmKYH_qUS4BJ5pNFqi_eLPA4TPQ0Ij_YNpuYoBph7pV0sHZu2f8XmU5sayMagMvvqcEJibgKbvc23myFUIPtaJstme-VlIWsF48CF-Kj_XpeDTZpvwxBAcXfJqfPRojLltZte0epOZp-d9gJbNY7-T7yJVZzJO_HLr9UJJZqayqeIjhyL5EfABxcVsUL8cLt09It7NOChR-CCUGAu5VBw53s7yjEsK-NMY7Lf2wHP1RmqTqHBqiZy7TGa_tsfZwATTtuamvQSSBQQIBBgBkgUECAUYBKAGLoAHnfykowSoB9m2sQKoB47OG6gHk9gbqAfulrECqAf-nrECqAeko7ECqAemvhvYBwDSCBYIgOGAEBABGAAyAqoCOgKAQEi9_cE68ggNYmlkZGVyLTg1OTU5NIAKBMgLAaIMCCoGCgTDsLEC2BML0BUBgBcBshcICgYIABIAGAA&sigh=NG0vxRjhFnk&uach_m=[UACH]&pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw&cid=CAQSKQBpAlJWE6rWaW9RSDCAKSCVa2jsdGaqDPSKwaYpFKCqf4mBhyg3SFtuGAE&template_id=494&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Sun, 30 Jul 2023 13:38:21 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adview
securepubads.g.doubleclick.net/pagead/ Frame 5F8C
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CYZfdzGfGZMTAA72378EPuZ2eiAGeoaGuXKH56P6fA8CNtwEQASAAYJWCgICYB4IBF2NhLXB1Yi01OTk3Njg5MzgwNTgzMzAxyAEJ4AIAqAMByAMCqgSHA0_QmJEWCYIcXfJ_p2131_-jTuWngfSwU7sHtJVMYpDZqmDfCTX3jYaJFBgbLOiYKuKWj6DwTYNPlJVKZSxYCGvy9ISO6ez-3ycV4g-5t9ZfnMpXVYcReF98RxJqW0ORvEWWnX67R7dGI_XargJtC4kfRdk8JsBUNkxdJZY4IfDjqR1Mzax8zG9RUL6W0YAa9Nho-acrNeuLEqKd50Gt4ohB6-M_9-6anSuKm6CpQOOtMP2n7LAn3nrdHE5YHTCVNLrdOPRd5c-lrwEs2V3a0sOiLbbNFmqnNA1yk4SB7_brzIgzTx4yDinOF3h_eRtAwY7WBVOU7bpwDV3Ythxe2_6ElfRfRlOrC5_hmvUEcEIwD2MdzD3DKtK87ncWyjTf_M1Zz2GNWtvEITUlUWXCAw4dVPysHsa80pLBrZQPh7nVKNOnPIeLAX5Xe0NVlyCM7WMz4fjWtnbQOZti7fsadHsq0CWAsrTUnSw1wy4dtoXlmOrd60M9cA7O9ECe2V8uZvptFuF9aC_gBAGABqmX-5_srpr_BKAGIagHpr4bqAeW2BuoB6qbsQKoB4OtsQKoB_-esQKoB9-fsQLYBwDSCBQIgOGAEBABMgKqAjoCgEBIvf3BOoAKA_oLAggBgAwB0BUBgBcBshccChoSFHB1Yi01OTk3Njg5MzgwNTgzMzAxGMubEg&sigh=gg5KWpR0Fr8&uach_m=[UACH]&cid=CAQSKQBpAlJW6ad0XyX-rEmrHCk-trrprEIMTNHR_STZsHMZPK15BSDUatNLGAE&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

adview
googleads.g.doubleclick.net/pagead/ Frame 81D0
0
19 B
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/adview?ai=Cns-XzGfGZNCpDM_i3wPJsYuoDdvU5etxqsv4mtcRr7a-z4gKEAEgt-WEIWCVAqABocCY8SjIAQmoAwHIA8sEqgSPAk_Qri9zsZsLxVfgcViJ4Xvibhnwaf7uEx4Mu-inzTMDkficFgEd8tw-yOkrHz0-MLGKXZFhpHUuERtD5l8AjyUl2f154KIdMd0LBYy8CAD0Rcx3IohRSLmDKvrQYRSEizDQvnZGOX-lk1yHfdQHEFd5svA6dce9FHR6eNDGd_k4LE59P_G-TZaA1AEC8PrDo3gKfaTuT2v4t8vwis7PFMusM5JzkMe1RggDoW4CoJgVMLz_mbnSoD1ePvHWLSsRZw_avua_SCjDyxJB_3Bb9zN8Q_UCoEvGtyTK3d3Roqe-jxM-L2JzgurjhTzeaT7tXkodrJCs_aCrUjR78lF4aBzvkYnhQsxTnuUwr5MdYsvABNO25qa9BJIFBAgEGAGSBQQIBRgEoAYugAed_KSjBKgH2baxAqgHjs4bqAeT2BuoB-6WsQKoB_6esQKoB6SjsQKoB6a-G9gHANIIFgiA4YAQEAEYADICqgI6AoBASL39wTryCA1iaWRkZXItODU5NTk0gAoEyAsBogwIKgYKBMOwsQLYEwvQFQGAFwGyFwgKBggAEgAYAA&sigh=CNJW6iBlWaE&uach_m=[UACH]&pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ&cid=CAQSKQBpAlJWG0YFTTJ4Qiz3dopjdMz5JP8acx5cwzX4CCKOs-pH4JpCbHGqGAE&template_id=494&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-security-policy
script-src 'none'; object-src 'none'
date
Sun, 30 Jul 2023 13:38:21 GMT
x-content-type-options
nosniff
server
cafe
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
adview
securepubads.g.doubleclick.net/pagead/ Frame 59E0
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CDd8_zGfGZKfjA_-278EP9omt-AKeoaGuXKH56P6fA8CNtwEQASAAYJWCgICYB4IBF2NhLXB1Yi01OTk3Njg5MzgwNTgzMzAxyAEJ4AIAqAMByAMCqgSHA0_QWiiVOl61mysezo4EzEF37rkei7r0qz45BQR5T9XDvSsHPb2fzKg4zpE3DP6pvHNJDg-_9x6kvaWFahTAzwv7e7ooSj4RPuc9kd_PXqDtDPvx7cdral18ajiu1kGI974XMqAscM6-m9URARc4rkCnrTx3e7iGtMBJRw6eaGVDtxRLomt01iMiitUFiS0KGKa19B3qWcvDewOQTq0RVY2yUl5rC_Sd-D0HYi4vwDnJmfQW1XxuioSPcb0zajtFg4L3j2u6uqy9XXStO6FGObjqPCQdamivlZaEyt4uExLTPoifQtVspFVbi5Mjp_SEMoAe81S1IHjxj5Wn2xe3y-PBXSWQQA8aN_FRoIG4lQ4jdW06jpFfRCpSY-qps9e0P99_TsMSwswblUHkj9SJNJm0lFrQL6k2SuwHGUO6y9H4ZD-smU6Nc2VYTpfa_qisY9MmOVHjzGXeXllb5iidLXCGnJGHb8xGB1JvG4MTDXBp-RAUpLNSYsFYq0IFZ99Sa52DN1vGk9DgBAGABqmX-5_srpr_BKAGIagHpr4bqAeW2BuoB6qbsQKoB4OtsQKoB_-esQKoB9-fsQLYBwDSCBQIgOGAEBABMgKqAjoCgEBIvf3BOoAKA_oLAggBgAwB0BUBgBcBshccChoSFHB1Yi01OTk3Njg5MzgwNTgzMzAxGMubEg&sigh=eLlcLlwd6KE&uach_m=[UACH]&cid=CAQSKQBpAlJWmQXL89uPjqBhuj79UedrHMlkYddCdgH0EcjQVeKbe04iyCrSGAE&cbvp=2&vis=1
Requested by
Host: 819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
URL: https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
pagead2.googlesyndication.com/bg/ Frame F445
37 KB
14 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcC1vaIAij5iALE_YgC6v2IAidCqgIoQqoCKUKqArhlqgKUaqoC_niqAk16qgKAm6oCgZuqAoKbqgKiqKoCZKyqAsO9qgLbv6oC0MiqApbUqgLw2qoCoOWqAl3uqgJ08qoCY_iqAiX7qgJC-6oChCerAlQoqwL7K6sC1DarArA3qwLhOasCJTqrAik6qwItOqsC5jqrAg08qwIjPKsC_T6rAiU_qwI-QasCtESrAmxKqwJgTqsCdU6rArhOqwKkUKsCAlGrAgpRqwKxUqsCQ1irAiBcqwLSaqsCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKyd6sCFXirAgp5qwJWe6sC3HurAsJ9qwKof6sCU4CrApGBqwLxgasCDIKrAnqCqwKzgqsCMIOrAumDqwLChKsCEIWrAjuFqwJxhasCr4WrAt6FqwIohqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAt-KqwIDi6sCxourAu2LqwKqjKsCIo2rAlKOqwKdkqsC0IYjCkZvpg9po_sSCqj7Ej-x-xKItPsS07n7EgbJ-xJWyvsSO_D7Ev0A_BKeC_wSSg78EvQO_BJWD_wS_hH8EiAT_BKuE_wSDhT8ErwU_BIeFfwSNxX8EpwV_BK-8-UW91ZrGlsAkimiSfpCY7EbeA&awbid_c=AKAmf-DPHrFZTPDo4QMbGe9ayRDFME1-qzjULmpMQkeLgaSRQ6RQuIg0bmEekXJgWGOijrK4e5csXM-NN5usiCUj6h1DnDWp4Almb0j35dWZDCUxqNHOa6XkmueoAoQQrfNB3t-QAsivmvz0uIKqFCT2UE8DrTs6bR6ohhprPKE5_ycbq14E7TwZnyo7MfYrTrnveOCXLsCr0JZH1Eiha35Bajc7R4O6BGeXjkDUKVzG1QYifmwW859e5vbAHyR6tOXRecaiqrLQvA6kaH1xTghTx1DLhY3FlFptNEJSMV1oW5aAnm1r1_P3ulzwG7XzcO2zI7iU-Sqe0y7CiyKUguopM8eU6EDsQe_CW0LlNY6eNDvJ_Ifbgr-cjj4aD_PJZze2uN3v996TGVcMLReJnztzaENFavHVPVpULrYiENlalZTLp2bnaZJatell7sqb7N0tekAJIQ8SyyiVfYH9CFWJehf5QSQzlaQc3SpAzzC8wXtQsg2X06m74Lgrw4Yd3z-95xLABcIWsUkKmN1AsYLvb0V1V1_fuLCrhAyrh0yGLqznD9eQZsdApZ7XTOog6AMkd73acYSRwUVNIMTZavYPZRJoZ1-gBg&awbid_d=AKAmf-B9LdcolMFdIXgo8m_Bmz222cR2VGnVfO_EEpbESJrctWlOJeee4DYS0Yy305ZCSma3KKGlv3AN5S2KHBXFKx8JSFp0nLGPP3FkpaoliDYvBrrRI8x-KeaeDa6s8NxbFKnl-t_-npqWGC0KFTW0yUkStYgaG2KZhw3RPycug1_k62jsKxAKtx0iNKdx3qvXTTpGjPHGP8PyygkS7bhcQfsao6tGuI-0boYxwq97pnMMMNSVITm0t3nJshud4XzlITgjoRjx9oscKBqJZar4hqxocyhoCJkkbus3axoiJ-p9le1A_7ADNK-t-aG2MM8azdyT2H_nQ1bka26lmHFZT84CqXfQa40Jt-rf5h737I-6O80d7un6DAeJ7P8geeBt_HI9oZxkQevaF6zWAXqFdQme5wuj2QmGmIqOnlxZX0NnUG6wj69Bq6cWnknDI_PWwIbW00X0uo4gklsslvpgOUXIfg9AL7JqRUdjtj0ZkfLSLPIEXeSmMWumffv7BzA2KTDtofAzA36JcDrjLuwQWz9FamqA0juyE6JmCcDSRS2MYabWFGUNP4jBqFnWb09tmLac6aq67hKaalEY_yF_Yi9wb451N_IBKjBv73SfwOTo1bweyH4qcUv7sSqSDLV0C9CctGrakT-dXnoSEgI4MDbIQXA7w1Gja5YYgFR_PYPBFx_QNx880PaSb4AutetMx-lTiwy5Nb7lVQnfC97BfLPyo3Hol9VeyELut0ch-S61Fws58nr51-BZZBv88B9bM4h20kMKTRq8owSCdDokULjlHFSkrJuqh19kbf117xaCiB0r-oerYnwJFHKTokwov9D87ycmYpW_zfrjHluAAcdF2o7GGYZJkUmIL1XpGvTwiKQytZukXDhag6I-SNccQuldiUZhSLh9Px2FA2zqabv9_Am_yKqW9hQKymZ-yn0pC1xV3JDDBgxXzVcYpUsl4kIpXXAeNeY_Gf0IwQI3aB3OLXuGU7a5Rm4vi0UzSDNEHJEBN9CXZlCgK1MyojbKK8hOrldhFcd6RTrAfGhpZ2vCC0J3j8Gl9gpHruV7MagzucCW1a_JXsQ3PXqeBn8Yly7QTrolRp_OpkPrvffWHplaPvZKzNd9mwHSXBHx04OZ935G97yHjdxTo0lqveCrE_Y6JNdyjDoy1cmznGvOLGiqTaTqFF0FaFxCgd_gLENmWXhlNwCFVjATE1-ys-IPuSWI3twP&cid=CAQSGwBpAlJW6x0eJ3ewL9FAullrk3IzN84GHf78DRgB&exk=2142339329&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAAACVM6tcl_LKCvuXs5RAtw_UiLlRw
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
616caa77f3b26bf752bc7e76e496c90f09e972978a16e9fd7111d8f23009f504
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 15:07:26 GMT
content-encoding
br
x-content-type-options
nosniff
age
167455
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14704
x-xss-protection
0
last-modified
Mon, 24 Jul 2023 13:39:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sat, 27 Jul 2024 15:07:26 GMT
YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
pagead2.googlesyndication.com/bg/ Frame AE58
37 KB
14 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Requested by
Host: googleads.g.doubleclick.net
URL: https://googleads.g.doubleclick.net/pagead/adfetch?adk=3155870058&adsafe=medium&client=ca-pub-5722610347565274&format=300x600_as&ip=2001:1b60:1010::&output=html&unviewed_position_start=1&url=https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials&sub_client=bidder-859594&aceid=MBgdtAD6WDQBaYY0AWqLNAHPjDQBuo00AUGONAG3jjQB4Y40AeyONAHxjjQB8o40ARKPNAETjzQBI480ASePNAEpjzQBMY80ATaPNAE3jzQBQo80AUuPNAFOjzQBUI80AViPNAFijzQBS3NBAVNzQQEfhAcCDiBcAnP5iALq_YgCJ0KqAihCqgIpQqoClGqqAv54qgJNeqoCgJuqAoGbqgKCm6oCoqiqAmSsqgLDvaoC27-qAtDIqgKW1KoCddqqAqDlqgJd7qoCdPKqAmP4qgIm-6oCQvuqAoQnqwJUKKsC-yurAtQ2qwKwN6sCJTqrAik6qwItOqsCDTyrAiM8qwIlP6sCPkGrArREqwJsSqsCYE6rAnVOqwK4TqsCAlGrAgpRqwKxUqsCQ1irAiBcqwKiY6sCrWirAtJqqwKcbasCG3GrAvFxqwI5cqsC2XKrAoBzqwKVdKsCynSrAkt2qwLtdqsCGHerAh13qwIid6sCJ3erAix3qwKzd6sCqXirAsV4qwIKeasCVnurAuV7qwLCfasCU4CrAvGBqwIMgqsCeoKrArOCqwIwg6sC6YOrAsKEqwIQhasCO4WrAnGFqwKvhasC3oWrAiiGqwL5hqsCcoirApeIqwINiasCdomrAu2JqwL0iasCoIqrAgOLqwJAi6sCxourAu2LqwIqjKsCqoyrAiKNqwJpjasCUo6rAtuQqwKdkqsC0IYjCkZvpg8KqPsSP7H7Eoi0-xLTufsSBsn7ElbK-xI78PsS_QD8Ep4L_BJKDvwS9A78ElYP_BL-EfwSIBP8Eq4T_BIOFPwSvBT8Eh4V_BI3FfwSnBX8Er7z5Rb3VmsaWwCSKaJJ-kJjsRt4&awbid_c=AKAmf-Cx1iG09dXmWC1HVOueEFcnnZ7KOw2PnK2vpn9jhvCAGXI9gV8Ngm6rY6_ZdTS17flmMgy1Po3RAz3PuJxm8HO0Px9jnCU4G32rsulJofUVvjCyilBGD-jC_dSSMqrzyzVPOskTVvsnHZ8TLDIDJ3qSR2PEeJ2ur1jUeHuqN2SO2slOO61sgoknKZGbaLGG6ls3ICssMBAXv8fs4H9sCpiN3sC3IYZSoWTFj4eDq6IaNORIGX8RYXinDCEz2EzFE_e8eR2x4TWfdLfI7P_JKN6julF-qK-eMhKKB1EdCPYyp8LlpbOcDCdFSvAfgN7df50DK5BZ78qo1CcPulIQts-E73icHqCP0SF1g_MdE26L6v8ClRKyTTEtbA8BQFed_-K9u6srvOO-jr4oy5dmJnJZ6-8p_8Av_tnfZAy57JCwVO9fWx0m3qhSx3TdgyAk_-QTz1IoPJ3h9qDekPe2F22FIrWORMZZOomfy_GdAJXOHeDQcewnD2DwrgavNVl9Ujvv4jDQ-9WXzIyu0B_9-XEROWYoHi1_HjjZX8VUw2MVPpPGw-nGzoXhZfSwdgyqoO39PzrzdXBvHXlxjhThDrXcGxcfRw&awbid_d=AKAmf-Cr9oRIRY70Dw18cokVxNLSHtsmaya0wOSgqvrqMNibEb-7CiZPbtVW-md-bczhl_ng1rF_jBZw-wkMZ_Xa2WlpQinDMfb-zT_tdeOSsrHSLMMe61hGefNf4AxSMyw9vJZjrJEXra6z1jgyC2H6ehSIv09H0PF9jqbFf1ZH26SzBOchkmz1_Ym609U-dcZ93hxIio8er7XctwOs_ZNuRSRifvJ3vFeUwtEyae59uSKO58zDC7mW1ZPD-3r4EJGnPasZ7WfP2Gb-CVxRrwLHtoMJVqf7SQMjdtxX7gxueTUqdGZYhe4e-QQmEsK97Q2aWmLwVZ6caOLX1UMkHtZwYNv8SXd2MiItMWaYd_tQTh-sIfY7Wrm2_pFB8hDaihfqLQfdtgl6wki_nAUjSfC1a1YIzI9LLWkuLiyzdl-PqHe8A6YzVzkuvam4tNMrxcOZDEr9YxE-JF2TmEbfqDHN9irc9ifp0tADc8ZpFey0laplce4fPRSRteRykhv1d-qclOFZX_I0zqRHL-RfRiMBr4nmeulNecTs8uuMhKPVXjNPOL-_pAjqDfCVGKaP_7P_j-9bFGmv9GtWQ_IuWtuNYXWcCcWjh8CyYHG9q2bBmn6TIouBa6wZTvGZUEBKBz_Whe886Bog_4zsDuGLsiGN4uCaqHBzCImuAbwV2oHtCUdJkJjyXyxev0M6ORAdXAbkczneuPKaWXfAsDJk65jUU91iQQ4CVznJmn3prVngL582peTLP5PmnWhxi_Sa41g5rHnO8ku0UEm7Jztbj75i3F-T4YAt496AVT1WfAfwNrgY4scK5rGw-V1Y48hDR4NTep1FnglzBU_LcjQfhXuF85kvc-1AzsPWCEwSN_nN0PDW-5q2RcMmsMtpC3e8Z0NOLX3yQpfiEMk5EGv_7U4nUK9DD0NM0ElivWZAgZffdtRXETAJyiU9SwJw80aXQETUZKUWd21ihg_AZ2XG3rByvWT7iSEZY65gcMvXEYrrK19sT2cz16JBc8tX4vCluPVusyRU22BNnBoo_HRXmjplwSueNgSYRsVGITkzvJyteEMrBXDTjhAGVqVD3l4dDtrUwMWWhdNkm8n2YnslVITCiuqC_xPiQThsAwdJxl6aTKzjMAwoM5wpB8CMwkIldBknkI1zVONLY_MaE71IPJAjdVWhEE8DCFg3CMAg6uQsQEyWkRSn5WUC1jZfYesjApeXMtlwdPvI&cid=CAQSGwBpAlJWX8W2ZlNO-_gmFeV_sONnmBtM8jTlRxgB&exk=740344628&rfl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials&a_pr=13:ZMZnzAAAAACMuqaNrip8QvpE3EaTghqkZVGmVQ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
616caa77f3b26bf752bc7e76e496c90f09e972978a16e9fd7111d8f23009f504
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://googleads.g.doubleclick.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 15:07:26 GMT
content-encoding
br
x-content-type-options
nosniff
age
167455
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14704
x-xss-protection
0
last-modified
Mon, 24 Jul 2023 13:39:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sat, 27 Jul 2024 15:07:26 GMT
p
cdp.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://sample.dragonforms.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Origin
*
Access-Control-Max-Age
1800
Connection
keep-alive
Content-Length
0
Date
Sun, 30 Jul 2023 13:38:30 GMT
Keep-Alive
timeout=5
Server
Apache
vary
access-control-request-method,Access-Control-Request-Headers
p
cdp.omeda.com/olytics/segments/ Frame 394F
0
244 B
XHR
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

Date
Sun, 30 Jul 2023 13:38:30 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Access-Control-Allow-Origin
*
Connection
keep-alive
Keep-Alive
timeout=5
X-XSS-Protection
1; mode=block
sodar
pagead2.googlesyndication.com/getconfig/
15 KB
11 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gda&tv=r20230726&st=env
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-1234567890123456&plah=www.fiercebiotech.com&bust=31076543
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
42e23f57908a08950b7e221bca83b2c9ea5c1694fbebdb634ab921a5ae72eb3c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
11632
x-xss-protection
0
roundtrip.js
s.adroll.com/j/
75 KB
24 KB
Script
General
Full URL
https://s.adroll.com/j/roundtrip.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:4000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
24531586243716024441a7e3cc9205ce05b292bd83cb5312d2d493c97eac5da5

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

X-Amz-Version-Id
xO0585DcUO7TuvCzz4QVg5es_RQa70eJ
Content-Encoding
gzip
Via
1.1 b2ba97e9b6a83eff85433dad7f6e6288.cloudfront.net (CloudFront)
Date
Sun, 30 Jul 2023 13:19:04 GMT
Age
1158
X-Amz-Cf-Pop
FRA60-P4
X-Amz-Server-Side-Encryption
AES256
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
Connection
keep-alive
Last-Modified
Thu, 27 Jul 2023 14:03:53 GMT
Server
AmazonS3
Etag
W/"38df04c992cef7a8d4a8f07976c72fa5"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Access-Control-Max-Age
600
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
Q2-W5M5DS3jaTlNVBrRuUjC-lXN3OSuIH3woFxLupMxX2_AgHgHA_A==
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
67 KB
14 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.32.99.85 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-32-99-85.fra60.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
c9e503c45296aa48ca5f2ceb1f169618c5480f2d0f2362321cdca912d395bb68

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sat, 29 Jul 2023 20:34:16 GMT
Content-Encoding
gzip
Via
1.1 0c792defeeaa18965559ad74895ea56a.cloudfront.net (CloudFront)
Last-Modified
Wed, 28 Jun 2023 18:00:17 GMT
Server
AmazonS3
X-Amz-Cf-Pop
FRA60-P3
Age
61461
x-amz-server-side-encryption
AES256
ETag
"a0046de59a0810b9abbf594e83d2ee9b"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
13595
X-Amz-Cf-Id
kTmNw2SdAtnLp9usLzguEog3HhRANTOyDOj2sEJ_sYiStx-1uxwUhQ==
fbevents.js
connect.facebook.net/en_US/
171 KB
47 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f083:100:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
52ea134848cf261f25b89a48cf302f4d97f3d69ef6db75c3648ff1ea6cd6fb3a
Security Headers
Name Value
Content-Security-Policy default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-security-policy
default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Sun, 30 Jul 2023 13:38:22 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
47009
x-xss-protection
0
pragma
public
x-fb-debug
PtHsWdtCFo//nbbehwy6IQgRE+/719KvrozybIajvbf/s8FGKsOWcnN79iBq7WP8zmv59aIJ1c9iXDAhA/PIPQ==
cross-origin-opener-policy
same-origin-allow-popups
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), gyroscope=(), hid=(), idle-detection=(), magnetometer=(), microphone=(), midi=(), payment=(), screen-wake-lock=(), serial=(), usb=()
expires
Sat, 01 Jan 2000 00:00:00 GMT
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
250 KB
70 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: www.fiercebiotech.com
URL: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:218e:3a00:1e:5cef:3780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
0ec6b927b371fe810fa20ec9b5c7a67520672a6123b29cfa8508cedc99c3f428
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 08:55:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
via
1.1 25ad1b0937f8931040e6831f872b7398.cloudfront.net (CloudFront)
x-amz-cf-pop
CDG52-P1
age
18899
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
last-modified
Fri, 02 Jun 2023 00:54:56 GMT
server
Apache
etag
W/"256386-1685667296000"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=21600
x-amz-cf-id
BrF4ibN_SLqPPHAftVmEk7_IVZDjCzSVbjebhducQ4aTNqlTwgzpSQ==
expires
Fri, 07 Jul 2023 08:22:08 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M98WT45
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:218e:3a00:1e:5cef:3780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 12:25:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
via
1.1 25ad1b0937f8931040e6831f872b7398.cloudfront.net (CloudFront)
x-amz-cf-pop
CDG52-P1
age
4380
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
last-modified
Fri, 27 Aug 2021 04:05:28 GMT
server
Apache
etag
W/"28820-1630037128000"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=21600
x-amz-cf-id
vcyaJX8u0H-pH0y7RXGdkl5YzBNFhkRcfpxmGeiUtbMO-ybPqKJR_Q==
expires
Thu, 27 Jul 2023 00:25:25 GMT
blank.gif
rdcdn.com/images/
Redirect Chain
  • https://rdcdn.com/rt?aid=19932&e=1&img=1
  • https://rdcdn.com/eow
  • https://rdcdn.com/images/blank.gif
42 B
198 B
Image
General
Full URL
https://rdcdn.com/images/blank.gif
Protocol
H2
Server
3.218.41.11 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-218-41-11.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 /
Resource Hash
47043e4823a6c21a8881de789b4185355330b5804629d23f6b43dd93f5265292

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
last-modified
Thu, 23 Dec 2021 21:40:22 GMT
server
Microsoft-IIS/10.0
accept-ranges
bytes
etag
"0e70b045f8d71:0"
content-length
42
content-type
image/gif

Redirect headers

date
Sun, 30 Jul 2023 13:38:22 GMT
x-aspnetmvc-version
5.2
server
Microsoft-IIS/10.0
x-aspnet-version
4.0.30319
content-type
text/html; charset=utf-8
location
https://rdcdn.com/images/blank.gif
cache-control
private
content-length
151
olytics
oqs.omeda.com/oqs/rest/ Frame
0
0
Preflight
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.165 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercebiotech.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Access-Control-Allow-Headers
Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Access-Control-Allow-Origin
*
Access-Control-Max-Age
600
Connection
keep-alive
Content-Length
0
Content-Type
text/plain
Date
Sun, 30 Jul 2023 13:38:21 GMT
Keep-Alive
timeout=5
Server
Apache
X-Content-Type-Options
nosniff
X-Frame-Options
SAMEORIGIN
X-XSS-Protection
1; mode=block
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50506
x-xss-protection
0
server
cafe
etag
12377293121200424089
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:22 GMT
olytics
oqs.omeda.com/oqs/rest/
15 B
359 B
XHR
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.165 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
8fed0359a978607741335672c13815cef49036c52f9d3c3173d365840a967ccb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
application/json

Response headers

Date
Sun, 30 Jul 2023 13:38:22 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Vary
Accept-Encoding
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
15
X-XSS-Protection
1; mode=block
sodar2.js
tpc.googlesyndication.com/sodar/
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202307260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-1234567890123456&plah=www.fiercebiotech.com&bust=31076543
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
6386
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
etag
"1637097310169751"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Sun, 30 Jul 2023 13:38:22 GMT
index.js
s.adroll.com/j/exp/M44CQYIBABACREQHDLDG2L/
54 B
811 B
Script
General
Full URL
https://s.adroll.com/j/exp/M44CQYIBABACREQHDLDG2L/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:4000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e9f6b7adef81eaa57f5ac0afaab01f012e6aa4d9e313422ceb1fd48eaf4704b9

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

X-Amz-Version-Id
rOBM9Y7f7hz4kk2MhNmlqfpG2amzPoVc
Date
Sat, 29 Jul 2023 15:30:31 GMT
Via
1.1 b2ba97e9b6a83eff85433dad7f6e6288.cloudfront.net (CloudFront)
Age
82873
X-Amz-Cf-Pop
FRA60-P4
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
54
Last-Modified
Tue, 21 Mar 2023 16:35:00 GMT
Server
AmazonS3
Etag
"92f236985154a498583372b1231d6526"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Max-Age
600
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
kBK5Xa2pqifplusii_A2xPuxUefMRgb4xYCLRclPZW9JDt-mKWUCzA==
index.js
s.adroll.com/j/pre/
Redirect Chain
  • https://s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/fpconsent.js
  • https://s.adroll.com/j/pre/index.js
0
756 B
Script
General
Full URL
https://s.adroll.com/j/pre/index.js
Protocol
HTTP/1.1
Server
2600:9000:225e:4000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

X-Amz-Version-Id
nQEe8wQ7h0ROt7P4GJfDfstto6x684Hy
Date
Sat, 29 Jul 2023 15:25:39 GMT
Via
1.1 b2ba97e9b6a83eff85433dad7f6e6288.cloudfront.net (CloudFront)
Age
79968
X-Amz-Cf-Pop
FRA60-P4
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Last-Modified
Wed, 15 Jan 2020 23:54:18 GMT
Server
AmazonS3
Etag
"d41d8cd98f00b204e9800998ecf8427e"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Max-Age
600
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
3vQTO-SJvJHIyW_HrDjKLR5aW_X5lMQe9AF0oNZCWPzlTCebu5jmuw==

Redirect headers

Date
Sat, 29 Jul 2023 14:40:21 GMT
Via
1.1 b2ba97e9b6a83eff85433dad7f6e6288.cloudfront.net (CloudFront)
Age
82680
X-Amz-Cf-Pop
FRA60-P4
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Server
AmazonS3
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/xml
Location
https://s.adroll.com/j/pre/index.js
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
QIiVH1aE-rtJa3h7sc0-q2rTKAkajH00I4U_FEDgStLwPo610R0Exw==
index.js
s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/
0
809 B
Script
General
Full URL
https://s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:4000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

X-Amz-Version-Id
5F2736iJwLBceBH4ggiOfwKNn.YLWIWv
Date
Sun, 30 Jul 2023 13:12:03 GMT
Via
1.1 18c9dea802c00b7c060142aad49f7288.cloudfront.net (CloudFront)
Age
1583
X-Amz-Cf-Pop
FRA60-P4
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Last-Modified
Tue, 25 Jul 2023 12:03:22 GMT
Server
AmazonS3
Etag
"d41d8cd98f00b204e9800998ecf8427e"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Access-Control-Max-Age
600
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
KmRHYV6fDzyv4trKue_1AenhsY_hwpXe02GDXlNwMYRUIwZGU7rKiA==
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&zn%3D%26sn%3D%26q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D851416%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww....
  • https://a.dpmsrv.com/dpmpxl/index.php?id=9180574489285656783&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=851416&tzOffset=0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-fundin...
263 B
1009 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=9180574489285656783&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=851416&tzOffset=0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
Protocol
HTTP/1.1
Server
52.71.196.103 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-71-196-103.compute-1.amazonaws.com
Software
/
Resource Hash
b1f4fc34cd2c8865e4fa2d1e044a7a41e2e57795003111f775a56f1dc440fae2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
Content-Type
text/javascript
Access-Control-Allow-Origin
*
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
230
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
an-x-request-uuid
f88c3f51-f8f4-47e5-bc24-77f9d1bbe60d
server
nginx/1.21.3
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://a.dpmsrv.com/dpmpxl/index.php?id=9180574489285656783&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=851416&tzOffset=0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497
x-proxy-origin
217.114.215.131; 217.114.215.131; 952.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
2257373971216750
connect.facebook.net/signals/config/
377 KB
108 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/2257373971216750?v=2.9.119&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f083:100:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
2c7c94f261088e8c78b8331865755b8633d03eb704105dbee6a76fea60067090
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Sun, 30 Jul 2023 13:38:22 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-xss-protection
0
pragma
public
x-fb-debug
oc1uYQgX03Jsm7kkm4Mqrzepdunp0eE8Sg5vSt20Bj8Iz6XQs2gcbTewdG6IzVAmFlb9L+kc8XsJalGKKlFJcA==
cross-origin-opener-policy
same-origin-allow-popups
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/x-javascript; charset=utf-8
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), gyroscope=(), hid=(), idle-detection=(), magnetometer=(), microphone=(), midi=(), payment=(), screen-wake-lock=(), serial=(), usb=()
expires
Sat, 01 Jan 2000 00:00:00 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/225/ Frame 9D46
13 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
bytes
age
55507
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=31536000
content-encoding
gzip
content-length
5046
content-type
text/html
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
cross-origin-resource-policy
cross-origin
date
Sat, 29 Jul 2023 22:13:15 GMT
expires
Sun, 28 Jul 2024 22:13:15 GMT
last-modified
Mon, 21 Jun 2021 20:47:05 GMT
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
server
sffe
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
aframe
www.google.com/recaptcha/api2/ Frame EA91
783 B
536 B
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
a488725856de6dc4c99103ad14773ad004871fa52aa58b23e5ba8bf08d1f4278
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-B3sJ1bRxPHJcFkxajWX-sA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private, max-age=300
content-encoding
gzip
content-length
514
content-security-policy
script-src 'report-sample' 'nonce-B3sJ1bRxPHJcFkxajWX-sA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:22 GMT
expires
Sun, 30 Jul 2023 13:38:22 GMT
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
gpt.js
www.googletagservices.com/tag/js/
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
27718
x-xss-protection
0
server
cafe
etag
920 / 19568 / m202307250102 / config-hash: 5693953215715342715
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Sun, 30 Jul 2023 13:38:22 GMT
YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
pagead2.googlesyndication.com/bg/ Frame 9D46
37 KB
14 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/YWyqd_Oya_dSvH525JbJDwnpcpeKFun9cRHY8jAJ9QQ.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
616caa77f3b26bf752bc7e76e496c90f09e972978a16e9fd7111d8f23009f504
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Fri, 28 Jul 2023 15:07:26 GMT
content-encoding
br
x-content-type-options
nosniff
age
167456
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14704
x-xss-protection
0
last-modified
Mon, 24 Jul 2023 13:39:59 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sat, 27 Jul 2024 15:07:26 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame EA91
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&li=gda_r20230726&jk=2093194126477304&rc=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

M44CQYIBABACREQHDLDG2L
d.adroll.com/consent/check/
466 B
558 B
Script
General
Full URL
https://d.adroll.com/consent/check/M44CQYIBABACREQHDLDG2L?pv=97067085231.08168&arrfrr=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&_s=fc6a6f5286a55f441378914a59d61ae6&_b=2
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:d018:cc3:fe04:94a6:fd27:12f4:717e Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.22.1 /
Resource Hash
0007e12cf68776cdd9133b1f90e53a6c273614d0ec437f6ffbace7da1f7d8dd4

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
server
nginx/1.22.1
content-length
466
content-type
application/javascript
/
www.facebook.com/tr/
0
185 B
Image
General
Full URL
https://www.facebook.com/tr/?id=2257373971216750&ev=PageView&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&rl=&if=false&ts=1690724302606&sw=1600&sh=1200&v=2.9.119&r=stable&ec=0&o=30&fbp=fb.1.1690724302603.1987925541&cs_est=true&it=1690724302428&coo=false&exp=a1&rqm=GET
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f176:84:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Sun, 30 Jul 2023 13:38:22 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
generate_204
tpc.googlesyndication.com/ Frame 9D46
0
10 B
Image
General
Full URL
https://tpc.googlesyndication.com/generate_204?Om0mgA
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/sodar/sodar2/225/runner.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
report
creative.spotible.com/creative/F0xc/
43 B
117 B
Image
General
Full URL
https://creative.spotible.com/creative/F0xc/report?,1690724301,693001;TIME_TO_DELIVERY!0,1,0;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0;IN_VIEW!0,1,1!18,1,1!55,1,1!69,1,1!113,1,1!120,1,1&referrer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
cache-control
no-store
content-type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
26 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuD7HHKykTOqH7Q0-1gOrBMNz1zILAXT-gjVv158UnNqcSnUG_iEHfLTvLvV9j5-e0q6J7dP7b_Zurp-549S7tPzylZl1h62xeqO9X0QzNJ45426_iaUUsWZIvgx68QtJlr4nKofrOHArrNyCzBmpUehAB4gAYIundVNfb_5DuyeC1HsJ1BIivI_CBBE2qsdlJj7GOKARMYPSX1blPR2HBSMEC04caRjspkT7BeLB-KNXXfjjIPca9bx06jgQluk4P4x_MCUjkU4Nt2PSCU__B3XPxsSwcHGjKV9MPzh34gNAa55cG78HCxQCo1kK1LxNtuqp156LtwKegTenpD3WYh5x-jxgOh9MqZbZs3haNhQ88bS-5Bf3I&sai=AMfl-YS26uDnzHYqotiWCdo6huIW24J40Wox-K2OybWQ4m6NStfX3QjzdFTUuAFo7r7v_oeVDaxVpqtXBWn4x4AusPxiy9-hTNGFmDzHaQ&sig=Cg0ArKJSzJ30o_FF8OWoEAE&uach_m=[UACH]&urlfix=1&adurl=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:22 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=9180574489285656783&pixelIndex=0
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=9180574489285656783&pixelIndex=0&google_gid=CAESEKJM-nkwDi7yNK8TtOyA1vQ&google_cver=1
0
598 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=9180574489285656783&pixelIndex=0&google_gid=CAESEKJM-nkwDi7yNK8TtOyA1vQ&google_cver=1
Protocol
HTTP/1.1
Server
52.71.196.103 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-71-196-103.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Content-Type
text/javascript
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:22 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=9180574489285656783&pixelIndex=0&google_gid=CAESEKJM-nkwDi7yNK8TtOyA1vQ&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
348
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/
0
99 B
Image
General
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=9180574489285656783
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
68.174.244.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:23 GMT
via
1.1 google
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
/
www.facebook.com/tr/ Frame FB5A
0
77 B
Document
General
Full URL
https://www.facebook.com/tr/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f176:84:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Content-Type
application/x-www-form-urlencoded
Origin
https://www.fiercebiotech.com
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

access-control-allow-credentials
true
access-control-allow-origin
https://www.fiercebiotech.com
alt-svc
h3=":443"; ma=86400
content-length
0
content-type
text/plain
cross-origin-resource-policy
cross-origin
date
Sun, 30 Jul 2023 13:38:23 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
956.svg
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 394F
2 KB
1013 B
Image
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/956.svg
Requested by
Host: hostedcontent.dragonforms.com
URL: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/958.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:ec00:c:860d:a440:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Apache /
Resource Hash
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/958.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:12 GMT
content-encoding
br
x-content-type-options
nosniff
via
1.1 04ce5a607a98db6d08257633417b84d6.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
age
11
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
last-modified
Mon, 04 Oct 2021 17:02:01 GMT
server
Apache
etag
W/"1609-1633366921470"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
access-control-expose-headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
x-amz-cf-id
b7hs4hetoYXwjj-mGzica9nP4Ha6lFmNHCVQ2DcS85VsQptUshDLTA==
sodar
pagead2.googlesyndication.com/pagead/
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=225&t=2&li=gda_r20230726&jk=2093194126477304&bg=!_f6l_qrNAAZGOVy5Zjk7ADkAdvg8WoMQZPZaKQzEkJBb8S3HH1LHc2vjLHHga9IklTGlWkdwsIzQVPBM127TJ-sbSWcVeQWcqsACAAAAn1IAAAANaAEHCgCs_GEukcHIefGGGn-ew4eemhuJBkIfzzRdLk42BBBEHe5Ad00atonJ5fEuMIcQk15yz5BJEoFf7WVQDypSNK1rMD-NbAcFMFhQqE106WOjegb11p9i50QrJBb6mrBGDfVtgbKl2lt1S2s4Mnl1cgDCIiR2wBwtXbQ1cm12LrtCX7dyGNXMsrxNGnn4PzoY24WV-rlWFQWsOXhAhohGIZJ785yeWIevgsRjcJhAGJkCq82dees76ouzEt1GGHjKVVrKnJ37ovhLb5DQcD-D-vobwKrf_lUCDGV8DtltQtD9mqKDnsoa_AbkcMCm1sTJwBNT47ZsZ8lmOGCTIeCH2A_Q_PB4_E5hsVqEa04gQJObi526Z6DfLz2zLSsJ2JeZYtttDKlV_0mipR8de9Cwh49VPgC9oG5OEKwK2pDoXFPz6NIotP3JBY6QBuC3UaiXvqjpqTm0-DqOPacjsBontJxWeM31eLdzSKXs4EtubgdlZdhUMc8BTqGe-ch2FV5Zix1MmDiX9KRuU2SAbdw6U37laEh0kVLN-ii52piTTYJp43vUgGlBA1w71O91p8kLF3b8M07soNeojGYr35IFRjv5ZQleiEW9BrLBpWxuwbd7MQ1qS5tyxIfl1G5E9n0HsgqnWit24dArqExrTeqgSFhWr21WJAIOPGXUBXSx-e1Zgcz4JprS4Yl3xHulHCBOA9eWbIGn70QEPCh1WQgOgsvdPR5ZVXHgmWqRzEc2jxEQpAnnW-WnwbBoyEI5LRkoY879P-bnkPPiW9ZUIMfBmjU1Gfz7lCTyIHFhFj2ZUUclTaOOWncSZ-ZTmign9QAOvfuJ71q071-cznVVUpdAEgmvE3W3uuh2qDzUmmdSwT83Zybc-EnrPhTF0fYzo6Q-kTVYGWMUTZYJKdGj_Ac3ux9nw-xAjpYe6Fe2Y1C3A1zcWzNj-pSL_ZrHMtwnWtEcJOawVNP9kKPZO6FFCyJyF_nbxx5eBVOulc4ykRkDxfIJiOub-2RVsfuOB7Ix2RSKjwdFXrI6szScy07_fuIX4k88kEgOF47OTPuMbhY_sezhgzyJwCS0M8pPNYR5MP5qArI5hnGiApMMVR6FiufjzSsVwiO9xZlnU-ntw8iY61PQSIHGOMGjiosbxMAW
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

p
cdp.omeda.com/olytics/segments/
5 KB
5 KB
XHR
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
6949a2ed4ae7376b016792e21581479483d6a8848b60f07a6e087fda32d6fd3d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

Date
Sun, 30 Jul 2023 13:38:22 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
4691
X-XSS-Protection
1; mode=block
p
cdp.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercebiotech.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Origin
*
Access-Control-Max-Age
1800
Connection
keep-alive
Content-Length
0
Date
Sun, 30 Jul 2023 13:38:31 GMT
Keep-Alive
timeout=5
Server
Apache
vary
access-control-request-method,Access-Control-Request-Headers
QRTZ22+Cookies+Consent+-+Close.svg
s3.amazonaws.com/publicaudience.qtxasset.com/All+Brands/Omeda+Assets/Icons/
479 B
839 B
Image
General
Full URL
https://s3.amazonaws.com/publicaudience.qtxasset.com/All+Brands/Omeda+Assets/Icons/QRTZ22+Cookies+Consent+-+Close.svg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.231.135.88 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
fcfe47ed943044cf2222be54bb97f838b5c8a3ff0668dbb8452aae6db388a877

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Date
Sun, 30 Jul 2023 13:38:24 GMT
Last-Modified
Tue, 07 Jun 2022 15:36:55 GMT
Server
AmazonS3
x-amz-request-id
F6A04RH5HR7CZ59Y
ETag
"c2c81d349f706817873eb7298d232ea1"
Content-Type
image/svg+xml
Accept-Ranges
bytes
Content-Length
479
x-amz-id-2
OXh5fudVyxd8VQ+DMQQuPVC9GrH+0NwlVD9MnYHAEt9QJKAHUQAd6IeJNpk9bq2KLdZRvtT+Nxg=
collect
region1.google-analytics.com/g/
0
17 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-LESW06PJYD&gtm=45je37q0&_p=268259825&ul=en-us&sr=1600x1200&cid=1294825810.1690724299&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_eu=ABAI&ngs=1&_s=2&dl=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&dt=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&sid=1690724299&sct=1&seg=0&en=read%20title&_ee=1&ep.event_category=User%20Article%20Consumption&ep.event_label=Power%20debuts%20with%20%247M%20seed%20funding%2C%20focus%20on%20clinical%20trials&ep.value=1&_et=11
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-LESW06PJYD&cx=c&_slc=1
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:24 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercebiotech.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
report
creative.spotible.com/creative/F0xc/
43 B
103 B
Image
General
Full URL
https://creative.spotible.com/creative/F0xc/report?,1690724301,693003;IN_VIEW_TIME!0,4,0!18,4,0!55,4,0!69,4,0!113,4,0!120,4,0&referrer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:25 GMT
cache-control
no-store
content-type
image/gif
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?zn=&sn=&q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C29028703%2C16013439%2C16594949&cl=913&pixelIndex=0&r=402969&tzOffset=0&url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials%3FmsID%3D545a7775-efc3-4481-8f80-a3244d80c497&id=9180574489285656783
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.71.196.103 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-71-196-103.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
Content-Type
text/javascript
Access-Control-Allow-Origin
*
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
844 B
Image
General
Full URL
https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,16013439,16594949
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.89.210.82 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
952.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net
Software
nginx/1.21.3 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 30 Jul 2023 13:38:25 GMT
an-x-request-uuid
f94fa761-8066-456a-818d-fa3c9cc4344f
server
nginx/1.21.3
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
image/gif
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
217.114.215.131; 217.114.215.131; 952.bm-nginx-loadbalancer.mgmt.ams3.adnexus.net; adnxs.com
content-length
43
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
report
creative.spotible.com/creative/F0xc/
43 B
103 B
Image
General
Full URL
https://creative.spotible.com/creative/F0xc/report?,1690724301,693004;IN_VIEW_TIME!0,3,0!18,3,0!55,3,0!69,3,0!113,3,0!120,3,0&referrer=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Fpower-debuts-7m-seed-funding-focus-clinical-trials
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.206.144.175 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-18-206-144-175.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/115.0.5790.110 Safari/537.36

Response headers

date
Sun, 30 Jul 2023 13:38:28 GMT
cache-control
no-store
content-type
image/gif

Verdicts & Comments Add Verdict or Comment

115 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| 13 object| 14 object| 15 function| mobileCheck object| dataLayerValues object| dataLayer boolean| loadExternal function| _bmb object| googletag object| vmpbjs object| vpb function| initGam function| bomboraDependentInitWithTimeout object| meta string| gamPath object| pubAds object| adUnits object| webpackChunkquartz_vuejs number| lastScroll function| floatMainMenuOnScroll function| closeMobileSubNavs function| getClosest function| setCookie function| getOlyticsGamSegments function| olyticsDfpSegments function| loadOlyticsSegmentsFromOmeda boolean| __VUE__ object| google_js_reporting_queue number| google_srt object| google_logging_queue number| tmod object| google_ad_modifications object| ggeac object| google_persistent_state_async boolean| google_measure_js_timing object| google_tag_data object| google_reactive_ads_global_state object| adsbygoogle object| google_sa_queue function| google_process_slots function| google_spfd number| google_unique_id object| google_sv_map number| google_rum_task_id_counter object| google_tag_manager string| google_user_agent_client_hint string| GoogleAnalyticsObject function| ga object| _ml function| gtag object| configOptions function| onYouTubeIframeAPIReady object| gaGlobal function| _typeof object| PARSELY object| gaplugins object| gaData function| google_sa_impl boolean| _gfp_p_ number| google_global_correlator object| google_prev_clients object| ampInaboxIframes object| ampInaboxPendingMessages object| vmpbjsChunk object| mnet string| nobidVersion object| nobid object| teadsscript object| teads object| spotible object| w7eDOMEvents string| adroll_adv_id string| adroll_pix_id boolean| __adroll_loaded function| fbq function| _fbq string| method string| bid string| oid object| olytics object| a string| qtxSection function| setImmediate function| clearImmediate function| normalize object| GoogleGcLKhOms string| adroll_sid object| adroll object| __adroll boolean| adroll_optout object| adroll_loaded object| adroll_ext_network object| adroll_callbacks function| adroll_tpc_callback object| dpmPixels object| adroll_exp_list object| __adroll_consent_data boolean| __adroll_consent boolean| __adroll_consent_is_gdpr string| __adroll_consent_user_country string| __adroll_consent_adv_country object| google_image_requests

57 Cookies

Domain/Path Name / Value
.fiercebiotech.com/ Name: _ga_KG49J84SR4
Value: GS1.1.1690724298.1.0.1690724298.0.0.0
.fiercebiotech.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497%22%2C%22sref%22:%22%22%2C%22sts%22:1690724298743%2C%22slts%22:0}
.fiercebiotech.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=bd9d32bbd3203e200084758c32ca6732%22%2C%22session_count%22:1%2C%22last_session_ts%22:1690724298743}
.fiercebiotech.com/ Name: _ga
Value: GA1.2.1294825810.1690724299
.fiercebiotech.com/ Name: _gid
Value: GA1.2.820736630.1690724299
.fiercebiotech.com/ Name: _gat_UA-336524-7
Value: 1
www.fiercebiotech.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.fiercebiotech.com/ Name: _pubcid
Value: 81280f35-12e3-4930-994e-3a71fb54ca68
sample.dragonforms.com/ Name: JSESSIONID
Value: E39CE2057D09FC312ED576F49CABB576
.fiercebiotech.com/ Name: _ga_LESW06PJYD
Value: GS1.2.1690724299.1.0.1690724299.0.0.0
.fiercebiotech.com/ Name: __gads
Value: ID=f182b9d1d1a6d7e5-22ddb5a11ee30080:T=1690724299:RT=1690724299:S=ALNI_MYLTYRaQF2-8eNW-iM81GiRo9c_uA
.fiercebiotech.com/ Name: __gpi
Value: UID=00000d3129a99992:T=1690724299:RT=1690724299:S=ALNI_Mbu_aGQ441VxvRxKEIZ20Uda9ucBg
.doubleclick.net/ Name: IDE
Value: AHWqTUkqDuJqEKAjLMV0gcBiw8XlcFyDiCcHWRsgsw9cNwvTpPxHxoiKo-3iZxLVAm8
.casalemedia.com/ Name: CMID
Value: ZMZnzDmk.f3TY-1Sf2WW4QAA
.casalemedia.com/ Name: CMPS
Value: 3213
.casalemedia.com/ Name: CMPRO
Value: 3213
.quantserve.com/ Name: d
Value: EBkBDQHLKbjvsQA
.mathtag.com/ Name: mt_mop
Value: 4:1690724301
.pubmatic.com/ Name: KTPCACOOKIE
Value: YES
.quantserve.com/ Name: mc
Value: 64c667cd-b3dff-778e6-fbeb4
.simpli.fi/ Name: suid
Value: D6E86F92BADF4A1FBF50EFFE981BC6CA
.360yield.com/ Name: tuuid
Value: 62ccab2a-4b17-4ff3-9e79-425ce4a5031d
.360yield.com/ Name: tuuid_lu
Value: 1690724301
.w55c.net/ Name: wfivefivec
Value: RvIBoM9u1Qq6CN5
.1rx.io/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-1d7b6303-569c-4993-ae31-08396ea207ef-003%22%7D
.lijit.com/ Name: ljt_reader
Value: HETyqGZHt8EOulvRQhmP-hJI
.pubmatic.com/ Name: KADUSERCOOKIE
Value: 15802CCD-B271-4B93-ABBE-7AEC898D089E
.turn.com/ Name: uid
Value: 4488842556472222677
.adform.net/ Name: C
Value: 1
.adnxs.com/ Name: uuid2
Value: 9180574489285656783
.w55c.net/ Name: matchgoogle
Value: 5
.everesttech.net/ Name: everest_g_v2
Value: g_surferid~ZMZnzQAAApD3_AA_
.adform.net/ Name: uid
Value: 1097296699308755260
.targeting.unrulymedia.com/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-1d7b6303-569c-4993-ae31-08396ea207ef-003%22%7D
.tribalfusion.com/ Name: ANON_ID
Value: a0ntuJS3n0gryoxDmDmSUkZb8YFZdD3AsSA2CZab8tsAJ3Gbg2ekZaQUZcNfdZb1MF1K3UyhHf3Y0V7ZbyafW0dgubjX56v
sync.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-13bff1a0-a01e-5a5a-7e29-c3c018bc9ae7.iZ7mpvQE9CEeG37lYW7y%2BsdFBjhtOCtH17HrcYGGyU4
.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-13bff1a0-a01e-5a5a-7e29-c3c018bc9ae7.iZ7mpvQE9CEeG37lYW7y%2BsdFBjhtOCtH17HrcYGGyU4
sync.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3AE7_xoKAeWlp-KcPAGLya59ly14M.QB9YztoNAJUU6crgxHm7zlzM%2BuAJ%2Feblk1adWAk5QtE
.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3AE7_xoKAeWlp-KcPAGLya59ly14M.QB9YztoNAJUU6crgxHm7zlzM%2BuAJ%2Feblk1adWAk5QtE
sync.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKIHA3H2EEmQtKCcneGn8odvHKBl4NWP20rZid3RNg5kptEHwYBCDOz5mmBjABOgRVNED5QgSadqkd.l7ZFTNQ2pNVDlx1mBXOjUSSZnkPoBa06jKOCLxNs5TY
.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKIHA3H2EEmQtKCcneGn8odvHKBl4NWP20rZid3RNg5kptEHwYBCDOz5mmBjABOgRVNED5QgSadqkd.l7ZFTNQ2pNVDlx1mBXOjUSSZnkPoBa06jKOCLxNs5TY
.dragonforms.com/ Name: oly_anon_id
Value: fcfbbe0d-681f-4799-b406-d36a92ab1018
.fiercebiotech.com/ Name: _gcl_au
Value: 1.1.507521068.1690724302
.fiercebiotech.com/ Name: oly_fire_id
Value: 2894E1346578A7L
.fiercebiotech.com/ Name: oly_anon_id
Value: 5f97bd03-5912-4af0-bfb1-337e5140ae20
www.fiercebiotech.com/ Name: dpm_url_count
Value: 1
.fiercebiotech.com/ Name: _fbp
Value: fb.1.1690724302603.1987925541
rdcdn.com/ Name: aid
Value: 19932
rdcdn.com/ Name: ref
Value: https://www.fiercebiotech.com/cro/power-debuts-7m-seed-funding-focus-clinical-trials?msID=545a7775-efc3-4481-8f80-a3244d80c497
rdcdn.com/ Name: img
Value: http://rdcdn.com/rt?aid=19932&e=1&img=1
.dpmsrv.com/ Name: dpm_pxl
Value: e57ab72655f44869d7487fb1e306857aba9889a6
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 9180574489285656783
www.fiercebiotech.com/ Name: hasLiveRampMatch
Value: true
.adnxs.com/ Name: anj
Value: dTM7k!M4/8CxrEQF']wIg2GTzwtU#!!]tbP6j2F-XstGt!@DFU$^7uv
.dpmsrv.com/ Name: xdpm_segsid_913
Value: 16013439%2C29315652%2C29315642%2C16594949%2C29028703
.dpmsrv.com/ Name: xdpm_segs_913
Value:
www.fiercebiotech.com/ Name: dpm_time_site
Value: 4.004

3 Console Messages

Source Level URL
Text
other warning URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Message:
Origin trial controlled feature not enabled: 'attribution-reporting'.
network error URL: https://dmp.brand-display.com/cm/api/index?cm_dsp_id=191&cm_user_id=%3cIndex_user_id%3e&gdpr=1
Message:
Failed to load resource: the server responded with a status of 502 ()
network error URL: https://idsync.rlcdn.com/423396.gif?partner_uid=9180574489285656783
Message:
Failed to load resource: the server responded with a status of 451 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

819e50b9cbd74797145642ae83b31f45.safeframe.googlesyndication.com
a.ad.gt
a.dpmsrv.com
a.teads.tv
a.tribalfusion.com
a3257.casalemedia.com
a3352.casalemedia.com
a5200.casalemedia.com
ad.turn.com
ap.lijit.com
api.parsely.com
c1.adform.net
casale-match.dotomi.com
cdn.omeda.com
cdn.parsely.com
cdn.spotible.com
cdn2.teads.tv
cdp.omeda.com
cm.g.doubleclick.net
cms.quantserve.com
code.jquery.com
connect.facebook.net
creative.spotible.com
d.adroll.com
dis.criteo.com
dmp.brand-display.com
dpm.demdex.net
dsum-sec.casalemedia.com
dsum.casalemedia.com
encrypted-tbn0.gstatic.com
encrypted-tbn1.gstatic.com
encrypted-tbn3.gstatic.com
fonts.googleapis.com
fonts.gstatic.com
ghb.hbmp.mediafuse.com
googleads.g.doubleclick.net
hostedcontent.dragonforms.com
ib.adnxs.com
idsync.rlcdn.com
image6.pubmatic.com
in.ml314.com
integrations.api.mailshake.com
js-sec.indexww.com
match.360yield.com
match.adsrvr.org
ml314.com
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p1.parsely.com
pagead2.googlesyndication.com
partner.googleadservices.com
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
pm.w55c.net
qtxasset.com
r.turn.com
rdcdn.com
region1.google-analytics.com
rtb.openx.net
s.adroll.com
s.amazon-adsystem.com
s.dpmsrv.com
s.tribalfusion.com
s3.amazonaws.com
sample.dragonforms.com
secure.adnxs.com
securepubads.g.doubleclick.net
ssum-sec.casalemedia.com
static-cdn.dragonforms.com
stats.g.doubleclick.net
sync-tm.everesttech.net
sync.1rx.io
sync.adotmob.com
sync.mathtag.com
sync.srv.stackadapt.com
sync.taboola.com
sync.targeting.unrulymedia.com
sync.teads.tv
t.teads.tv
tpc.googlesyndication.com
um.simpli.fi
ups.analytics.yahoo.com
vi.ml314.com
w1.msonr.net
www.facebook.com
www.fiercebiotech.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.googletagservices.com
www.gstatic.com
x.bidswitch.net
104.16.93.165
104.18.0.165
104.18.10.47
13.32.99.85
141.226.228.48
142.250.186.98
151.101.194.49
178.250.1.9
18.193.242.108
18.200.152.171
18.206.144.175
18.66.100.58
184.30.21.51
184.72.142.9
185.170.61.158
185.183.112.155
185.239.173.226
185.29.134.244
185.64.190.78
185.80.39.216
185.89.210.82
2.23.193.36
2001:4860:4802:32::36
2001:4de0:ac18::1:a:3a
2001:678:cb4:bbbb::11
204.180.130.159
204.180.130.165
204.180.130.190
216.52.2.6
23.35.233.56
2600:9000:20e1:4000:0:d27a:1440:93a1
2600:9000:218e:3a00:1e:5cef:3780:93a1
2600:9000:21f3:ec00:c:860d:a440:93a1
2600:9000:225e:4000:6:9280:1080:93a1
2606:4700:10::6816:445
2606:4700::6812:18ad
2620:116:800d:21:93ca:31d8:d86e:38f6
2a00:1450:4001:801::200a
2a00:1450:4001:803::2002
2a00:1450:4001:806::2002
2a00:1450:4001:80e::2002
2a00:1450:4001:812::200e
2a00:1450:4001:81c::2001
2a00:1450:4001:81c::2003
2a00:1450:4001:81c::2008
2a00:1450:4001:81c::200e
2a00:1450:4001:829::2004
2a00:1450:4001:82a::2001
2a00:1450:4001:82a::2002
2a00:1450:4001:830::200e
2a00:1450:4001:831::2002
2a00:1450:400c:c0c::9d
2a02:fa8:8806:16::1370
2a03:2880:f083:100:face:b00c:0:3
2a03:2880:f176:84:face:b00c:0:25de
2a05:d018:cc3:fe04:94a6:fd27:12f4:717e
3.121.2.145
3.218.41.11
3.33.220.150
3.71.149.231
34.111.151.213
34.111.234.236
34.199.107.80
35.201.104.135
35.204.158.49
35.227.252.103
35.244.174.68
37.157.2.234
45.133.44.3
45.133.44.4
46.228.174.117
51.89.9.254
52.17.99.225
52.45.228.109
52.46.155.104
52.50.218.26
52.71.196.103
54.161.101.43
54.231.135.88
54.242.108.196
85.91.45.114
85.91.45.166
99.86.4.16
0007e12cf68776cdd9133b1f90e53a6c273614d0ec437f6ffbace7da1f7d8dd4
00daef3b4a945d15f73efa05e0ce2ca51f2f8252e1da8fae5c2efb0f6dddacce
02bdfd091f909a233b77e4bd3a1350a2f29346ba77e624a42db18db92e791f9c
04c427901e1cf06d8a972099bc153b023a27c4363ccb81cde103bcc50a205a9b
056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085
05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e
08204982c484faf6890c60557a4e642971f17625ddddc0559dc0e3ca728ac9e0
0b2c524428c1a3604e3d1cdc61c2ae371a8f2fc767f801180fcf892db9e07c3c
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
0c3dcfcc937a70bbad86dd39d6f3d40c13ea8a3475e0b68603b4fee9bca75891
0cac808009bfcc42b61e3ade0e57c689c205423cb27fc399d5d2b29804da197a
0df1eaf1f271afa113a8edca24af447a0b5062f782b458d39570b2a83bd762f9
0ec6b927b371fe810fa20ec9b5c7a67520672a6123b29cfa8508cedc99c3f428
0f419f9cd92714729152f780c08164bbb1393aeae2ac23b140e0b3f617ee6250
15956d2c3095d247b78831890d6535c7a33fe83bd3b049133a438ee959d48556
18e7a53e3b3abd7ac0242719f7f62cb56b8efe7065091585b8ad22cbc2b8c41c
23f95a90d6e6ba09a92bd4eae99823b0a6b0137a9abe10e3c050c062fb15efe4
24531586243716024441a7e3cc9205ce05b292bd83cb5312d2d493c97eac5da5
26767f0b7032e460e8500deff8d9077a9f8fdc3f43fceb30d3a6ec067c5e8382
27700283771396d86710e130a67bb11bbe5d0acf594ba7b8abfb6fd8cbc4fb22
2b81d74611b86412eaacf368de07f273ab99505e5a80df3de33c4360f8dd9555
2c7c94f261088e8c78b8331865755b8633d03eb704105dbee6a76fea60067090
2deb0d094a307e99fcaa3dfd02f9802de8e485134d85a2f1d2d77d453dc8b934
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363
2e8bef1c0272cff37e8a4abbb9af3cc9d83405c6c68acb9ecc1b687b629426dd
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
328d9d45dbe2d59730428d1a063867908cd2e1e50322766040ce094755e3410e
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7
330e88d1e97d756be9ba0bb0c910088d8198326050b129ac8dbf97d96a6d235b
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586
3861f9a97b280968f74ff648c5b31585999177de35d08f7e6ca5abe7e5a623a1
3aa8da2b1af8f47cf5061213e2995ce49a61551aa96557c56b3cdbed3c413567
3c844e2c3788b54e86e8b004cc0a7fc8b55e30057cc3ec68abf1207687fc0d34
3d2d41c2a37cccee3fce2b93c9f7ac27e33093b96646cd5fd328038c1f4377d1
3d6da5e9b28773a4962683b187b59a29a690a7389acc8746461ef2a8b4703ac7
3ebd87f2d77fd3e9e91c8428e779214c25477c750665d3683d57024155fda1d7
3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d
400d057eb35236224a79263c14b87a5c94c3489b6f24c1d91a710970f8391dda
40a4c209d794b190383c83ea7c770a4234472a4a224ed8bf6ff7a38c7aa5c336
41559d2aea8b60a1190d8489501bb6a3544ef6b4e0a8021406442bf4aaa6a1c3
41c5548067978ac1de20d971fe35fbbd96dd0cd57f82b58e1aa3aef3aa12e80a
42e23f57908a08950b7e221bca83b2c9ea5c1694fbebdb634ab921a5ae72eb3c
444a82c74d7b9711b6bb1188114e3b5903babf5ca11cadbd161123d74f8886ce
468959e93f9b4e6f07c6a8f8d0e93d8fcb37d76a8615a93ec153f5842247ba99
47043e4823a6c21a8881de789b4185355330b5804629d23f6b43dd93f5265292
48a33ca9f42b91902d57ad8ac52e1ce32b92c8c10c732f2dbb6fe960ebfd9438
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
50d6a3f1b2331e167bf8d7cd4cddbaee88cc3047f1320e26eed0fc06194ca06d
518f889d84d6e986d0a32e570bd2f9e4be4125ab5c2402fc6a977781f0ddfb6d
52ea134848cf261f25b89a48cf302f4d97f3d69ef6db75c3648ff1ea6cd6fb3a
541342cb8883e2e67cb464fb8869443cc630394b994f233bcc4ad72ace08a7eb
542a28184522f926e475ece8fefd244ff3c3e1d6b694156d2be685a9746f812e
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87
55a119c0394f901a8a297e109c17b5e5402689708b999ab10691c16179f32a4a
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
5772c5185f32dda5764c242078a94d4a3f3e7c10ee856a3c885a9f0126660927
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1
5b7d1e63e50218b22558bc94b9d37faac51551fcdb29a7390226a6669d24d8de
5c9b4d60d249c0af9b6635bfcacbc6fc4346168ece6a7d03413326490d3b6b48
5cefa7d9ed7ba581514db5e5b3f5f9abfffc08d50185bfc76ffe32896ace5968
5f8237942a2a3f26d6570af6d5f28ead053dc54f18fb19c4785e50ebafd202dc
608097e02a29b4e0529f117d8736728d47b76432ecb8ff5771545f21da82cecd
616caa77f3b26bf752bc7e76e496c90f09e972978a16e9fd7111d8f23009f504
61c32059a5e94075a7ecff678b33907966fc9cfa384daa01aa057f872da14dbb
66bf4c2d75c9ed6d00de0d5494f1e7120f55e8943f4fc41bd5cefccd6fe9d14e
66d2ae6f0dd37ea1c071a5c32cdb63379674a4037262a1f179e5d9217b3068e8
66f97ec646c2992df1b75f5e9910d1087ea2ea82a3313bbfa675350ff484c674
685316e33a221d88556076ed38c8a8e7b4ab24c5fbb04359876ba04522e2f73f
68a38c70cdcf275ff1085a753d5d2ad47e5c9015d30c307f2a6b191364d30b7c
69434dcf569899319d3feb056f81ca5561d2c462e025d22f8f427a03edb7fdb2
6949a2ed4ae7376b016792e21581479483d6a8848b60f07a6e087fda32d6fd3d
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
6d4a9753ce2e97fd3d769b770dca35575f51ef917b52971add6e794e1145267b
716a727e47216ad28191f60fb09d59015b1bcb3df8cc32b5bb94f73d534a5732
73087a4e156ffd1207ac58c9cf3a3e3f5bd3288017c9eb8364df6a12bed5fb13
75aa8016193d3f8a36dc043dcb078fb89662b0616a4a55d45d84df688b5f90ed
765cf476d0036d6a839472b05a76bda1e912b7bcea8a85466615a96f81c51308
7665f2a504287bfd2eb09327c773e3f1070e5bd3e74e11f182ef47e738a2d686
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
79d3ce1fd6ca1f40809005d4d753594d61d4226a05894f656f8d37e2026d0da7
7d8cb6b8c715157d0408d58ab980e0c806035483ccf5dc62d700ef0c6932f125
7dae4cc5e14edeba5777dde5e36077420a8ccb6d3b04f5c5724ed19600410bb0
8056b4c761c0b2608915c5766eebbc2bb28bd4d9a66649b396730f403dd10e2a
80c19f8e41b3c27da8dadd95c33434fff889c54332ad6ea87f44711c1edb8f47
8149596c69a0006b78550042ddfbb6591a08ba4595dde390bbd3ccc3e904bdec
818502f001f9c69158b04d01ca0ddf5a83baf93615494415b06c564b426293d6
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
839f40c37f4c88c16bc324dfaa50cbb12a5b9410cc3fe4257e065d9812cf12f3
8503954201ae92ce8050534484ff98b82fd4c68b48c7b42b4888d165b4f173c3
852b3532441a29f2ba7e869ecfbc38eb772c2a3051d4783e49f4dc68c185191e
862716246fb796d1bb62c00a8d05ab75f3868767459dd174c436b3ef753350cd
86584c6311b265f2e288a8d601ae7ed7dee455340d8b8afe8482f310c6938984
87a92e159459b46d503d7ca9301e076e886bf1eb91abaae349f8b6a69deb2571
87cde7e3a0d50565da3c4bea1eed191b23e45a96125fb011b593f02566db17bf
88a577b7767cbe34315ff67366be5530949df573931dd9c762c2c2e0434c5b8a
89e0d5e92136af3c2f1d53d4bd524e308554a0ddf9e44a5bd89ab2e2bdbddd7a
8a06273da12004406db887c374db20974879a73bdddd60bae86711e45c1e5f1f
8bfec167931638e76d261249490dcb1bd356f5ff635f2b7ab640775a6f8204c2
8d13111280abae1597984e96c31e8a576d55c243afab55c2c8e511658381d4e3
8d70b3e6badb6973663b398d297bb32eaedd08826a1af98d0a1cfce5324ffce0
8ecb4fb492aee0a820dfc4a395fb80e2ac2e864bbf38aa1ae28d6d70fb9e6da3
8fed0359a978607741335672c13815cef49036c52f9d3c3173d365840a967ccb
93028274da1d373cd41165f6a442568ddd482370e8093e45d14a4ad0f6981f19
948a4f113aad42e705767c8ff100658f8a9482f8f22fa11c13e9576ff69a13f8
964783a75f5a7ecc32d48da45cc6025af80e263d6ba6530dc62cc25865b2eb00
9a9b7fb32e01fd70747f32efdbd0472fd681c85eebb0c42d10c7a514820a0062
9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229
9dffa69c86b42874d87a4f145f153ab01f6e6d726fc47cd887b95cad3c523f82
9dffbd45ce48bf5e8eeb90b3d8567f8270f217c174de81fe3693d6dcdbaa1588
a15bcf9de1b6526c514d0ca464febaff9c812af74ed54f47073335de9d71da03
a192bdb8325fc9b2baf91666d21176c29b63c99128d7accd7e3c874a1854daf7
a488725856de6dc4c99103ad14773ad004871fa52aa58b23e5ba8bf08d1f4278
a5f066312e6bb6dfd587b36a4308a97bd8232131822d7ce26a76cfd359d43ae0
a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50
a91dace5fd27f94061a03d6dafe4bc5fa4500a7f5c0935b7ed7c8fe4ad5d50e1
ab3777c1f26944dddbdab95a113dfa280d8ab7b61870646fc20914d02cde03aa
ac5819dc7e9882d90e5ac18e79faf3bf3fb69bc916b3c6918879b9b8faa40ca8
acc5497e76f832d950d14fcfa047dc3c864f7a0aae4c7a20521c0c655a53033b
acccc501aa6afa3cfac15e8ddccf1561deed2ed08c2f7d652abbdbe9aa71609a
ad468a8c90a205765dae08a05886e3e9ce8a155e7b0ad5e289ca131562e0842f
af414f1b40ee5f8ed0364c9c2c27a6d6e40a5948d8e4792cf2f6eba161d5f192
afcba172b543881ef65966311d62dc32a2e13f9a98631d3b1d05f3a7cdad3949
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
b1f4fc34cd2c8865e4fa2d1e044a7a41e2e57795003111f775a56f1dc440fae2
b4e2fb954a69fbec249310839570544f574d2d2290f5b6a450cab9b6260bc213
b4faac680e6757159c6365d482309c52c1285489df688c01c724fcef5f185fc3
b61d2f7ab860044189ab4e2b4d95b0936dfd4e31592cebaf49713ded005eca12
b9e93402d8e2ccc25635c3e54e89db3d67cc810d5b1ca9cb70dbdf506c21d6ff
befb55188d1fc6bfca46b1da87cce77f09058c0b7a00b67f7cf7233aa4b570d3
c1d222778644925bcc3b323bc56b7564fc200e442c722de525fd8d030525addc
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
c4f393315ffc75417c9c350e709bbcca2d2e9d5640fa0925b32088ff1ed6c84f
c68a092cd58255720dd1f42499305d5a18ab3980c0c5b627fdfd4a9b54a6a4ab
c9e503c45296aa48ca5f2ceb1f169618c5480f2d0f2362321cdca912d395bb68
ca71dc26c7fbc6bebb241337131f300bdfdb32c070a47739c5af541e3fa62c2a
cae2660518f22b45acda581d90ed118a6727785eb1e99075a5f5e09a2f918dc1
cdf059465216c25327a08fc3f24fc52f36762daf5d7d9ab0dfcb746aefe9e553
cf10355a5c8d65784d49e8e943b0a193d29f89c5f63218ed059b92ce62d56449
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
d04a32ce120b54e1fc49a0d736454d4a0e9d50963a01323dec083980e9723907
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7
d4a4bd1836268e9c59e5a61d99fc72173b66d4122556a3f35494ee6de0fd6bf9
d85f6474893e823b6eb6ce2ad936235ff13be5d10d1c1dba6517f6dd3a731c59
d871e085c5801e167e7f68b96f15455c39dda9b8122cde756eddc7d0855b57c0
d9354329b02c3cbae54eb3ffbbf38e80e3578d0417f047375d2f0b8b03c5439d
daf4fe1515892c71cdd95f5c6eb3a9cc0aa4ad0a93247c9a6e971bf6f169f53e
db27b46a4a62774e7a25ba94e38849128d93e9d1c9f0ccbf24fe1d0c3f6ed076
ddb473a5e77e4b93193284c6162d397514ea2b4ed9eac543f859d7dee311a261
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
e0b374d64219f25c480983127d46b1dad0d87e14292b621df9205a2c3c5ce98a
e0dcfebee962c0c8ec488c8d64e708fff2fb2712f2970698c8e7af26570e79f0
e0f887fbf8f31f2602ee1b897ede24e2e37e19a9e620f617e185816ec023afdb
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e414ef5501ce6098b8d10ee8c0d7d9a2c763c6489096afefdf3334c7bf3203e2
e5485aa213667c84a51961dc5a1f2600acc5004aab1333a1cd7b9707a7b967f5
e586a84d8523747f42e510d78e141015b6424cf67d612854e892a7bcedc8ec9e
e721448de4149c59b99e49159d0b8be3557227c4f317c688d02ab5eafe5ce580
e9f6b7adef81eaa57f5ac0afaab01f012e6aa4d9e313422ceb1fd48eaf4704b9
eaafa7b35dbc1bfbe920271234077f1c8d869f12abe74948d8984d72bfa8e750
ec221f02e697f63d8341d806d3c8934d1ea4a483300e50309a66e5e52c6aff51
edf41f0e9b71117ce17dc6c6f56006e8a439ff8b4b2fb5d1334c343c84730333
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f084eb3b60be7c6309cc5ff62056f29deba6ae55270642089f04f035d9cb3738
f0fcf21d81d3a7aed66fe15d099a87109fc09978bd02570033ca7716aa8fedd5
f30a8eae1d630055090711cb91ccf5cef1228185f3a19f9b1fcadffeee0cbeaa
f397f4e666b9e83b883504951e6327b1cf1b9ff4ca8ae34ea09cd5d68fd091f9
f62e7be11cf9f105f7aa6e7f74aabcf51bce9cde2258e1f2b1742631109fcc53
f6c4d62e7e9acc1725e7ca85db6ba03fd8258f16e06379e347ecd365c3d0a6f7
fb751b2dfff03aad8dab268dcb376e1f200bd948e8ea5a0aea09dbd4e9c38ab5
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b
fcfe47ed943044cf2222be54bb97f838b5c8a3ff0668dbb8452aae6db388a877
fe90d114ed4f762dd50543858d328c3b4d78fca8325e3f87c1f1fba16379ed3a
ffcb40fbcac563fda59588771cdd7afa9caa4ef23c6376873228aa93b9ec120a